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1 Introduction 
The environment contains a huge variety of pathogenic microbes - viruses, bacteria, fungi, 
protozoa and multicellular parasites. These can cause disease, and if unchecked they 
eventually kill the host. The immune system has developed to combat infectious agents, to 
protect the host from these pathogens and to avoid permanent damage. Moreover, it 
monitors the cells of the host to recognize mutant cells and to avoid tumour development. 
Because microorganisms come in many different forms, a wide variety of immune responses 
are required to deal with each type. The immune systems developed multiple protective 
mechanisms consisting of soluble factors and cells with distinct roles in defence against 
infections. The site of the infection and the type of pathogen largely determines which 
immune response will be active. 
 
Any immune response involves firstly, recognition of the pathogen or other foreign, 
hazardous material, and secondly a reaction to neutralize or eliminate it. The coordinated 
cooperation of soluble mediators and cells leads to an adequate immune response by 
initiating inflammation and elimination of the pathogen or mutant cell. 
The different immune responses can be classified into two categories: innate immune 
responses and adaptive immune responses. The important difference between these two 
mechanisms is that an adaptive immune response is highly specific for a particular pathogen 
whereas innate immunity recognizes broad, conserved structures of pathogens. Innate 
responses are not altered on repeated exposure to one infectious agent whereas the 
adaptive response improves with each successive encounter with the same pathogen 
leading to immunological memory. A key component to establish and coordinate immune 
responses are cytokines. These are soluble factors released by cells endowed with the 
property to initiate, modulate and regulate immune responses. 
 
NKT cells are specialized T cells equipped with innate immunity-like and adaptive immunity-
like properties. They are thought to function at the interface of innate and adaptive immunity 
and are involved in a wide range of immune responses like antitumour responses, host 
defence to infections and in inflammation. A key factor and unique property of NKT cells is 
the concomitant production of Th1 and Th2 cytokines. 
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1.1 Cells comprising the immune system 
Immune responses are mediated by a variety of specialized cells with diverse funtions and 
by soluble molecules which they secrete. These cells arise from a single progenitor, the 
pluripotent hematopoietic stem cell in the bone marrow. These pluripotent cells divide into 
two types of progenitor stem cells; the common lymphoid progenitor and the myeloid 
progenitor cell. The lymphoid progenitor cell gives rise to natural killer (NK) cells and T 
lymphocytes (T cells) and B lymphocytes (B cells). Unlike T and B cells, NK cells lack 
antigen specificity. The common myeloid progenitor cell gives rise to macrophages, 
neutrophils, dendritic cells (DCs), basophils / mast cells, eosinophils and red blood cells. The 
number and localization of myeloid cells is dynamic and largely depends on the occurence of 
an immune response and the cytokines and chemokines produced thereby. Myeloid immune 
cells circulate in the blood and enter tissues only at sites of infection or inflammation. 
Neutrophil numbers are massively increased during infection and are recruited to sites of 
infection and inflammation to phagocytose bacteria. Immature Monocytes also enter tissues 
where they differentiate into macrophages. Macrophages are found in all organs and tissues. 
Depending on the tissue they reside in, they can further differentiate into specific 
macrophage like cells, for instance Kupfer cells in the liver and Langerhans cells in the skin. 
Immature DCs travel through the blood to enter peripheral tissues. Upon encounter with a 
potential antigen, they mature and migrate to lymphoid tissues where they activate antigen 
specific T cells. NK cells are important for eradication of pathogen-infected cells, especially 
during the early phase of infection (Biron et al., 1999). NK cells recognize cell surface 
changes that occur on a variety of virally infected cells and tumour cells and are believed to 
be involved in tumour surveillance (Diefenbach and Raulet, 2002).  
 
B cells combat extracellular pathogens in an antigen specific way. Having recognized its 
specific antigen, B cells multiply and differentiate into plasma cells which produce large 
amounts of antibodies. T cells can be characterized by the cell surface receptors they 
express. The majority of T cells express a T cell receptor (TCR) composed of an α and β 
chain (α/β T cells). A minor group of T cells displays a TCR composed of an γ and δ chain 
(γ/δ T cells). γ/δ T cells seem to be important in immune responses to bacteria, however their 
role in adaptive immunity remains unclear (Chen and Letvin, 2003; Kaufmann, 1996). T cells 
can be further characterized by the specific expression of the coreceptors CD4 and/or CD8. 
CD4+ and CD8+ T cells differ fundamentally from each other and perform distinct regulatory 
and effector functions. T and B cells are located in the central lymphoid organs, the thymus 
(T cells) and the bone marrow (B cells). It is in these compartments where they develop and 
differentiate. Mature T and B cells can be detected in the peripheral lymphoid organs (e.g. 
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spleen, lymph nodes, Peyer’s patches). Here, they develop further into effector cells. During 
infection, effector T cells are found notably at the site of inflammation. Cells of the lympoid 
and myeloid lineage interact and function in an orchestrated fashion to establish a successful 
immune response. These immune responses can be divided into innate and adaptive 
immune responses 
  
1.2 Innate immunity 
Innate immune responses are initiated instantaneously after recognition of foreign antigens. 
It is the first and rapid, although relatively unspecific, response of the immune system to an 
invading pathogen. Innate immune responses are essential to mount an effective immune 
response and crucial for establishing an adaptive immune response. 
1.2.1 Cells of the innate immune system 
Activation of innate immunity is initiated by recognition of antigenic, non-self structures by 
receptors expressed on immune cells. Macrophages located in the submucosal tissue are 
usually the first cells to encounter pathogens. They are supported by massive infiltration of 
neutrophils. Macrophages and neutrophils are specialized in phagocytosis and subsequent 
killing of the invading pathogens. Macrophages and neutrophils recognize pathogens by 
means of their cell surface receptors, such as mannose receptors or scavenger receptors, 
which enable them to discriminate between “self” and “non-self” structures (Janeway, Jr. and 
Medzhitov, 2002). Furthermore, they express receptors for antibody and complement, which 
increases phagocytosis of antibody- or complement-coated microbes. 
 
NK cells are innate immune cells that mediate cellular cytotoxicity and produce chemokines 
and inflammatory cytokines such as IFNγ and TNFα (Trinchieri, 1989; Medzhitov and 
Janeway, Jr., 1997). NK cells are usually constitutively active and shortly after the initiation of 
infection, NK cells undergo ”clonal expansion” by proliferation. The resulting activated NK 
cells persist over a period of a few days (Dokun et al., 2001). Although the expanded NK cell 
populations may help clear the virus, they do not, unlike T cells, provide long-lasting NK cell-
mediated memory. NK cells also participate directly in adaptive immune responses, by 
interacting with DCs and by triggering T cell responses. For instance, induction of DC 
maturation to produce TNFα and IL-12 and upregulation of co-stimulatory ligands is triggered 
by NK cells (Gerosa et al., 2002). Moreover, NK cells proliferate and acquire cytotoxic activity 
and the capacity to produce IFNγ through the interaction with DCs (Fernandez et al., 1999). 
Apart from activation of other cells of innate immunity, NK cells also enhance induction of 
CD8+ T cell responses (Mocikat et al., 2003). T cell responses are influenced by IFNγ derived 
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from NK cells, which promotes antigen processing and presentation to T cells and T helper 
type 1 (Th1) cell polarization. 
 
DCs are, together with B cells and macrophages, professional antigen presenting cells 
(APCs) and are thought to be key players in initiating an adaptive immune response (Hanada 
et al., 2005). Immature DCs are specialized in antigen capture and processing. Upon antigen 
update, DCs mature, display large amounts of major histocompatibility complex (MHC)–
peptide complexes at their surface, upregulate their co-stimulatory molecules and migrate to 
lymphoid organs where they liaise with and activate antigen-specific T cells. DCs are the 
most potent antigen presenting cells and their activities can be induced by infectious agents 
and inflammatory products, so that DCs are mobile sentinels that bring antigens to T cells 
and express co-stimulators for the induction of immunity (Banchereau and Steinman, 1998). 
1.2.2 Receptors for innate immune response 
Microorganisms display repeating patterns of molecular structure on their surface as well in 
their nucleic acids. Bacterial DNA, for example, contains unmethylated repeats of the 
dinucleotide CpG. The innate immune system recognizes such pathogens by means of 
pattern recognition receptors (PRRs) that bind to features of these regular patterns. This 
strategy is based on the detection of a limited set of conserved molecular patterns 
(pathogen-associated molecular patterns (PAMPs)) that are unique to the microbial world 
and invariant among entire classes of pathogens (Janeway, Jr. and Medzhitov, 1998). 
Innate recognition of PAMPs through Toll-like receptors (TLRs) initiates an inflammatory 
response characterized by the recruitment of cells to sites of infection which augments the 
killing of invading pathogens. Activation of TLRs induces the expression of genes encoding 
chemokines, chemokine receptors and integrins that regulate cell migration to the sites of 
inflammation and initiate responses to inflammation (Huang et al., 2001; Mantovani, 1999). 
Stimulation of TLRs through pathogen products also induces the activation of macrophages 
and DCs and leads to the induction of several important mediators of innate immunity, such 
as cytokines (Kamath et al., 2005; Pierer et al., 2004). Additionally, surface expression of co-
stimulatory molecules like B7.1 (CD80) and B7.2 (CD86) on macrophages and DCs is 
evoked by the Toll pathway. Along with antigen presentation by MHC class II proteins on 
DCs and macrophages, these molecules activate CD4+ T cells and are needed to establish 
an adaptive immune response.  
Most mammalian species have 10 to 15 TLRs which detect multiple PAMPs (Takeda et al., 
2003), including lipopolysaccharide (LPS) (detected by TLR4), bacterial lipoproteins and 
lipoteichoic acids (TLR2), flagellin (TLR5), the unmethylated CpG DNA of bacteria and 
viruses (TLR9), double-stranded RNA (TLR3) and single-stranded viral RNA (TLR7) (Heil et 
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al., 2004). TLRs 1, 2, 4, 5 and 6 seem to specialize in the recognition of mainly bacterial 
products that are not made by the host. Especially, TLR2 detects bacterial cell wall 
components like peptidoglycan, lipoteichoic acid and lipoarabinomannan of gram+ bacteria 
and mycobacteria (Akira and Takeda, 2004). TLRs 3, 7, 8 and 9, in contrast, specialize in 
viral detection, are localized to intracellular compartments (Heil et al., 2003) and detect viral 
nucleic acids in late endosomes-lysosomes. Pattern recognition receptors activate conserved 
host defence signalling pathways that control the immune responses in a wide variety of 
cells. 
 
1.3 Linking innate and adaptive immunity 
Adaptive immunity commences with DCs capturing microbial antigens in the peripheral 
tissues. Subsequently, DCs migrate to the draining lymph nodes to present the processed 
antigens to naive T lymphocytes in the context of antigen presenting molecules such as MHC 
molecules and CD1 molecules. During transit, DCs undergo a maturation program that 
provides the cells with the ability to stimulate naive T lymphocytes. Inside the lymph nodes, 
DCs contact antigen-specific T cells and induce their activation and differentiation into 
effector cells. T cell activation is achieved by co-presentation of MHC class II molecules with 
co-stimulatory receptors and the recognition of this complex by the appropriate TCR. The 
main pathway by which DCs become activated and mature to provide the second signal to 
naive T cells occurs via the TLR recognition of PAMPs (Medzhitov, 2001). Induction of the 
co-stimulatory molecules CD80 and CD86 on the DC surface is coupling microbial 
recognition with the induction of co-stimulators that allows activation of pathogen-specific T 
cells. Since T cells receive the antigen-specific activation signal only in the context of a co-
stimulatory signal, TLR-induced expression of co-stimulators transforms the pattern 
recognition signal into antigen-specific immune responses.  
 
1.4 The adaptive immune system 
In contrast to innate immune responses, adaptive immunity is characterized by two 
hallmarks: specificity and memory.  
1.4.1 Cells of the adaptive immune response 
The adaptive immune response is induced by activation of B and T cells leading to clonal 
expansion of B and T cells following recognition of their cognate antigen. B cells recognize 
soluble antigens via the B-cell receptor (BCR), a membrane bound form of antibody. Upon 
antigen recognition B cells start to proliferate and differentiate into IgM secreting effector 
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cells, the plasma cells. In a T-cell dependent process, a subpopulation of activated B cells 
undergoes differentiation to produce other antibody isotypes, a process called isotype switch 
(Oettgen, 2000).  
T cell activation is achieved by co-presentation of the MHC/antigen complex with co-
stimulatory receptors and the recognition of this complex by the appropriate TCR/CD3 
complex. Co-stimulatory receptors expressed on DCs trigger CD28 expressed on naive T 
cells and activation leads to clonal expansion and the generation of effector T cells. A 
fraction of the activated B and T cells matures to long-living memory B and T cells providing 
the basis for a fast and highly specific response to further infection with antigen. 
1.4.2 Receptors for adaptive immune responses 
The TCR and BCR are, unlike the receptors of innate immunity, highly specific for their 
cognate antigen. They are generated in immature B and T cells by recombination of different 
germline gene segments. This process provides the means for the generation of a highly 
diverse pool of T and B cells, each expression a unique TCR or BCR. To avoid the 
generation of TCRs and BCRs that recognize structures of the host, developing T and B cells 
are eliminated by negative selection in case their TCR or BCR recognizes host derived 
structures. CD8 and CD4 molecules are coreceptors expressed on the surface of T cells and 
bind to MHC class I or MHC class II molecules, respectively. They support MHC molecule 
recognition by the TCR/CD3 complex and increase the sensitivity of antigen recognition by 
the T cell (Weiss et al., 1991). 
1.4.3 Different T cell populations produce different adaptive responses 
Depending on the types of co-stimulatory molecules expressed and cytokines secreted by 
the DCs, naive CD4+ T cells differentiate into either T helper 1 (Th1) or T helper 2 (Th2) cells 
(Constant and Bottomly, 1997). While the presence of IL-12 promotes the development of 
Th1 cells, IL-4 induces the development of Th2 cells. Th1 and Th2 cells secrete different 
types of cytokines and thereby mediate different types of adaptive immune responses (Farrar 
et al., 2002). Th1 cells produce IFNγ, TNFα, IL-2 and lymphotoxin. These pro-inflammatory 
cytokines augment the microbicidal capacity of monocytes and macrophages, mediate the 
development of cytotoxic CD8+ T cells and are important in establishing inflammation. Th2 
cells produce IL-4, IL-5, IL-10 and IL-13. Biological functions of these cytokines are activation 
of B cell, regulation of IgE secretion by B cells, modulation of TH2 cell development and 
suppression of inflammatory responses (McKenzie and Heath, 1996) (Figure 1).  
CD8+ T cells are cytotoxic effector T cells (CTL) and essential for the host defense against 
intracellular pathogens, like viruses and bacteria like listeria and mycobacteria (Kaufmann et 
al., 1995; Mittrucker and Kaufmann, 2000). CTLs identify infected cells by the recognition of 
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foreign peptides presented by major histocompatibility complex (MHC) class I molecules on 
the surface of virtually every cell of the host. CTLs attack and destroy cells infected with 
cytosolic pathogens by various mechanisms. In addition, they also produce IFNγ which 
inhibits viral replication and induces increased MHC class I presentation and macrophage 
activation (Chan et al., 1991b). Primary activation of CD8+ T cells requires costimulatory 
signals from DCs, whereas memory CD8+ T cell responses require CD4+ T cell help 
(Shedlock and Shen, 2003). 
 
 
CD4+CD25+ T (Treg) cells comprise an auto-reactive T cell subset that regulates and 
suppresses immune responses. Although the regulatory mechanism remains unclear, 
secretion or expression of either IL-10, TGF-β, CTLA-4 or a combination of these molecules 
appears to be involved (Mills, 2004). In addition to Treg cells, another important self-reactive 
T-cell sublineage was identified, Natural Killer T (NKT) cells.  
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Figure 1: Schematic representation of Th1 and Th2 cell development and selected effector functions. Naïve CD4+ T cells 
differentiate into Th1 or Th2 cells dependent on the presence of IL-12 or IL-4 at the time of APC contact. Cytokines 
secreted by the two CD4+ T cell types are indicated with their positive (green arrows) or negative (red arrows) effect on 
proliferation (blue arrows) or activation (black arrows) of other cells of the immune system. Parts of this figure were 
adapted from the book Cellular and Molecular Immunology by A.K. Abbas, A.H. Lichtman and J.S. Pober (Abbas et al., 
2000)  
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NKT cells posses both regulatory and effector functions, are self-reactive and express a 
semi-invariant T-cell receptor (TCR) specific for conserved glycolipid ligands (Bendelac et al., 
1997). In contrast to Treg cells, which have a dedicated suppressor function, NKT cells can 
facilitate autoimmune pathology as well as take part in protective mechanisms (Table 1). 
 
 
1.5 Antigen presentation  
Antigen processing and presentation to T cells with specific recognition of these antigens by 
the TCR of the T cells is essential for elicitation of a T cell response. Protein antigens can be 
processed and presented by two pathways. Cytoplasmic peptides are presented by MHC 
class I molecules and proteins from the endosomal pathway are presented via MHC class II 
molecules. Cytoplasmatic proteins, such as self-proteins or proteins derived from viruses and 
some intracellular bacteria are degraded to peptides in a proteolytic enzyme complex, the 
proteasome. The peptides are thereupon transported into the endoplasmatic reticulum (ER)-
lumen in an ATP-dependent fashion by the transmembrane proteins TAP-1 and TAP-2 
(Goldberg and Rock, 1992; Shepherd et al., 1993). Binding of these peptides by newly 
synthesized MHC class I molecules induces a conformational change within the MHC class I 
protein which enables the release of MHC class I from the chaperones calnexin and 
calreticulin and the binding of β2-microglobulin (β2m) (Degen et al., 1992). Complete MHC 
class I-β2m-peptide complexes are transported to the cell surface where they can be 
recognized by the TCR of CD8+ T cells in a peptide specific manner (York and Rock, 1996) 
(Figure 2).  
Table 1: Comparison of Treg cells and NKT cells 
Feature  Treg cells  NKT cells 
Distribution 
Thymus, lymph node, spleen, 
circulation, sites of 
inflammation 
Thymus, spleen, circulation, 
liver, bone marrow, sites of 
inflammation 
Prevalence (spleen 
and thymus) 5 - 10 % 0.5 - 1 % 
TCRs Diverse Invariant Vα, limitied Vβ 
Co-receptors Mostly CD4 CD4 or double neagative 
Specificity 
Diverse autologous peptides 
bound to MHC class II. 
Capable of recognizing non self 
peptides 
Autologous and bacterial 
glycosphingolipids presented by 
CD1d 
Effector functions IL-10, TGFβ, CTLA-4, 
cytotoxicity? Other? 
Diverse Th1 and Th2 cytokines, 
chemokines, FasL, CD40L 
Mode of action Suppression  Suppression or activation 
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MHC class II molecules 
present peptide fragments 
derived from proteins taken 
up via phagocytosis and 
which are processed by the 
phagosome-endosome 
pathway (Ramachandra et 
al., 1999). Moreover, MHC 
class II molecules have 
access to peptides of some 
pathogens like 
mycobacteria which are 
taken up by macrophages 
but manage to survive and 
replicate inside the 
phagosome of the host cell 
(Ramachandra et al., 
2001). During phagosomes 
maturation, phagosomes 
get acidified and thereby 
activate proteases such as 
cathepsins. These proteases cleave proteins to peptide fragments which are loaded onto 
MHC class II molecules. This process takes place in MHC class II positive vesicles (MIIC 
compartment) and is catalysed by HLA-DM (human) and H2-M (mice) (Watts, 1997). The 
transit of MHC class II proteins to the MIIC is mediated through binding of the MHC class II 
protein to the invariant chain (Li) which possesses a sorting sequence for the MIIC (Denzin 
and Cresswell, 1995). Li is cleaved in an acidified endosome, leaving a short peptide 
fragment, CLIP, still bound to MHC class II. Binding of LI and CLIP to MHC class II proteins 
prevents binding of peptides to MHC class II molecules in the ER. HLA-DM binds to MHC 
class II molecules, releasing CLIP and allowing binding of peptides to MHC class II 
molecules. Peptide-MHC class II complexes travel to the cell surface and are specifically 
recognized by CD4+ T cells (Figure 2).  
MHC class I and class II molecules only present peptide antigens to CD8+ and CD4+ T cells, 
respectively. Lipid antigens, either endogenous or bacterial lipids, are presented by the 
alternative antigen presenting molecules of the CD1 family.  
 
Figure 2: Intracellular trafficking of MHC class I and II molecules. MHC class I and II 
intracellular trafficking. MHC class I and II molecules are assembled in the 
endoplasmic reticulum (ER). MHC class I molecules associate with β2-microglobulin 
(β2m), acquire peptides delivered from the cytosol and follow the secretory route to 
the plasma membrane. MHC class II molecules assemble into invariant chain (Ii) 
complexes in the ER that prevent peptide binding and direct their trafficking to 
endosomal compartments. In lysosomes, the Ii is cleaved, peptides are loaded and 
MHC class II molecules traffic to the cell surface. These pathways allow peptide 
sampling from the cytosol and endosomal compartments by MHC class I and class 
II, respectively. Nuc, nucleus; HC, heavy chain; G, Golgi; TGN, trans Golgi network; 
TAP, transporter associated with antigen processing. This picture is adapted from 
the publication: CD1: Antigen presentation and T cell function, Manfred Brigl and 
Michael Brenner, Annu. Rev. Immunol. 2004. 
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1.6 CD1 molecules 
During the recent years it became clear that not only peptides are presented to T cells, but 
that T cells also recognize lipids antigens. CD1 proteins bind lipids to form CD1-lipid antigen 
complexes displayed on the cell surface of APCs which contact T cell receptors and activate 
T cells. The five, non-polymorphic CD1 genes are encoded in close proximity on 
chromosome 1 in humans and chromosome 3 in mice and are not associated with the 
mammalian MHC gene locus (Calabi and Milstein, 1986). The CD1 family of antigen 
presenting molecules is composed of five members: CD1a, CD1b, CD1c, CD1d and CD1e 
(Ernst et al., 1998). They can be classified into two groups: CD1a, CD1b, CD1c and CD1e 
comprising group I CD1 molecules, found in humans but not in mice, and CD1d belonging to 
the group II CD1 molecules, present in humans and mice. Mice express two CD1d genes, 
CD1d1 and CD1d2, with the 
latter having no assigned 
function (Gozalbo-Lopez et 
al., 2004). CD1a - CD1d are 
involved in antigen 
presentation (Brigl and 
Brenner, 2004; Kaufmann 
and Schaible, 2005) 
whereas the CD1e gene is 
expressed as differentially 
spliced protein products but 
has no know function in 
antigen presentation. 
However, it could be 
involved in facilitating ligand 
binding to CD1 proteins 
(Angenieux et al., 2000). 
CD1 molecules are 
evolutionary conserved and 
CD1 genes, unlike MHC 
class I and II genes, show 
very limited polymorphism 
(Brossay and Kronenberg, 
1999). CD1 polypeptides 
are expressed as 
heterodimers composed of 
α1
β2m
α2
α3
β2m β2m
α1
α2
a)
b)
 
Figure 3: CD1 structures. a) CD1 atomic structures. (left) Front and (right) top 
view of mouse CD1d (mCD1d) structure without ligand. α1-α3 domains and β2-
microglobulin (β2M) are shown in light gray ribbons, α1 and α2 helices in brown. 
This picture was adapted from the publication: CD1: Antigen presentation and T 
cell function, Manfred Brigl and Michael Brenner, Annu. Rev. Immunol. 2004. b) 
CD1 pockets and portals. Two-dimensional schematic renderings of MHC class I 
and CD1 grooves, and their constituent pockets, were drawn based on the 
silhouettes of the crystal structures of mouse CD1d. The grooves of the CD1 
proteins are deeper than those of the MHC class I molecules. Mouse CD1d 
contains two pockets for binding of the lipid chains, A’ and F’ This picture was 
adapted from the publication: Anatomy of CD1-lipid antigen complexes, Moody et 
al, Nature Reviews Immunology, 2005. 
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the CD1 heavy chain noncovalently paired with β2m (Figure 2). CD1 proteins are presented 
TAP-independently but association with β2m appears to be necessary for cell surface 
expression as shown by lack of surface localization in β2m-deficient cells (Sugita et al., 
1997). The CD1 structure revealed a striking structural similarity to MHC class I in which the 
αchain folds into three domains, α1, α2, and α3 (Figure 2) (Zeng et al., 1997). However, the 
antigen binding groove of CD1 molecules is larger, deeper and more hydrophobic than the 
groove of MHC class I and II proteins. The CD1 isoforms have distinctly shaped antigen 
binding grooves and several recent crystal structures of antigen-CD1 complexes show how 
the lipid moieties of antigens are inserted into the deep hydrophobic antigen binding grooves. 
Thereby, the carbohydrates, peptides or other hydrophilic elements of the antigen are 
exposed to the surface of the CD1 molecule where they can directly contact the TCR (Figure 
2) (Gadola et al., 2002; Zajonc et al., 2003).  
The structural similarities to MHC proteins initially led to the idea that CD1 molecules could 
be involved in antigen presentation (Calabi and Milstein, 1986). The function of CD1 in T cell 
activation was discovered through studies of the direct recognition of CD1a and CD1c 
proteins in the absence of exogenous antigens, and the first known exogenous antigen 
identified as presented by CD1b was the large, unusually hydrophobic mycobacterial lipid 
mycolic acid (Porcelli et al., 1992; Porcelli et al., 1989). The most striking expression of CD1 
molecules is found on DCs and professional APCs. CD1a, b and c are found on DCs 
whereas Langerhans cells express CD1a and CD1c but lack CD1b. CD1c is unique among 
group I CD1 proteins for its expression on B cells (Pena-Cruz et al., 2003; Porcelli, 1995; 
Smith et al., 1988). CD1d expression was detected for intestinal ephithelia, hepatocytes and 
hematopoietic cells like B and T cells, DCs and macrophages (Balk et al., 1994; Bleicher et 
al., 1990; Brossay et al., 1997) 
1.6.1 CD1d 
Despite the overall similarity in domain organization, striking differences between CD1d and 
MHC class I and II are found in the topography and molecular surfaces of the antigen-binding 
grooves (Zeng et al., 1997). For CD1d, the overall volume and surface area of the groove is 
larger than any MHC class I molecule, and the smaller pockets characteristic of MHC 
molecules are coalesced into two large pockets, designated A and F (Figure 3). The CD1d 
groove is closed at both ends but is accessible at the top of the molecule through a narrow 
opening. Few amino acid side chains that line the groove of CD1d are capable of hydrogen 
bonding. As a result, the likelihood of forming an extensive hydrogen bonding network at the 
ends of a peptide (as in class I) or along the sides of the longitudinal axis of the groove (as in 
class II) is not apparent in CD1d (Moody et al., 1997). 
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CD1 heavy chains are 
translocated into the ER 
where N-linked glycans are 
attached, interactions with 
ER chaperones occur, and 
association with β2m takes 
place (Sugita et al., 1997). 
CD1d associates in the ER 
with both calnexin and 
calreticulin and the thiol 
oxidoreductase ERp57. This 
process is coupled to 
disulfide bond formation in 
the CD1d heavy chain (Kang, 
2002). It was suggested that 
lipid ligand binding to CD1d 
can occur in the ER (De Silva 
et al., 2002). CD1d contains 
a signal sequence in the 
cytoplasmatic tail which is responsible for localization to the late endosomal and MIIC 
compartments (Porcelli, 1995). Newly synthesized CD1b and CD1d molecules are rapidly 
delivered from the Golgi to the plasma membrane, presumably along the secretory pathway. 
CD1d molecules are internalized from the plasma membrane and traffic through early and 
late endosomes to lysosomes (Jayawardena-Wolf et al., 2001) (Figure 4).  
 
1.7 Infection with mycobacteria 
Pathogens can be categorized into two major groups based on their habitat. Intracellular 
pathogens reside and grow inside cells of the host whereas extracellular pathogens reside 
and grow in body fluids and extracellular spaces. Bacteria like streptococci, staphylococci as 
well as parasites and fungi such as Candida albicans belong to the group of extracellular 
pathogens. Viruses, some parasites (Toxoplasma gondii, Leishmania major) and a group of 
bacteria including Listeria monocytogenes, Salmonella typhimurium and pathogenic 
mycobacteria belong to the category of intracellular pathogens (Kaufmann and Hess, 1999). 
Mycobacteria are aerob, gram+, non-sporulating and immotile microorganisms. Many 
mycobacteria are widely found and e.g. can be isolated from soil. In contrast, pathogenic 
mycobacteria grow very slowly and need a complex nutrition. The pathogens causing 
Figure 4: Murine CD1d intracellular trafficking. Newly synthesized CD1d 
molecules may or may not assemble with β2m in the ER, acquire self-lipids, and 
traffic to the plasma membrane along the secretory route. A subset of CD1d 
molecules associate in MHC class II/Ii chain complexes and may be directed to 
endosomal compartments from the trans Golgi network (TGN). CD1d molecules 
are internalized from the plasma membrane and traffic through the early and late 
endosomal compartment and are delivered to lysosomes in an AP3-dependent 
manner. CD1d then acquires distinct self-lipid antigens in late 
endosomal/lysosomal compartments. This picture was adapted from the 
publication: CD1: Antigen presentation and T cell function, Manfred Brigl and 
Michael Brenner, Annu. Rev. Immunol. 2004. 
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tuberculosis in humans (Mycobacterium tuberculosis) as well as bovine tuberculosis 
(Mycobacterium bovis) belong to this group. Infection with mycobacteria are problematic 
primarily because they mycobacteria are resistant to most common antibiotics and 
chemotherapeutic agents (Jarlier and Nikaido, 1994).  
1.7.1 The mycobacterial cell wall 
Mycobacteria are characterized by a stable, rigid and hydrophobic cell wall which protects 
against lysosomal enzymes, reactive oxygen and nitrogen metabolites and other defense 
mechanisms of the host. The cell wall is composed of a complex mixture of various 
compounds and is unique for mycobacteria (Brennan and Nikaido, 1995). The primary cell 
wall structure is composed of a plasma-membrane stabilized by a murein backbone. 
Attached to this is a arabinogalactan layer, esterified with mycolic acids. Free lipids and a 
capsule composed of phosphatidylinositol-mannosides (PIMs) are attached to the outer face 
of the cell wall. The plasma membrane is mainly composed of phosphatidylethanolamin, 
phosphatidylinositol and diphosphatidylglycerol (Cardiolipid, CL). Lipoarabinomannan (LAM) 
is a major constituent of the mycobacterial cell wall. LAM is composed of a PIM core, 
anchored to the plasma membrane and a polymer composed of arabinose residues to which 
mannose residues are attached. 
1.7.2 Immune responses to mycobacterial infection 
Mycobacteria have developed extensive mechanisms to avoid degradation by the 
microbicidal arsenal of macrophages and to interfere with lymphocyte activation. 
Mycobacteria mainly persist intracellularly in phagosomes of macrophages. Phagocytosis of 
bacteria usually leads to their degradation in the endosomal pathway. Endosomes mature, 
are acidified and fuse with lysosomes which contain a variety of decomposition enzymes like 
proteases and lipases as well as reactive oxygen and nitrogen metabolites (Kornfeld and 
Mellman, 1989). However, mycobacteria, although taken up into the phagosome, prevent 
their degradation by the host. They inhibit the acidification of the phagosome and the fusion 
of the phagosome with endosomes and lysosomes which disconnects them from the 
endosomal/lysosomal maturation and degradation pathway (Hasan et al., 1997; Sturgill-
Koszycki et al., 1994). Moreover, they compete with the host for intracellular iron (Russell et 
al., 1996; Schaible et al., 1998). Components of the mycobacterial cell wall are responsible 
for mycobacterial survival within phagosomes of macrophages through the modulation of 
macrophage functions and lymphocyte stimulation (Chan et al., 1991a; Vergne and Daffe, 
1998). Mycobacterial LAM inhibits T cell stimulation and Protein Kinase C activity, interferes 
with IFNγ mediated macrophage activation and neutralizes oxygen radicals (Kaplan et al., 
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1987). Additionally, inhibition of antigen-specific monocyte activation can be inhibited by 
PIMs. 
However, there are several ways the immune system competes with mycobacterial infection. 
IFNγ activated macrophages exhibit a range of anti-mycobacterial devises. Activated 
macrophages downregulate the amount of transferrin-receptor and ferritin leading to 
decreased availability of iron within the phagosome (Schaible and Kaufmann, 2004). 
Furthermore, INFγ induces the production of reactive oxygen and nitrogen metabolites by the 
macrophage empowering them to attack and destroy intracellular bacteria (Fazal, 1997). 
Mycobacterial protein antigens are presented by MHC class II molecules to CD4+ T cells. 
These T lymphocytes are essential for establishing an immune response to mycobacteria, 
since mice lacking CD4+ T cells are highly susceptible to mycobacterial infection (Caruso et 
al., 1999). The main function of these T cells in defence against mycobacteria is the 
production of IFNγ. Despite CD4+ T cells, other lymphocytes are important for anti-
mycobacterial immune responses. Cross presentation mediates activation of CD8+ T cells 
which lyse infected target cells with the residing mycobacteria via perforin / granzme B and 
also secrete IFNγ (Flynn and Chan, 2001; Schaible et al., 2003). Antibody production against 
mycobacterial lipids and proteins was detected in human tuberculosis patients. Although 
antibodies against mycobacterial LAM, PIM, trehalose dimycolate and cardiolipin could be 
detected, these do not play a role in immune defence against mycobacteria (Fournie et al., 
1991; Julian et al., 1997; Pan et al., 1999; Santiago et al., 1989). Furthermore, lipids shed by 
mycobacteria during infection (Fischer et al., 2001) can be presented by CD1 molecules and 
are recognized by lipid-antigen specific T cells. These lipid specific T cells could have an 
important role in immune responses against bacterial pathogens (Moody et al., 2000) 
 
1.8 CD1 lipid antigens and CD1 reactive T cells 
CD1 molecules, except CD1a contain a signalling sequence that direct their trafficking to late 
endosomes and lysosomes (Porcelli, 1995). Mycobacterial lipids have access to these 
compartments as well. It was shown that lipoarabinomannan (LAM) is taken up via the 
mannose receptor and could be detected in late endosomes and MIIC compartments 
together with CD1b. This implies that CD1 molecules could meet different (mycobacterial) 
lipid antigens in specialized compartments, bind them and present them on the cell surface 
to T cells (Prigozy et al., 1997). This is supported by the presence of a wide range of 
degradative enzymes, such as glycosidases and lipases in the acidified 
endosomal/lysosomal vesicles. These enzymes could be involved in the processing of lipid 
antigens, derived from the mycobacterial phagosome (Reimann and Kaufmann, 1997). 
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The identification of the first antigen presented by CD1 molecules to T cells demonstrated 
that CD1 presented antigens are lipids (Beckman et al., 1994). So far, it has been shown that 
both hydrophobic peptides and lipids/glycolipids can be presented by CD1 molecules 
(Porcelli and Modlin, 1999). The foreign antigens presented by CD1 molecules that have 
been characterized include a range of diverse lipids found in the cell walls of mycobacteria. 
Mycolic acid, glucose-monomycolate (GMM) and lipoarabinomannan (LAM) are presented by 
CD1b molecules (Beckman et al., 1994; Moody et al., 1997; Sieling et al., 1995). 
 
Mycobacterial mannosyl-β1-phosphoisoprenoid, a glycophospholipid with only a single short 
lipid tail, is recognized by a CD1c-restricted T cell line (Moody et al., 2000). CD1a-restricted 
T cells recognize a lipopeptide (didehydroxymycobactin) from Mycobacterium tuberculosis, 
defining a new biochemical class of antigens for CD1-restricted T cells (Moody et al., 2004). 
T cells that are group I CD1 restricted display a CD4-CD8- double negative (DN) or CD8α/β+ 
or CD4+ phenotype. DN T cells predominantly express an α/β-TCR but can also carray a γ/δ-
TCR (Shamshiev et al., 2000; Spada et al., 2000). The common structural feature of all lipid 
antigens presented by CD1a, b and c is a hydrophobic moiety composed of 2 acyl chains 
which bind to the 2 hydrophobic pockets of the CD1 molecule, and a polar head group 
displayed on the surface of the CD1 molecule and recognized by the TCR. Removal of acyl 
chains leads to loss of CD1 binding and removal or modification of the polar head groups 
diminishes T cell recognition and activation (Moody et al., 1997). 
 
Microbial lipids or lipopeptide antigens presented by CD1 have been confirmed only for 
CD1a, b, and c. There have been conflicting reports whether murine CD1d-restricted T cell 
(NKT cells) recognize glycosylphosphatidylinositol (GPI)-anchored glycoproteins from 
Plasmodium or Trypanosoma spp. in vitro or affect the IgG response to GPI-linked proteins 
in vivo (Duthie et al., 2002; Procopio et al., 2002; Romero et al., 2001; Schofield et al., 1999). 
Mycobacterial phosphatidyinositol-dimannosid (PIM2) was shown to elicit a NKT cell 
response. However, this response was CD1d independent (Gilleron et al., 2001). Until 
recently, the only CD1d-presented antigen that elicits a NKT cell response was α-Galactosyl-
ceramide (αGalCer) (Kawano et al., 1997). It strongly induces actvation of NKT cells and 
rapid production of cytokines. However, this sphingolipids is derived from the marine sponge 
Agelas mauritianus and is of unclear physiological relevance. 
 
 
 
 
 
Introduction 
 
16 
1.9 NKT cells 
Unlike classical T cells reactive to peptides presented by MHC molecules, NKT cells are 
reactive to lipid antigens presented by CD1d. The majority of NKT cells can be either CD4+ or 
CD4-CD8- double negative and express a very limited range of TCR variable region genes. In 
mice, most NKT cells express an invariant Vα14Jα18 TCR with predominant coexpression of 
Vβ8, Vβ2 and Vβ7. Human NKT cells express a Vα24Jα18 rearranged TCR α chain typically 
coexpressed with Vβ11. CD1d and NKT cells are evolutionary highly conserved with mouse 
NKT cells recognizing human CD1d and vice versa (Bendelac et al., 1997; Bendelac et al., 
1995; Brossay and Kronenberg, 1999; Dellabona et al., 1994). Most NKT cells express the 
NK cell marker NK1.1 (NKR-P1C). However, since NK1.1 expression is variable this 
description is not sufficient. Many conventional T cells upregulate NK receptors upon 
stimulation while many CD1d-restricted NKT cells do not express them (Godfrey et al., 
2004). The most accurate description of the majority of NKT cells is expression of an 
invariant TCR and reactivity to αGalCer as can be detected with αGalCer-CD1d tetramers 
(Gumperz et al., 2002). The relative frequency of these cells varies in a tissue-specific 
fashion, the significance of which is not known (Hammond et al., 1999). Murine NKT cells are 
found at the highest frequency in liver (10 - 40% of liver lymphocytes) and with lower 
frequencies (≤1%) in thymus, bone marrow, spleen, lymph node, and blood (Emoto et al., 
1999a). The distribution of human NKT cells in different tissues is not well defined but NKT 
cells are clearly less frequent (≤1%) in human liver compared with the NKT cell numbers in 
the liver of mice (Exley et al., 2002; Kenna et al., 2003). 
NKT cells were initially characterized by their autoreactivity to CD1 molecules (Bendelac et 
al., 1995). Their surface phenotype resembles activated memory T cells even in the absence 
of exogenous stimulation indicating that self lipids presented by CD1d are sufficient for a 
certain degree of activation (Park et al., 2000). NKT cell activation by TCR ligation leads to 
extensive production of various cytokines within 1 - 2 hours after stimulation (Godfrey et al., 
2000). NKT cells release substantial amounts of Th1 cytokines like IFNγ and TNF but also 
Th2 cytokines like IL-4, IL-10 and IL-13 (Chen and Paul, 1997; Mendiratta et al., 1997; Smyth 
and Godfrey, 2000) (Figure 5). They appear to store pre-formed mRNA for some of these 
cytokines even in the absence of activation by exogenous antigens (Matsuda et al., 2003; 
Stetson et al., 2003). The simultaneous expression of Th1 and Th2 cytokines by the same 
cell is a unique hallmark of NKT cells. However, the mechanism which determines the 
cytokine production profile of NKT cells is unknown. αGalCer induces both IFNγ and IL-4 
secretion whereas OCH, an analogue of αGalCer with a truncated sphingosine chain, 
induces predominantly IL-4 (Miyamoto et al., 2001). Due to the production of Th1 and Th2 
cytokines, NKT cells have been implicated both as pro-inflammatory lymphocytes that 
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enhance cell-mediated immunity and immunosuppressive cells, respectively (Smyth and 
Godfrey, 2000). Apart from cytokine production and immune regulation, NKT cells express 
effector molecules like CD40L 
and FasL (Fujii et al., 2004; 
Lisbonne et al., 2004). 
NKT cells are involved in various 
immune responses. They play a 
role in suppression of tissue 
destruction, autoimmunity, 
antitumour responses, host 
defence, allergy and 
inflammation (Akbari et al., 2003; 
Chan et al., 2003; Cui et al., 
1997; Gumperz and Brenner, 
2001; Sakai et al., 1999; Seino 
et al., 2001; Sonoda et al., 2001; 
Terabe and Berzofsky, 2004; 
Van Kaer, 2004) (Figure 5). NKT 
cells participate in protection of 
mice from a variety of bacterial, 
viral, and protozoan parasites, 
although some of these results 
are controversial (Behar et al., 
1999; Emoto et al., 1999a; 
Emoto et al., 1997; Flesch et al., 
1997; Godfrey et al., 2000; Pied 
et al., 2000). However, IFNγ 
secretion was shown to be 
important (Kronenberg and 
Gapin, 2002). This does not mean that NKT cells act solely as effectors, since the majority of 
IFNγ secretion could be due to NK cells, stimulated as a result of NKT cell activation 
(Carnaud et al., 1999; Hayakawa et al., 2001). Furthermore, it is unresolved to which extent 
NKT cells respond directly to microbial glycolipids or whether activation of NKT cells by 
microbes is indirect. So far, knowledge is limited about the mechanism underlying NKT cell 
activation. It was demonstrated that NKT cells can be activated and recruited to sites of 
infection in a CD1d-independent manner (Gilleron et al., 2001). 
 
Figure 5: Schematic outline of how NKT cells influence the immune 
response in either a Th1 or Th2 direction. The green part shows factors 
supporting the Th1 responsiveness by NKT cells, while the red part shows 
factors supporting Th2 responsiveness by these cells. The environment in 
which NKT cells are found, including the type of cytokines and APCs and 
the strength of antigen-mediated TCR stimulation they receive, determines 
the cytokine output. Upregulation of cell-surface CD40L by NKT cells 
stimulates IL-12 release by DCs, which cooperate with NKT cell-derived 
IFNγ to stimulate Th1 responses. IL-7 has been reported to enhance Th2 
cytokine production by NKT cells, while cell-surface molecules that mediate 
immune suppression or Th2 deviation by these cells have not been 
identified. Time after stimulation may also be an important factor, as NKT 
cells also tend to produce Th1- and Th2-like cytokines in the short term (1-3 
hours) following stimulation but may then switch to a Th1 output, which can 
last for several days. This picture was adapted from the publication: Going 
both ways: immune regulation via CD1d-dependent NKT cells, Dale I. 
Godfrey and Mitchell Kronenberg, JCI, 2004 
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Furthermore it was shown that 
proinflammatory cytokines secreted 
by APCs after exposure to microbial 
products augmented the basal weak 
responses of CD1d-restricted T cells 
to unknown self antigens to yield 
potent effector functions. 
Recognition of microbial products 
and activation of APCs was 
mediated by TLRs expressed on the 
APC surface (Brigl et al., 2003) 
(Figure 6). This mechanism could 
account for rapid, indirect activation 
of CD1d-restricted T cells in a 
variety of microbial infections. 
However, it was demonstrated that 
NKT cells directly and specifically 
recognize antigens presented by 
CD1d. This mechanism depends on 
antigen-uptake, -processing and -
presentation by APCs and is 
antigen-specific and sensible to modifications of the antigen structure (Kawano et al., 1997) 
(Figure 6). 
 
It remains to be elucidated how NKT cell activation is regulated and which mechanisms 
determine the type of NKT cell response and its influence on the systemic immune system. 
Moreover, an analysis of the genetic décor of NKT cells could provide a mean for a global 
characterisation and an understanding of NKT cell functions in diverse immune responses. 
 
a)
b)
IL-4
IFNγ
IL-4
IFNγ
Figure 6: Models of NKT cell activation. a) Foreign lipid antigens are 
presented via CD1d on the cell surface of professional APCs and are 
sprecifically recognized by the NKT cell TCR leading to activation of 
NKT cells. b) Professional APCs presented endogenous NKT cell 
ligands via CD1d and “pre-activate” NKT cells by providing the first 
signal for activation. TLRs expressed on APCs mediate recognition of 
microbes by the APCs thus leading to activation and production of IL-
12 by APCs. IL-12 in turn activates NKT cells, thus providing the 
second stimulation signal. Picture is courtesy of Stefan H.E. Kaufmann 
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2 Aims of this thesis 
NKT cells are a unique T lymphocyte lineage that has been implicated in the regulation of 
immune responses associated with a broad range of diseases, including autoimmunity, 
infectious diseases, and cancer. In stark contrast to both conventional T lymphocytes and 
other types of regulatory T cells (Treg), NKT cells are reactive to the nonclassical antigen-
presenting molecule CD1d, and they recognize glycolipid antigens rather than peptides. 
Moreover, they can either up- or downregulate immune responses by controlling the 
secretion of Th1, Th2, or immune regulatory cytokines. 
 
Although there are numerous publications describing NKT cells in infection and disease, little 
is known about the properties of NKT cells and the mechanisms of NKT cell activation on a 
molecular level. Moreover, there is little knowledge about bacterial and endogenous ligands 
for NKT cells. Until recently, αGalCer, a sphingolipid from a marine sponge, was the only 
described agonist for NKT cells. A preceding study from this group identified 
Phosphatidylinosotol-mannoside (PIM) as lipid antigen, presented by CD1d and recognized 
by NKT cells (Fischer et al., 2004). In 2005 a publication by Zhou et al demonstrated that 
NKT cells recognize mammalian iGb3 and characterized this lipid as the endogenous NKT 
cell antigen (Zhou et al., 2004). 
 
The aims of this thesis are:  
- characterization of NKT cell properties and functions by analysis of their gene 
expression profile; 
- identification, characterization and analysis of endogenous NKT cell antigens;  
- analysis of NKT cell activation by endogenous ligands during lipid storage disease; 
- characterization of PIM-reactive NKT cells; 
- identification of mycobacterial lipids stimulating NKT cells via direct or indirect 
activation. 
 
In summary, this thesis aims to define NKT cell properties by examination of their gene 
expression profile and to identify and characterize NKT cell antigens. Transcriptome analysis 
of naïve and activated NKT cells should allow to coalesce the diversity of NKT cell functions 
to their gene expression décor. Identification of new lipid antigens as well as characterization 
of PIM reactive and iGb3 reactive NKT cells was performed to get a detailed view of NKT 
cells during infection and disease. 
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3 Material 
3.1 Cells, Cell lines 
A20 Murine B-Cell lymphoma line (ATCC) 
A20-mCD1d A20 Cells transfected with DNA for the full-length murine 
CD1d molecule (kindly provided by Dr. Mitchell Kronenberg, 
La Jolla Institute of Allergy und Immunology, CA, USA) 
NKT NAD II Human NKT cell line 
B-EBV Bois Human B-Ebstein-Bar-Virus transfected cell lines 
 
3.2 Cell culture medium 
Dulbecco´s Modified Eagle´s Medium (DMEM), RPMI 1640 medium, human serum, fetal bovine 
serum, penicillin/streptomycin solution, L-glutamine, HEPES, sodium pyruvate and non-essential 
amino acid solution were obtained from Biochrom.  
 
Standard DMEM and RPMI medium: 10%    FCS 
2mM   L-glutamine 
1mM sodium pyruvate 
50 µM  Mercaptoethanol 
10U/ml   penicillin and streptomycin 
10 mM  HEPES 
 
For studies with human cells, cell culture medium was 
supplemented with 8% human serum instead of FCS 
 
Macrophage medium Complete DMEM or RPMI with 10-30% L-cell supernatant  
from L929 cells 
 
3.3 Bacteria 
Mycobacterium bovis bacille Calmette 
Guérin (M. bovis BCG) 
Statens Institut, Kopenhagen, Dänemark 
 
 
3.4 Bacteria Culture medium 
Luria Bertani (LB) medium:  
1% (w/v) Bacto-Tryptone, 0.5% (w/v) yeast extract and 85.5 mM NaCl were dissolved in autoclaved 
water, the pH was adjusted to 7.5 with NaOH and the medium was autoclaved. Were indicated the 
appropriate antibiotics were added. Ampicillin was used at 50-100 mg/l. For plates 1.5 % (w/v) agar 
was added prior to autoclaving. 
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Middlebrook medium: 
4,7g Middlebrook 7H9 Broth, 2ml Bacto glycerol and 0,5g Tween 80 were dissolved in 900ml ddH2O 
and autoclaved. Subsequently 100ml Bacto-ADC enrichment was added under sterile conditions. 
Materials were purchased from Difco, USA. 
 
3.5 Mice 
Mice used in the experiments were on the genetic background of C57BL/6 (H-2b) mice and between 6-
10 weeks old.  
Apart from wildtype mice, experiments were performed using knock-out mice with a deficiency for the 
CD1d gene. Moreover, mice with a transgene expression of the Vα14-Jα281 TCR were used.  
Transgenic animals, C57BL/6 mice and CD1d -/- mice were bred in our facility at the Federal Institute 
for Health Protection of Consumers and Veterinary Medicine (BGVV) in Berlin. Mice were kept under 
specific pathogen-free (SPF) conditions in filter bonnet cages with food and water ad libidum. The 
experiments were conducted according to the German animal protection law. 
 
3.6 Human samples 
Blood samples from patients with Fabry disease were obtained from the University Children's Hospital 
of the University of Mainz in collaboration with Professor Dr. M. Beck. Blood samples from healthy 
donors were obtained from people working at the MPI for Infection Biology. 
 
3.7 Antibodies 
Monoclonal antibodies (mAb) used are listed in the table below. Monoclonal antibodies (mAb) marked 
with an asterisks (*) were purified from hybridoma supernatants by protein-G sepharose. The mAb 
used for flow cytometry were conjugated with the fluorescent dyes FITC, PE, APC, Cy-5 or PE-Cy-7. 
ATCC = American Type Culture Collection 
 
Anti-mouse antibodies 
Specificity Clone Application Source 
ATAC / Lymphotactin IGH6 FACS Dr. R. Kroczek 
B220 / CD45 RA3-6B2 FACS Pharmingen 
CD3 145-2C11 FACS Pharmingen 
CD4 YTS191.1 FACS ATCC* 
CD8α YTS169 FACS ATCC* 
CD11a 2D7 FACS Pharmingen 
CD11c HL3 
N418 
FACS Pharmingen 
ATCC 
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Specificity Clone Application Source 
CD16/CD32  
(anti-FcR) 24G2 FACS ATCC* 
CD25 PC61 FACS Pharmingen 
CXCR4 2B11 FACS ATCC* 
F4/80 F4/80 FACS ATCC* 
FasL MFL-3 FACS ATCC* 
IgG1  FACS ATCC* 
IL-4 11B11 ELISA ATCC* 
IL-4 BVD6-24G2 ELISA ATCC* 
IL-4 11B11 FACS Pharmingen 
IFNγ XMG1.2 ELISA ATCC* 
IFNγ R4-6A2 ELISA ATCC* 
IFNγ XMG1.2 FACS ATCC* 
Mac-1 MI/70 FACS Pharmingen 
NK1.1 PK136 FACS Pharmingen 
anti-CD1d 20H1, 1B1 FACS Dr. M. Kronenberg 
Thy1.2 53-2.1 FACS Pharmingen 
TLR 2  FACS Dr. Egil Lien 
TLR 4 MTS510 FACS eBioscience 
TNFα XT22 FACS ATCC* 
 
Anti-human antibodies 
Specificity Clone Application Source 
CD3 UCHT1 FACS Pharmingen 
CD161/NK1.1 DX12 FACS Pharmingen 
CD1b M-T101 FACS Pharmingen 
Invariant NKT 6B11 FACS Pharmingen 
FcR block  FACS Miltenyi 
CD1d CD1d42 FACS Pharmingen 
 
Additional materials for FACS and ELISA 
Specificity Application Source 
Anti-rat PE FACS Pharmingen 
DAPI FACS Pharmingen 
PI FACS Pharmingen 
Streptavidin - PE FACS Pharmingen 
Streptavidin - PE-Cy7 FACS Pharmingen 
Streptavidin - POD ELISA Dianova 
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3.8 Primers 
The table below shows the sequences of the synthetic oligonucleotides used for semi-quantitative RT-
PCR. All primers were obtained from Thermo Electron and diluted to 100 µM stock solutions. The 
working solutions were prepared from stock solutions according to the requirements. RT-PCR primer 
sequences were chosen using the Primer express 2.0 software from Applied Biosystems. 
 
Primer-name 5’-3’ sequence Application 
mIFNγ Fwd CTGCTGATGGGAGGAGATGTCT RT-PCR 
mIFNγ Rev TGCTGTCTGGCCTGCTGTTA RT-PCR 
mIL-13 Fwd TTCCCTGACCAACATCTCCAA RT-PCR 
mIL-13 Rev GGGCCTTGCGGTTACAGA RT-PCR 
mIL-17 Fwd CCCTTGGCGCAAAAGTGA RT-PCR 
mIL-17 Rev CGTGGAACGGTTGAGGTAGTC RT-PCR 
mBLK Fwd TGAGACTCCCAGCATGAAGGA RT-PCR 
mBLK Rev GCCTTCCACGCACTCCAT RT-PCR 
mCCR3 Fwd GCACCACCTCAGTGCTTATGAC RT-PCR 
mCCR3 Rev TGGGAACGTGTTGTTGATGCT RT-PCR 
mIL-17B R Fwd GCGACTATAATGCCCTGAGTGTCT RT-PCR 
mIL-17B R Rev GAAAGCTGTGGCGTCCTTCA RT-PCR 
mKLF2 Fwd CCGCCACTACCGAAAGCA RT-PCR 
mKLF2 Rev TCGCACAAGTGGCACTGAA RT-PCR 
mL-sel Fwd TCAAGTCCTCCCGTGAAGATTT RT-PCR 
mL-sel Rev CGTTGAGCAAACACTGCATCTC RT-PCR 
mATAC Fwd TGGATGGCAGGGCCAGTA RT-PCR 
mATAC Rev TGGGCTCCTGTGGGAACA RT-PCR 
mFasL Fwd GCAGCAGCCCATGAATTACC RT-PCR 
mFasL Rev AGATGAAGTGGCACTGCTGTCTAC RT-PCR 
mCCL5 Fwd CCAATCTTGCAGTCGTGTTTGT RT-PCR 
mCCL5 Rev TCTCTGGGTTGGCACACACTT RT-PCR 
mGAPDH Fwd CTCGTCCCGTAGACAAAATGG RT-PCR 
mGAPDH Rev TGACCAGGCGCCCAATA RT-PCR 
 
 
 
 
 
Material 
 
24 
3.9 Plasmids 
pgD-hTLR2 Full length hTLR2 with NH2-terminal gD tag (Yang et al., 1998). The 
wild type signal sequence for hTLR2 was replaced by the signal 
sequence and an epitope tag for herpes simplex virus type 1 
glycoprotein D. (Mark, JBC, 1994). 
p pGL3-ELAM.tk: Firefly luciferase vector (Yang et al., 1998)) (Promega) 
pRLTK (Promega):  
 
 
 
3.10 Chemicals 
Addresses and contact information for suppliers are attached in section 13. Standard laboratory 
chemicals used to prepare buffers were purchased from Sigma, Merck or Roth in per analysis quality. 
Radioactive compounds were obtained from Amersham (England) or NEN (USA).  
αGalCer Kirin Brewery Co. LTD 
  
CD40L Alexis Biochemicals 
  
FuGENE Promega 
  
Gb3 Matreya Inc. 
  
iGb3, P15, PW16, PW17, PW18 
Dr. P. G. Wang,  
(Department of Chemistry, Wayne State 
University, Detroit, USA) 
  
iGb3 
Dr. A. Bendelac 
(Committee on Immunology, University of 
Chicago, Chicago, USA) 
iGb3 Alexis Biochemicals 
  
Jirimycin Sigma 
  
Lactosylceramide Sigma 
  
Magnetic cell sorting beads Miltenyi Biotec 
  
Recombinant αGalA Transkaryotic Therapies 
  
Recombinant murine and human cytokines Strathmann Biotec AG 
  
Cyanine 3-CTP, Cyanine 5-CTP NEB Life Science Products 
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3.11 Buffers and solutions 
Solutions were made up in H2O prepared with a Millipore water purifier, unless stated otherwise. 
Where indicated, solutions were sterilized by autoclaving for 25 min at 121°C, or filter-sterilized 
through a 0.2 µm membrane. 
 
Antibody 
Solution 
0.1 % BSA 
0.1% Tween 20 
0.1% sodium azide 
in 1x PBS 
Silver Stain 
developer 
3% sodium carbonate 
0.5% formaldehyde 
in ddH2O 
ELISA coating 
buffer 
PBS or 
100 mM Na carbonate / 
hydrogencarbonate  
titrated to pH to 9.6 
Silver stain 
fixing solution 
10% Essigsäure  
30% Methanol 
in ddH2O  
ELISA wash 
buffer 
0.1% BSA 
0.05 % Tween 20 
in PBS 
Fixing buffer 50 ml Ethanol and 10 ml 
Essigsäure with 40 ml 
ddH2O 
ELISA 
Blocking 
buffer 
PBS/0.1% BSA Separating gel 
buffer (4x) 
90.75g Tris Base 
20ml 10% SDS 
volume to 460mls 
pH to 8.8 with HCl 
Q.S. to 500ml 
ELISA 
Detection 
buffer 
PBS/0.1% BSA Stacking gel 
buffer (4x) 
12.12g Tris Base 
8ml 10% SDS 
bring volume to 180mls 
pH to 6.8 with HCl 
Q.S. to 200ml 
ELISA 
substrate 
buffer 
Citric Acid Buffer (0,1M; pH5) 
with 0.1% H2O2 
Sample  
buffer (3 x) 
187.5 mM Tris-HCl, pH 6.8 
6% SDS 
0.9 mM EDTA 
30% glycerol 
0.03% bromophenol blue 
7.5% b-mercaptoethanol 
ELISA stop 
solution 
20% H2SO4 Running 
buffer 
25 mM Tris-HCl 
0.1% SDS 
192 mM glycine,  
pH to 8.3 
Phosphate 
buffered 
saline (PBS): 
8g  NaCl 
0.2g  KCl 
0.2g   KH2PO4 
1.3g Na2HPO4 
ad 1000 ml 
Acrylamide 3.9 g Bisacrylamide 
146.1 g Acrylamide 
ad 500 ml ddH2O 
Erythrocyte 
lysis buffer 
8.3 g NH4Cl 
20.6 g Tris 
ad 1000ml ddH2O 
adjust to pH 7.65 
α-
Galactosidase 
A assay 
substrate 
buffer 
50 mM Citrate-Phosphate-
buffer, pH: 4.5 
Cell lysis 
buffer 
TE buffer (pH 6.5) 
Protease Inhibitors: TLCK, E64, 
Pepstatin, Leupeptin ((1/1000) 
8.55 % Sucrose 
α-
Galactosidase 
A assay stop 
buffer 
12.6 g Glycin 
18 g Na2CO3 
ad 1000ml ddH2O 
adjust to pH 10 
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3.12 Enzymes  
T4 DNA ligase 
reverse transcriptase superscript II 
DNAse I 
RNAse H 
Gibco 
  
Pfu DNA polymerase 
DNA polymerase I, large fragment (Klenow) Stratagene 
  
Taq DNA polymerase Gene Craft 
  
2x SYBR-Green PCR master mix Applied Biosystems 
 
3.13 Equipment 
FACS-Calibur, FACS-Canto, FACS-Diva Becton Dickinson 
  
Electrophoresis chambers 
 
Bio-Rad,  
Couldy Small II (Hoefer, USA) 
  
Electrophoresis Power Supply Bio-Rad 
  
Centrifuges Megafuge 2.0 R (Heraeus) Ultracentrifuge (Beckmann) 
  
ELISA-Reader SpectraMax 250 Molecular Devices  
  
Microscopes Zeiss 
  
Lyophylizer Lyovac GT2 Amsco/Finn-Aqua 
  
2100 bioanalyzer system 
DNA microarray laser scanner Agilent Technologies 
  
PCR thermocycler 
ABI DNA-Sequencer A377 
ABI Prism 7000 
Applied Biosystems 
  
Scales BP 210 S (Sartorius) BP 2100 S (Sartorius) 
  
Sonicator / Ultrasonic Desintegrator Branson Sonifier W-250 (G. Heinemann) 
  
CO2 Incubator Autoflow Incubator CO2 4500 E (NUAIRE) 
  
Sterile Workbench Sicherheitswerkbänke HS 12 (Heraeus) 
  
Heating Block  
  
MALDI - Masspectrometer Voyager Elite (Perseptive Biosystems) 
  
pH - Meter 761 calimatic Knick 
  
Electronic pipetter Pipetboy acu (Integra Biosciences) 
  
Bacterial counting chamber Hausser Scientific Company 
  
Cell counting chamber Neubauer improved (Brand) 
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Rotational Evaporator RotiVap (Büchi) 
  
Rocking Plate Biometra 
  
Vortex IKA-Labortechnik 
  
Stir- and Heatingplate IKA-Labortechnik 
  
Topcount NXT microplate scintillation counter PerkinElmer 
  
Filtermate 196 harvester PerkinElmer 
  
Luminometer monolight 3036 plate reader BD Bioscience 
 
3.14 Other material 
Dialysis filter, Type VS, 0.0025 µm Millipore Corporation 
  
Sterile filters and membranes Schleicher & Schüll 
  
Flasks, plates and sterile vials Nunc 
  
TRIzol ® Reagent Gibco 
  
TLC plates (high resolution) Merck 
  
Chromatography equipment Pharmacia 
  
C18 Sep Pak chromatography columns Waters 
  
Chromatography support / media Pharmacia 
  
Unifilter microplates and seals PerkinElmer 
  
Microscint LSC cocktail PerkinElmer 
  
Biocoll, Percoll solution Biochrom 
 
3.15 Kits  
Dual Luciferase reporter assay system Promega 
  
Human IFN-γ and IL-4 Cytoset ELISA Kit Biosource 
  
RNeasy mRNA extraction Kit Qiagen 
 
3.16 Software 
Tables, calculations, statistics GraphPad Prism 3.0 (GraphPad Software)  
Excel (Microsoft) 
Graphics    PowerPoint (Microsoft) 
Photoshop (Adobe Systems) 
Flow cytometric analysis  Cell Quest 3.0 (BD) 
FCS Express 2.0 (De Novo Software). 
DNA primer design   Primer express 2.0 (Applied Biosystems) 
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Text      Word (Microsoft) 
Microarray analysis   Resolver (Rosetta Inpharmatics) 
ELISA  Analysis   Softmax Pro, Spf 3.0 (Molecular Devices) 
Mass-spectrometry analysis  Perseptive Grams/386 (Galactic Industries Corp.) 
 
3.17 Web resources  
DNA sequence identification: 
http://www.ncbi.nlm.nih.gov/BLAST/ 
DNA sequence comparison: 
http://www.ncbi.nlm.nih.gov/gorf/bl2.htlm 
Oligonucleotide-primer design: 
http://www-genome.wi.mit.edu/cgi-bin/primer/primer3_www.cgi 
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4 Methods 
4.1 Immunological methods 
4.1.1 Cell culture 
Cell lines and primary cells were cultured under sterile conditions at 37°C, 95% humidity and 5 - 7% 
CO2. At confluency, cells were passaged and diluted. 
Adherent cells were detached by treating them with a Trypsin / EDTA solution for 2min (or until they 
start to detach) at 37°C and then carefully washed off and resuspended in complete medium. Semi-
adherent cells were incubated with cold PBS for 10 min at 4°C and subsequently carefully detached 
using a cell scraper. A20 Cells were detached using a cell scraper. 
 
To determine cell numbers and viability, an aliquot of the respective cell suspension was mixed with a 
Trypan blue solution (0.16%) and cell numbers were determined using a Neubauer cell counting 
chamber under the microscope. Cell vitality could be determined since living cells, in contrast to dead 
cells, actively export Trypan blue and do not stain blue. 
 
4.1.2 Bacterial cell culture 
M. bovis BCG was kept under sterile S2 conditions at 37°C in a shaking Middlebrook-media liquid 
culture. At a density of 2x108 bacteria per ml, bacteria were passaged in a 1:20 dilution into fresh 
medium. 
 
To determine the cell number, an aliquot of the liquid culture was drawn up and down a syringe with 
an 0.4 mm ∅ needle to homogenize the sample, transferred to a Petroff-Hausser bacterial counting 
chamber and counted under a microscope. 
 
4.1.3 Infection of cells with M. bovis BCG 
The number of bacteria and target cells were determined. Infections were done at a ratio of 10:1 
(bacteria:target cells). The needed amount of bacteria was centrifuged at 10,000 x g and the 
supernatant was discarded. The bacterial cell pellet was resuspended in complete medium and 
washed once.  Subsequently the bacterial cell pellet was homogenized by repeated transfer through a 
syringe with a 0.4 mm ∅ needle. After this, bacteria were added to the target cells. 
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4.1.4 Infection of mice with M. bovis BCG 
C57BL/6 mice were infected i.v. with 2x106 M. bovis BCG. Bacteria were grown in Middlebrook 
medium, washed twice in PBS, aliquoted in PBS, 10 % glycerol, frozen and stored at -80°C. For 
infection, aliquots were thawed and bacterial titers were determined. Aliquots were homogenized by 
repeated transfer through a syringe with a 0.4 mm ∅ needle and appropriately diluted in PBS. Bacteria 
were injected in a volume of 200 µl PBS into the lateral tail veins of mice.  
 
4.1.5 Generation of murine macrophages and dendritic cells from bone 
marrow 
Tibia and femur of a 6-10 week old mouse were prepared. Femur was cut off above the hip joint and 
Tibia was cut away at foot joint. Bones were put on ice in complete medium. Remaining tissue was 
removed from bones and the joints were removed. Bone marrow cells were rinsed out of bones by 
using a 20 ml syringe with a 0.6-25 mm ∅ needle and complete medium. The cell suspension was 
centrifuged at 1,500 rpm, 5 min, 4°C and the resuspended pellet was subjected to red blood cell lysis. 
Cells were counted and maximally 2x107 cells were plated in a non-cell-culture Petri dish in 10 ml 
complete medium. After incubating the cells for 2h at 37°C, 5% CO2, the supernatant containing non 
adherent cells was removed and plated on a fresh Petri dish. GM-CSF (20 ng/ml) was added to these 
cells to generate DCs. After removal of the supernatant, the remaining, adherent cells were incubated 
to macrophage medium to culture macrophages. Medium was changed after 3 and 7 days by taking 
away half of medium and adding fresh medium. DCs will be ready to use after 10-12 days and 
macrophages will be ready to use after 7 days after isolation. To remove cells from the Petri dishes, 
remove SN, add cold PBS, incubate 10 min at 4°C, carefully scrape off and wash cells. 
 
4.1.6 Generation of human DCs from peripheral blood 
Fifteen ml Biocoll solution was added to a 50 ml conical tube and 35 ml blood was carefully layered on 
top of it without mixing the solutions. Tubes were centrifuged at 1,900 rpm for 25 min at RT without 
brake. After centrifugation, a dense layer of PBMCs could be detected in the Biocoll gradient. PBMCs 
were recovered from the gradient and transferred to a 50 ml tube containing RPMI. Cells were washed 
and centrifuged at 1500 rpm for 5 min at RT. The cell pellet was resuspended in PBS and centrifuged 
at 1,200 rpm for 5 min at RT to deplete blood platelets. Remaining cells were treated with erythrocyte 
lysis buffer to lyse red blood cells. PBMCs were then resuspended in PBS, transferred to a cell culture 
flask and incubated for 60-90 min at 37°C, 5% CO2 to let macrophages and monocytes attach. Next, 
the supernatant was taken away and complete medium for human cells, containing GM-CSF (at 200 U 
/ ml) and IL-4 (at 100 U /ml), was added. Cells were incubated at 37°C, 5% CO2 to generate immature 
DCs. Immature DCs are generated at Day 3 after isolation. 
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4.1.7 Generation and restimulation of human NKT cell lines and clones 
Human NKT cell lines and clones were provided by Dr. M. Bonneville (Inserm U601, Institut de 
Biologie, Nantes, France). Briefly, T cells were stained for TCR Vα24 chain and CD4 expression using 
standard staining procedures and analyzed by flow cytometry. Vα24+ cells were sorted using 
streptavidin magnetic beads coated with biotinylated TCR Vα24 antibody, expanded using lectin, IL2 
and irradiated feeder cells as described, and analyzed for expression of Vα24 and Vβ11 TCR chains. 
For restimulation and expansion, 1x106 T cells were incubated with 1x106 irradiated, freshly isolated 
PBMCs, 1x106 B-EBV transfected B cells, PHA (at 1mg/ml) and IL-2 (at 300 U/ml) in a volume of 150 
µl in a 96 well plate. Cells were pooled and transferred to a cell culture flask with fresh medium 
containing IL-2 (300 U/ml) when the medium started to turn yellow. T cells were diluted every 2-5 days 
and cells were used earliest 10 days after stimulation. PBMCs and B-EBV transfected B cells were 
irradiated with 3,500 rad. B-EBV transfected B cells had been cultured in RPMI medium and PBMCs 
were isolated as described in chapter 3.1.6 
4.1.8 Single cell isolation from different tissues  
Spleen cells were isolated by homogenization using an iron mash sieve and subsequent red blood cell 
lysis using erythrocyte lysis buffer. 
Liver cells were isolated by use of a percoll gradient. Briefly, mice were sacrified, cut open and the 
liver was rinsed with sterile PBS injected through the vena hepatica. Liver cells were homogenized 
using an iron mash sieve and centrifuged at 400 rpm for 2 min at 4°C. Supernatant was collected and 
the remaining pellet was resuspended in 15 ml RPMI and centrifuged at 400 rpm, 4°C, 2 min. This 
was repeated 3 times and finally the supernatant from the first centrifugation and the supernatant from 
the following centrifugations were centrifuged at 1,500 rpm for 10 min at 4°C. Cells were resuspended 
and further purified over a 40% / 70% Percoll gradient and centrifugation at 1,900 rpm for 30min at RT. 
Lymphocytes were collected at the interface of the 40% / 70% percoll gradient and collected cells were 
washed twice in complete RPMI medium, red blood cells were lysed and cells were counted. Viability 
of the cells was determined by Trypan-blue exclusion. 
 
4.1.9 Red blood cell lysis 
After isolation of cells from organs, cells were washed in sterile PBS and resuspended in erythrocyte 
lysis buffer and incubated at 37°C for 2 min. Erythrocyte lysis was stopped by washing the cells with a 
1:1 mixture of PBS and complete medium. 
 
4.1.10 Flow cytometry 
To measure surface expressed proteins, 2x106 cells were washed and incubated in 200 µl PBS with 
rat serum and anti-CD16/CD32 mAb for 5 min at 4°C to block non-specific antibody binding. Next, 
fluorescent dye conjugated antibodies were added to the cells for 20 min on ice in the dark, washed in 
PBS and resuspended in 300 µl PBS containing 0.1% BSA for flow cytometry analysis. 
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To measure intracellular cytokines, cells were first stained for surface expressed proteins, then 
washed in PBS and fixed for 20 min on ice in the dark with PBS with 4% paraformaldehyde (Sigma). 
Cells were washed with PBS with 0.1% BSA, permeabilized with PBS with 0.1% BSA and 0.5% 
saponin (Sigma) and incubated in this buffer with rat serum and anti-CD16/CD32 mAb for 5 min. To 
stain the intracellular cytokines conjugated or conjugated isotype control mAb were added. After 20 
min on ice, cells were washed with PBS and fixed with PBS with 1% paraformaldehyde. Next, cells 
were washed and resuspended in 300 µl PBS containing 0.1% BSA for flow cytometry analysis. 
When using unconjugated primary antibodies, a second staining with a secondary antibody, usually an 
anti-rat antibody, recognizing the primary antibody, was performed. After the staining with the primary 
antibody, cells were washed with PBS with 0.1% BSA and excess rat Ig was added to block unspecific 
binding of the secondary antibody. Cells were incubated for 5 min on ice in the dark and subsequently 
the secondary antibody was added. Following an incubation time of 15 min on ice in the dark, cells 
were washed in PBS and resuspended in 300 µl PBS containing 0.1% BSA for flow cytometry 
analysis.  
For staining cells with CD1d-tetramer complexes, 2x106 cells were washed and incubated in 200 µl 
PBS with rat serum and anti-CD16/CD32 mAb for 5 min at 4°C to block non-specific antibody binding. 
Next, fluorescent dye conjugated antibodies and PE-conjugated CD1d-tetramers were added to the 
cells and incubated for 50 min on ice in the dark on a rocking platform. Subsequently cells were 
washed in PBS and resuspended in 300 µl PBS containing 0.1% BSA for flow cytometry analysis. For 
flow cytometry staining, 2.5 - 5 µg of tetramerized mCD1d was used. 
Detection of viable cells was achieved by staining the cells with PI or DAPI shortly before analysis. 
Counting of stained cells was performed with a FACS Calibur or FACS Canto (Becton Dickinson) and 
the software FCS-express and Cell Quest were used to analyze the data. 
 
4.1.11 Isolation and purification of cells by MACS and FACS sorting 
Magnetic cell sorting (MACS) with MicroBeads (Miltenyi) was performed to enrich cell populations by 
positive selection. For some applications it was decided to positively select “unwanted” cells and 
thereby negatively select and enrich the desired cells. Cells were either selected by beads conjugated 
to a certain surface molecule displayed on their surface, or stained with a fluorescent dye conjugated 
antibody first and then selected with magnetic beads conjugated with an antibody specifically 
recognizing the fluorescent dye. Cells were labeled according to the manufacturers protocol (Miltenyi 
Biotec MACS MicroBeads) 
After labeling the cells, the cell suspension was loaded on a column which was placed in the magnetic 
field of a MACS Separator. The magnetically labeled cells were retained in the column while the 
unlabeled cells passed through. After removal of the column from the magnetic field, the magnetically 
retained cells could be eluted as the positively selected cell fraction. 
 
Fluorescence activated cell sorting (FACS) was performed at the flow cytometry core facility at the 
MPI for Infection Biology. Cells were labeled with antibodies and/or tetramers and subsequently sorted 
using the FACS-sorter FACS-Diva (Becton Dickinson, BD Bioscience). All steps were done on ice and 
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cells were kept at 4°C at all times. The sorting regions were defined in the dot blot diagrams showing 
forward (FSC) versus 90° (SSC) scatter signals on a linear scale with cell debris characterized by 
FSC/SSC signals distinct from that of the intact cell population being excluded from sorting. Viable 
cells were detected by staining with PI or DAPI and cells were sorted into a tube containing 500 µl cold 
PBS, 0.1% BSA. The purity of sorted fractions was checked visually and by FACS reanalysis. The 
FACS-sorter was standardized with fluorochrome-containing beads, and fluorescence-reading in each 
channel was automatically adjusted to a constant value. 
 
4.1.12 Isolation of lysosomes from fibroblast 
Fibroblasts were grown to confluency and cells were scraped of on ice in 5 ml lysis buffer. All steps 
were carried out on ice. Cells were transferred to a cell douncer and the douncer was applied 20-30 
times to crack the cells. The cell suspension was centrifuged at 800 rpm for 10 min at 4°C to obtain 
the post-nuclear supernatant (PNS). An aliquot of the supernatant was examined for remaining cells 
and eventually the douncer was applied again till no cells were visible. The PNS was further purified 
using a 20% percoll gradient in lysis buffer. Four ml of PNS was added carefully to 10 ml of 20% 
percoll without mixing the solutions. The tubes were centrifuged at 18,000 rpm for 21 min at 4°C 
without brake and supernatant was discarded leaving 3 ml in each tube. Samples were pooled and 
ultracentrifuged at 50,000 rpm for 60 min at 4°C. After centrifugation, lysosomes were visible as a 
small cloud and were recovered from the tubes. Lysosome preparations were washed 2 times by 
adding 200-300 µl of the lysosome preparation to 1-2 ml PBS and centrifugation at 50,000 rpm for 60 
min at 4°C. Lysosomes were recovered from remaining gel-like pellet with a small amount of PBS. 
Aliquots of the lysosomal preparation were prepared and stored at -80°C. Protein content was 
determined using the Bradford Protein Assay. 
 
4.1.13 T cell stimulation assay 
Spleen cells derived from Vα14-Jα281 transgenic mice were used since they possess three times 
more NK1.1 positive T cells than wild type C57BL/6 mice and no alloreactivity to the APC (H-2D) was 
observed as assessed with splenic T cells from C57BL/6 mice. Isolated spleen cells were incubated 
for 1 h in cell culture flasks to remove adherent cells. To enrich for T cells, magnetic cell separation 
using anti-Thy1.2 FITC conjugated antibodies and anti-FITC coated magnetic beads were used. 
Purified T cells were seeded at 1x105 cells/well in 96-well round bottom plates. As APCs, A20-CD1d 
expressing cells or parental A20 cells, DCs or macrophages of C57BL/6 or CD1-/- mice (5x104 
cells/well) were pulsed with the respective lipids for 3 h at 37°C, irradiated (20,000 rad for A20 cells; 
5,000 rad for murine DCs or macrophages) and extensively washed before adding them to the T cells. 
Cells were incubated for 18-24 h. 
 
For human T cell stimulation assays, NKT cell lines and NKT cell clones, generously provided by Dr. 
M. Bonneville (Inserm U601, Institut de Biologie, Nantes, France) were used at 1-2x105 per well in a 
96-well plate. As APCs, human DCs were generated from healthy donor blood or from blood of 
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patients with Fabry disease. DCs and macrophages were pulsed with the respective lipids for 3-6 h, 
irradiated (5,000 rad) and subsequently T cells were added. Cells were incubated for 18-48h.  
 
Cytokines in the cell culture supernatant were detected using ELISA and proliferation of T cells was 
measured by [3H] thymidine incorporation. Cytokine levels and proliferation are expressed as mean 
+/- SD of triplicate cultures. 
The respective lipids were dissolved in DMSO at a concentration of 10 mg/ml, 1 mg/ml or 100 µg/ml 
and a range from 10 µg - 100 ng were added to the APCs.  
To block the α-GalA activity, APCs were pretreated with Jirimycin (20 µg/ml) for 45 - 60 min prior to 
addition of lipid antigens. To reconstitute the α-GalA activity in DCs derived from Fabry patients, α-
GalA (Replagal 1 mg/ml) was added 30 min prior to the lipid antigens to the APCs. 
 
4.1.14 Dual luciferase reporter assays for NF-κB activation.  
The NF-κB dependent luciferase reporter assay was performed as described previously (Aliprantis et 
al., 1999b). Briefly, HEK293 cells were seeded in 48-well tissue culture plates at a density of 1.5 x104 
cells/well. After 48 h, cells were transfected by FuGENE (Roche) with the expression plasmids pgD-
hTLR2 (coding for human TLR2) or empty vector (pRKN) 0.3 µg, 0.03 µg of pGL3-ELAM-tk and 0.003 
µg of the Renilla luciferase reporter vector pRL-TK (Promega) for normalization. A FuGene / serum 
free medium (DMEM) and a 3 / 1 ratio of FuGene / DNA was used. The DNA of the different plasmids 
were mixed, added to the FuGene / DMEM mix and incubated for 15 min at RT. Twenty µl of this mix 
were added to each well and the plate was gently swirled for even distribution. After 24h, cells were 
stimulated for 6 h with the bacterial lipopeptides and lipids as indicated and the reporter gene activity 
was measured according to the manufacturer´s recommendations (Promega) using a plate reader 
luminometer (BD Biosciences, Luminometer monolight 3036). The data shown represent 1 of 3 
separate experiments and are shown as the mean values ± S.D. of triplicate samples. Results are 
reported as fold induction of relative luciferase units (RLU) over unstimulated cells. Relative luciferase 
activity is calculated as the ratio between the value of the NF-κB inducible firefly luciferase and that of 
the constitutive Renilla luciferase reporter. 
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4.2 Biochemical methods 
4.2.1 ELISA 
Immuno-Maxisorp ELISA plates (Nunc) were coated with the primary antibody in 50 µl/well coating 
buffer and incubated for 60 min at 37°C. Plates were washed four times using ELISA wash buffer and 
blocked for 1 h at 37°C in 200 µl/well PBS containing 0.1% BSA. After repeating the washing step, 
standards and samples were diluted in tissue culture medium, 50 µl added to each well and left for 60 
min at 37°C for binding of the cytokine of interest to the primary antibody. Plates were then washed 
prior to the addition of 50 µl/well of the secondary antibody diluted to the appropriate concentration in 
PBS / 0.1% BSA and incubated at 37°C for 1 hour. After repeated washing, 50 µl/well streptavidin-
conjugated horseradish peroxidase (Dianova) diluted 1:1,000 in PBS / 0.1% BSA was added and 
incubated for 1 hour at 37°C. After further washing, 50 µl of the peroxidase substrate ortho-
phenyldiamine (OPD) (Sigma) in 50 µl citrate buffer was added. The reaction was allowed to proceed 
for 5-10 min in the dark before being stopped by addition of 50 µl 20% H2SO4. The plate was read by a 
Spectramax ELISA reader (Molecular Devices) and analyzed by Softmaxpro software. Control wells 
were left untreated with the primary or secondary antibody or filled with medium only. For murine IFNγ 
ELISA, primary antibody was R4-6A2, used at 2 µg/ml and secondary antibody was XMG1.2-biotin 
used at 3 µg/ml. The standard recombinant IFNγ was purchased from R&D and diluted from 500 U/ml 
in 2 fold dilutions. The IFNγ ELISA was linear in the range from 5 U/ml to 100 U/ml. For murine IL-4 
ELISA, primary antibody was 11B11, used at 1 µg/ml and secondary antibody was BVD6-24G2-biotin 
used at 2 µg/ml. The standard recombinant IL-4 was purchased from R&D and diluted from 5 ng/ml in 
two fold dilutions. The IL-4 ELISA was linear in the range from 5 U/ml to 100 U/ml.  
Detection of human IFNγ and IL-4 was performed with Cytoset ELISA Kits (Biosource) according to 
the manufacturers descriptions. Optical densities were measured at 490 nm. 
 
4.2.2 Detection of [3H] thymidine incorporation 
T cell proliferation was detected by measurement of [3H] thymidine incorporation into the DNA of 
proliferating cells. One to 2x105 cells were incubated with 20 µCi/ml [3H] thymidine in 200 µl RPMI for 
6 h. Cells were harvested and proliferation plates were washed 4x, dried and 40 µl Microscint LSC 
cocktail was added to intensify the detectable radiation. Proliferation was measured by [3H] thymidine 
detection using a Topcount NXT microplate scintillation counter. 
 
4.2.3 Isolation of lipids from M. bovis BCG 
Total lipid extracts were obtained by overnight incubation in chloroform/methanol (2:1; v/v). The 
solution was passed through a filter to remove the bacteria. The remaining cells were incubated in 
chloroform/methanol (1:2; v/v) and the solution was passed through a filter to remove the bacteria. 
Extracts were pooled and centrifuged for 10 min at 4,000 rpm. The supernatant was passed through a 
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filter and the volume of the chloroform/methanol extract was reduced by using a rotational evaporator. 
Lipids were further purified by liquid chromatography using a silica gel column (Pharmacia). The silica 
column was equilibrated with chloroform and the lipid extract was applied. The ration of lipid extract 
and amount of silica gel was 1/200. Elution of the different lipid fractions was performed with a 
gradient with increasing amounts of methanol and decreasing amounts of chloroform. Lipid fractions 
were analyzed for the desired lipids by SDS-PAGE and silver staining. Selected fractions were further 
purified by reverse-phase chromatography using C18 Sep-Pack ready-to-use columns and a 
chloroform to methanol gradient. Obtained fractions were analyzed by thin layer chromatography. 
LAM, LM and PIM were isolated from M. bovis BCG by Triton X-114 extraction. 1011 Bacteria were 
washed with 0.05 M Tris-HCl pH 7.5 (TBS) and lyophylized. Bacteria were resuspended in TBS, 5mM 
EDTA and sonicated on ice using a microtip-sonicator. TBS containing MgCl2 (10 mM) was added and 
proteins and nucleic acids were removed by RNAse/DNAse (1 µg/ml) digestion. Triton X-114 was 
added (8% v/v) to the crude extract, stirred for 16 h at 4 °C and cellular debris was removed by 
centrifugation for 30 min at 10,000 x g. After induction of phase separation and centrifugation, the 
Triton X-114 phase was recovered and the remaining solution was reextracted with the cellular debris 
using Triton X-114. The resulting Triton fraction were pooled and precipitated with cold ethanol. 
Precipitated glycolipids were collected by centrifugation at 10,000 x g for 30 min, the pellet was 
resuspended in ddH2O, stirred overnight and ultra-centrifuged at 35,000 x g for 16 h. The sediment 
was resuspended in ddH2O and treated with Proteinase K (1 mg/ml) for 2 h at 37°C. The solution as 
ultra-centrifuged and resuspended twice, reconstituted in ddH2O and lyophylized. Glycolipids were 
then dissolved in Tris-deoxycholic acid buffer (Tris-HCl 10 mM, pH 8.0; EDTA 10 mM; NaCl 0.2 M; 
Deoxycholic acid 0.25%; NaN3, 0.02%) and separated using a 100x1.5 cm column packed with 
Sephacryl S-200. Lipid fractions were eluted with Tri-deoxycholic acid buffer and the resulting fractions 
were analyzed by SDS-PAGE and silver staining. Selected fractions were pooled, dialyzed against 
ddH2O using dialysis tubes with a molecular cut out of 10,000 Da (LAM and LM) or 1,000 Da (PIM) 
and lyophylized. 
 
4.2.4 SDS polyacrylamide gel electrophoresis 
Lipids fractions, dissolved in DMSO, were separated on a discontinuous SDS-PAGE according to 
Laemmli using vertical slab gels (Laemmli, 1970). Samples were prepared in SDS-containing sample 
buffer and heated to 95°C for 3 min before electrophoresis. Lipids were visualized by silver staining. 
 
4.2.5 Silver staining 
SDS-PAGE gels were incubated for 1 h in fixing solution on a rocking platform. Proteins and 
glycolipids contained in the gel were oxidized by addition with 30 mM NaIO4 in for 10 minutes. Gels 
were then treated for 30 min with a 10% acetic acid, 10% methanol solution and subsequently 
incubated with 2.5% glutaraldehyde for 5 minutes. Gels were washed 4x with ddH2O, incubated with 
25 µg/ml dithiotreitol for 5 min and rocked for 5 min in ddH2O with 1 mg/ml silvernitrate. Gels were 
shortly washed 2x with ddH2O.  To visualize proteins and glycolipids, gels were treated with developer 
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which was replaced after 10 seconds with fresh solution. The reaction was stopped after 2 min by 
addition of citric acid (50%) in ddH2O. The gels were dried between cellophane sheets. 
 
4.2.6 High performance thin layer chromatography (HPTLC) analysis 
For two dimensional HPTLC glycolipid samples were spotted in one corner of a 10 x 10 cm HPTLC 
plate. For one-dimensional HPTLC, glycolipid samples were spotted as a line 1.5 cm above the lower 
edge of the HPTLC plate. The HPTLC plate was developed to 8 cm and solvents used were: 
chloroform/methanol/ammonium hydroxide (80:20:2; v/v/v), propanol/water/acetic acid (80:10:10; 
v/v/v), chloroform/methanol/water (65:25:4; v/v/v) or chloroform/acetic acid/methanol/water (40/25/3/6). 
Hundred µg lipid was spotted on the plate and lipids were analyzed for sugar residues using 1% α-
naphthol in 5% H2SO4/ethanol as a spray reagent. Using α-naphthol, carbohydrate residues are 
stained blue, whereas red staining indicates absence of carbohydrates. 
 
4.2.7 Matrix assisted laser disorption ionization – mass spectrometry 
(MALDI-MS) 
Lipids were analyzed for their structure using MALDI-MS. Fifty µg of lipid sample was dissolved in 
chloroform and mixed with 10 µl 2, 5-dihydroxybenzoic acid as a matrix. The mixture was dried and 
analyzed. Laser intensity was set at 1,200 and time of flight was determined in negative mode. 
MALDI-MS analysis was performed at the mass-spectrometry core facility of the MPI for Infection-
Biology. 
 
4.2.8 Protein quantification by Bradford 
Samples were diluted with PBS to an estimated concentration of 1 to 20 µg/ml. A standard dilution row 
was prepared containing a range of 1 to 20 µg protein (albumin was used) to a volume of 100 µl. One 
or 5 µl of unknown samples was added to 100 µl H2O and 900 µl dye reagent (Sigma) was added. The 
solution was mixed and incubated for 5 min at RT. Absorbance was measured at 595 nm and 
concentrations were determined by use of the standard dilution row. 
 
4.2.9 Generation of tetrameric mCD1d - lipid complexes 
Tetrameric mCD1d complexes were made in a baculovirus expression system as described previously 
(Crawford et al., 1998).The generation of tetramers was previously described (Matsuda et al., 2000) 
and the plasmid coding for the recombinant murine CD1d protein was generously provided by Dr. M. 
Kronenberg (La Jolla Institute for Allergy and Immunology, San Diego, USA).  
The CD1d tetramers loaded with different lipid antigens were generated at the biochemistry core 
facilities of the MPI for Infection Biology. Briefly, the mCD1d/mß2m expression vector was 
cotransfected with linearized BaculoGoldTM baculovirus DNA (PharMingen) into High FiveTM (BTI-TN-
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5B1-4) cells (Invitrogen) using the Lipofectin Reagent® (Gibco BRL) by following the manufacturer's 
protocol. Recombinant virus was collected 5 d after transfection, amplified, and cloned by serial 
dilution method. The virus with highest level of mCD1d secretion was used for protein production. 
Soluble protein was produced by infecting adherent High FiveTM cells at a MOI of 5-10. The mCD1d-
containing supernatant was harvested on day 4-5 after the infection, dialyzed against 0.15 M sodium 
phosphate buffer, pH 7.4, and passed over Ni–agarose (Qiagen) for one-step affinity purification. 
Purified mCD1d protein was biotinylated with BirA enzyme (Avidity) following the manufacturer's 
protocol. The αGalCer-loaded mCD1d was tetramerized by adding neutravidin–PE (Molecular Probes) 
in 4:1 molar ratio. "Unloaded" mCD1d tetramers were prepared by preincubating biotinylated protein 
with an equivalent amount of αGalCer dilution vehicle.  
 
 
4.3 Molecular biological methods 
The general molecular biological methods like agarose gel preparation, DNA electrophoresis, DNA 
precipitation and measurement of DNA / RNA concentration were performed according to Molecular 
Cloning: A Laboratory Manual (Sambrook and Russell, 2001). DNA sequences were compared using 
the web-based program Blast 2 Sequences (http://www.ncbi.nlm.nih.gov/gorf/bl2.html) 
 
4.3.1 Isolation and purification of RNA from single cell suspensions 
Total RNA was isolated by the TRIzol® Reagent RNA preparation method (Gibco). Briefly, cells were 
resuspended immediately after FACS sorting in 500 µl TRIzol®, shock frozen and stored at -80°C. 
Cells were thawed and further processed for total RNA isolation as described by the manufacturer. 
The amount of RNA was determined by OD260/280nm measurement and total RNA was purified by 
RNeasy (Qiagen). The RNA integrity and the amount of total RNA were measured with a Bioanalyzer 
2100 (Agilent Technologies). 
 
4.3.2 Generation of cDNA and RT-PCR 
Initially purified RNA samples were treated with DNAse (Gibco) to eliminate genomic DNA 
contamination. For this, 8 µg of RNA in 16 µl H2O and 1 µl of 10x reaction buffer were incubated with 2 
µl of DNAse I for 15 min at RT. The reaction was stopped by the addition of 2 µl 25 mM EDTA and the 
DNAse was inactivated by incubating the mixture at 65°C for 15 min. While 12 µl of this mixture were 
stored and later analyzed for the completion of the DNAse digestion, 10 µl of it were used for reverse 
transcription. For this 1 µl random hexamer primers (200 µg/ml) were added, the mixture was 
incubated for 10 min at 65°C and then placed on ice. After 5 min on ice, a reaction mix containing 4 µl 
5x first strand buffer, 1 µl 10 mM dNTPs, 2 µl 0.1 M DTT and 1 µl of superscript reverse transcriptase 
was added. This mixture was immediately incubated for 5 min at 25°C, followed by 60 min at 50°C and 
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finally incubated for 15 min at 70°C in order to inactivate the reverse transcriptase and to stop the 
reaction. 
 
4.3.3 Real-time RT-PCR 
Quantification of DNA using real-time PCR is based on the measurement of amplified products after 
each cycle of the PCR using fluorescent dyes interacting only with double stranded DNA. The more 
template is present at the beginning of the reaction, the lower the number of cycles it takes to reach a 
point in which the fluorescent signal is first recorded as statistically significant above background, 
which is the definition of the threshold cycle. Comparison of the threshold cycle for a specific template 
in each sample leads to semi-quantitative evaluation of original template concentration. For semi-
quantitative real-time PCR total RNA was isolated from cells as described in section 4.3.1 and 
transcribed to cDNA as described in section 4.3.2. All PCRs were run for 40 cycles with 20 sec 94°C 
and 60 sec 60°C in the ABI Prism 7900 Sequence Detection System (Applied Biosystems) using ABI 
PRISM optical 96-well plates (Applied Biosystems). When possible primers were designed to span 
large introns and to produce product sizes between 100 and 200 bp. Reaction mixtures were set up in 
30 µl final volume using 15 pmol of each primer, 5 µl template cDNA and 15 µl 2x SYBR-Green PCR 
Master mix (Applied Biosystems). For the quantification of GAPDH and β-actin, 5 µl of 1:150 diluted 
cDNA were used as template in each reaction and for the quantification of e.g. cytokines, 5 µl of 1:15 
diluted cDNA were used. Each quantification was performed at least twice with independent cDNA 
samples and in duplicates for each cDNA and primer pair. Data analysis was performed using the ABI 
Prism 7000 SDS Software and Microsoft Excel. The threshold cycle was determined for each sample 
and fold differences relative to the expression level in one of the analyzed cDNA samples was 
calculated for each cDNA sample and primer pair (fold-difference=2-∆Ct). Resulting fold differences for 
expression levels were corrected for different amounts of cDNA by multiplication with the average fold 
difference of GAPDH and β-actin expression within the same sample. The number of cycles necessary 
to produce enough PCR-product for detection but small enough to not exceed the log phase of the 
PCR was determined by serial dilutions of cDNA or multiple PCRs with different numbers of cycles. To 
compare the amount of cDNA used in each reaction, β-actin primers were included. Possible 
contamination with genomic DNA was estimated using 1:5 diluted DNAse digested, not reverse 
transcribed, RNA as template. 
 
4.3.4 RNA microarray 
Microarray experiments were done as two-color hybridizations. Total RNA was extracted from single 
cell suspensions as described in section 4.3.1. An amount of 4 µg total RNA was reverse transcribed 
with an oligo-dT-T7-promotor primer by a fluorescent linear amplification reaction (Agilent 
Technologies) and cDNA was labeled either with Cyanine 3-CTP and Cyanine 5-CTP (NEB Life 
Science Products) in a T7 polymerase amplification reaction according to the supplier’s protocol. In 
order to compensate specific effects of the dyes, e.g. incorporation and to ensure statistically relevant 
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data analysis, a color swap was performed. The RNA samples were labeled vice versa with the two 
fluorescent dyes (fluorescence reversal). After precipitation, purification and quantification, 1.25 µg of 
each labeled cRNA was mixed, fragmented and hybridized to the 8.4 K custom 'in situ' mouse array 
according to the supplier`s protocol (Agilent Technologies). Scanning of microarrays was performed 
with 5 µm resolution using a DNA microarray laser scanner (Agilent Technologies). Features were 
extracted with an image analysis tool Version A4.045 from Agilent Technologies using default settings. 
Data analysis was carried out on the Rosetta Inpharmatics platform Resolver Built 3.0.0.3.22.  
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5 Results 
5.1 Characterization of NKT cells 
NKT cells influence and regulate a wide range of immune responses. They play a role in 
autoimmunity, allergy, antitumour responses, host defence to infections and in inflammation 
(Godfrey and Kronenberg, 2004). NKT cells show high similarities to other cells including NK 
cells, CD4+CD25- (conventional CD4+ T cells) T cells and CD4+CD25+ T cells (regulatory T 
cells, Treg). Nevertheless, NKT cells possess unique features that distinguish them from 
other cells. In order to characterize NKT cells on the transcriptome level and to analyse their 
functional capabilities, gene expression profiling using RNA microarray technology was 
performed. 
 
5.1.1 Transcriptome analysis of NKT cells compared with NK cells, 
conventional CD4+ T cells and Treg cells 
To examine cell-type specific characteristics of NKT cells, microarray studies were designed 
comparing NKT cells to other T cells and NK cells. Experiments were performed using RNA 
extracted from spleen cells of C57BL/6 mice. RNA from naïve, unstimulated NKT cells was 
isolated and compared to RNA from naïve, unstimulated NK cells, conventional CD4+ T cells 
and Treg cells. In order to obtain RNA from highly pure and viable cells, cells were stained 
with antibodies for their characteristic surface markers. Subsequently cells were purified and 
enriched by MACS-sorting prior to FACS-sorting. To isolate NK cells, cells were stained with 
an APC-conjugated anti-CD3 and a FITC-conjugated anti-NK1.1 antibody. Subsequently, 
they were enriched by positive MACS sorting using anti-FITC magnetic beads selecting for 
NK1.1 positive (NK1.1+) cells. NK cells were sorted by FACS sorting as NK1.1+ and CD3-
 
cells. To sort NKT cells, spleen cells were stained with FITC-conjugated anti-NK1.1 antibody 
and NKT cells were enriched by MACS sorting with anti-FITC beads. Positively selected cells 
were then stained with APC-conjugated anti-CD3 and PE-conjugated αGalCer-CD1d 
tetramer. NKT cells were isolated as CD3+, NK1.1+ and αGalCer-CD1d tetramer+ cells. 
These cells will be referred to as NKT cells during the whole work.  
Surprisingly, microarray results showed a number of genes known to be expressed by 
macrophages, suggesting minute contaminations of macrophages in the sorted NKT cell 
population. This was unexpected since reanalysis of the sorted samples showed a purity of 
>95 % due to stringent sorting parameters and a blocking step was included to prevent 
unspecific antibody binding. To improve the sorting protocol further, the following steps were 
added: to enrich NKT cells and deplete macrophages, B cells, CD8+ T cells and dendritic 
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cells with high efficacy, spleen cells were stained with biotin-conjugated antibodies against 
Mac-1, B220, CD11c and CD8. Magnetic beads, coated with anti-biotin antibody were used 
to remove macrophages, B cells, DCs and CD8+ T cells. The non-binding cells (MACS-
negative) were further processed. Cells were stained with anti-CD3, anti-NK1.1 antibodies 
and streptavidin-PE-Cy7 was used to deplete left over cells from the positive depleted cells. 
NKT cells were sorted as CD3+, NK1.1+, αGalCer-CD1d tetramer+ and streptavidin-PE-Cy7-
negative, i.e. Mac-1-, B220-, CD11c-, CD8- negative cells (Figure 7). FACS analysis of 
purified cells revealed that NK cells were 99 % pure and NKT cells were > 90 % pure. 
 
Conventional CD4+ T cells and Treg cells were isolated from C57BL/6 mouse spleen cells by 
staining for CD4, CD25 and NK1.1. Cells were stained with an APC-conjugated anti-CD25, a 
FITC-conjugated anti-CD4 and a PE-conjugated NK1.1 antibody. Cells were enriched by 
positive MACS-sorting using anti-FITC magnetic beads selecting only for CD4+ cells. Both 
CD4 T cell populations were sorted as NK1.1- and either CD25+ or CD25-, CD4 expressing T 
cells. Conventional CD4+ T cells were 98 % pure and Treg cells were 97 % pure (Figure 8).  
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Figure 7: FACS sort of murine NK and NKT cells from C75BL/6 mice. Upper row: unsorted spleen cells with sorting gates 
and dot blot of unsorted NKT cells. Lower row: (left) sorted NKT cells and (right) sorted NK cells. Cells were stained with 
antibodies against CD3 and NK1.1 and CD1d-αGalCer tetramers. NKT cells were sorted as CD3+, Nk1.1+ and tetramer+
cells. NK cells were sorted as CD3-, NK1.1+and tetramer- cells. Percentages of positive cells are indicated in the 
quadrants. Dead cells were excluded by PI staining and only viable cells were sorted. 
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In all cell purifications, PI or DAPI was added shortly before sorting the cells to discriminate 
between viable and dead cells. Only PI / DAPI negative, i.e. viable cells were collected. Cells 
were maintained on ice, enriched by MACS at 4°C and sorted into tubes containing cold 
PBS, 0.1% BSA to avoid activation of the cells. At least 5x105 cells were isolated by FACS 
sorting and further used for microarray analysis. FACS sorts 
were repeated 4 times and duplicate samples of each sorted cell 
type were used for two independent microarray studies.  
After sorting NK cells, conventional CD4+ T cells, Treg cells and 
NKT cells, cells were centrifuged and resuspended in TRIzol® to 
avoid RNA degradation and samples were stored in liquid 
nitrogen. Cells were thawed and further processed for total RNA 
isolation as described in section 4.3.1. The amount of RNA was 
determined by OD260/280nm measurement and total RNA was 
purified by an RNA isolation kit (RNeasy; Qiagen). The RNA 
integrity and the amount of total RNA was measured with a 
Bioanalyzer 2100 (Agilent Technologies) (Figure 9).  
RNA was purified and analyzed from all sorted populations and 
characteristic bands for 28s and 18s RNA were detected. RNA 
amounts were in the range of 6 ng/µl to 175 ng/µl. The RNA of 
the isolated cell populations were labeled with Cy5 or Cy3 and 
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Figure 9: RNA isolated from 
FACS sorted cells of C57BL/6 
mice. RNA bands for 28s and 
18s RNA are marked. 
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Figure 8: FACS sort of murine CD4+ T cells from C75BL/6 mice. Upper row: unsorted spleen cells with sorting gates and 
dot blot of unsorted T cells. Lower row: (left) sorted CD4+ CD25- T cells and (right) sorted CD4+CD25+ T cells. Cells were 
stained with antibodies against CD3, CD4 and CD25. T cells were sorted as CD3+, CD4+ and CD25- or CD25+ cells. 
Percentages of positive cells are indicated in the quadrants. Dead cells were excluded by PI staining and only viable 
cells were sorted. 
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hybridized to Agilent custom made microarrays that contained oligonucleotide probes 
representing 8013 different gene sequences predicted to be involved in immunologic 
processes. The hybridization was repeated on a second array with the technique of “color 
swap” of the dye-labels to exclude artefacts due to labeling effects and to minimize errors. 
After measurement of spot-color and intensity on both arrays, data were analyzed using the 
Rosetta Inpharmatics Resolver software. Significantly up- and downregulated genes were 
selected for each cell type by correlating the ratio between the two colors of each measured 
sample from the first array with the ratio of the same sample in the second array where the 
dy-colors were swapped (Figure 10). 
Only anticorrelated genes were considered to be differentially regulated in the analysis of 
gene expression of the different cell types. Namely, those genes that were Cy5 positive in 
the first array and Cy3 positive with a similar intensity in the second array. The Resolver 
software calculates the probability value from a variety of internal controls, including the 
degree of anticorrelation for each measured ratio. This P value reflects the reliability of the 
measured data in the same way as P values for significances do. 
 
To exclude erroneous detection of genes and to make microarray results more reliable, two 
independent microarray analyses were performed. For the first comparative analysis, RNA 
from NKT cells, according to the initial sorting parameters, was used. For the second 
analysis, RNA of cells, depleted of B cells, macrophages, DCs and CD8+ T cells was used. 
NKT cell RNA was used as reference RNA, i.e. gene expression levels found in other cells 
were related to the levels detected in NKT cells. Therefore, genes are considered 
upregulated when their expression level is increased compared to NKT cells and 
downregulated when the expression level is lower in other cells, i.e. upregulated in NKT 
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Figure 10: Correlation blots of Log(10) ratios deducted from 2 independent hybridizations of Cy5 and Cy3 labeled RNA 
isolated from NKT cells, NK cells, CD4+CD25- and CD4+CD25+ T cells. Significantly different ratios were anticorrelated 
between the 2 hybridizations and are depicted in purple. Ratios depicted in blue were unchanged between both 
hybridizations and red or green ratios were only present in 1 of the 2 hybridizations.  
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cells. Only genes with P values <0,05 and a minimum of 2 fold difference are considered to 
be significantly regulated. 
 
In the first microarray analysis, 778 genes were found to be differentially regulated between 
NKT cells and NK cells, conventional CD4+ T cells and Treg cells (Figure 11). Of these, 121 
genes were found higher or lower expressed within all cell types compared to NKT cells. 
Four hundred-thirteen genes were detected to be upregulated in other cells, i.e. 
downregulated in NKT cells. Amongst these 413 genes, 10 genes showed an increased 
expression in all other cell types compared to NKT cells.  
A union of 440 genes with decreased expression levels in NK cells, conventional CD4+ T 
cells or Treg cells, i.e. higher expression in NKT cells, was detected. Sixty-two 62 of these 
genes were downregulated in NK cells, conventional CD4+ T cells and Treg cells, describing 
a set of genes, uniquely upregulated in NKT cells. 
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Figure 11: Venn diagram of microarray analysis of NKT cells compared with NK cells, CD4+CD25- and CD4+CD25+ cells 
from spleen of C57BL/6 mice. NKT cell RNA was used as the basis for gene expression profiling. The figure summarizes 
genes that are differentially expressed in the cell types described. Upregulated genes: upregulated in all other cell types 
compared to NKT cells. Downregulated genes: downregulated in all other cell types compared to NKT cells, i.e. upregulated 
genes in NKT cells. Numbers indicate the number of genes. Union: Number of all genes regulated. 
Results 
 
46 
 
The second microarray analysis detected 1,164 genes differentially expressed between the 
analyzed cell types with 135 genes up- or downregulated collectively within compared 
populations. Seven hundred thirty-two genes with higher expression in NK cells, conventional 
CD4+ T cells or Treg cells were identified. Of these, 58 genes showed increased expression 
in all cell types compared to NKT cells. The number of genes with decreased expression in 
NK cells, conventional CD4+ T cells or Treg cells compared to NKT cells was 476 with 50 
genes being downregulated in NKT cells (Figure 11).Only genes up- or downregulated in 
both microarray comparisons were considered as verified using two independent microarray 
analyses. These genes were used for further investigation.  
 
5.1.2 Unique gene expression of NKT cells 
Two hundred thirty-eight genes, containing 107 ESTs, were found with increased expression 
in both arrays in NK cells, conventional CD4+ T cells or Treg cells compared to NKT cells. 
One hundred ninety-two genes were detected with a decreased expression in conventional 
CD4+ T cells or Treg cells. Eighty-seven of these genes were ESTs. Only 6 genes were 
upregulated in all cell types in both arrays, i.e. downregulated in NKT cells. In comparison, 
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Figure 11 continued: Venn diagram of microarray analysis of NKT cells compared with NK cells, CD4+CD25- and 
CD4+CD25+ cells from spleen of C57BL/6 mice. NKT cell RNA was used as the basis for gene expression profiling. The 
figure summarizes genes that are differentially expressed in the cell types described. Upregulated genes: upregulated in all 
other cell types compared to NKT cells. Downregulated genes: downregulated in all other cell types compared to NKT cells, 
i.e. upregulated genes in NKT cells. Numbers indicate the number of genes. Union: Number of all genes regulated. 
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20 genes with lower expression levels in all other cells compared to NKT cells were identified 
in both arrays. These genes describe a group of genes upregulated uniquely in NKT cells. 
 
Genes with lower expression levels in NK cells, conventional CD4+ T cells and Treg cells 
were of major interest. They resemble genes that could be exclusively expressed in NKT 
cells or show a NKT cell specific expression pattern. A high proportion of these genes code 
for cytokines and chemokines or cytokine- and chemokine-receptors. Some of these genes 
were already described in the context of NKT cells, like IL-12 receptor β1, CXCR3 and 
integrin-α4β1 (VLA-4) (Franitza et al., 2004; Kim et al., 2002; Kitamura et al., 1999). The IL-
12 receptor-β1 binds to IL-12 which is a pro-inflammatory cytokine (Zhang et al., 2003) and 
CXCR3 binds to interferon-inducible CXC chemokines IP-10, MIG, and I-TAC and is a 
chemokine receptor for homing to non-lymphoid tissue (Tamaru et al., 1998; Xie et al., 2003). 
Integrin-α4β1 is involved in lymphopoiesis and inflammatory recruitment of leukocytes 
(Rivera-Nieves et al., 2005). The other genes, significantly expressed by NKT cells have not 
previously been attributed to this T cell subset. Among these genes are BLK, CCR3, DAO1, 
IL-17 receptor B and LIGHT. BLK belongs to the family of Bcl-2 proteins, which regulate 
programmed cell death. BLK is pro-apoptotic and essential for initiation of programmed cell 
death and stress-induced apoptosis (Coultas et al., 2004; Hegde et al., 1998). BLK was 
found in hematopoietic cell types but so far not associated with NKT cells. Microarray 
analysis detected BLK as 11 fold, 5 fold and 3 fold upregulated in NKT cells compared to all 
other cell types. The chemokine receptor CCR3 is expressed on eosinophils and Th2 cells 
and binds a variety of chemokines including RANTES and eotaxin (Lamkhioued et al., 2003). 
It was detected with a 14 fold higher expression in NKT cells compared to NK cells, 2.5 fold 
to conventional CD4+ T cells and 5 fold to Treg cells. The IL-17 receptor-B binds IL-17 which 
is produced by T cells after activation. IL-17 has pro-inflammatory capacities both directly 
and by amplifying effects of IL-1β and TNFα and is able to induce production of pro-
inflammatory cytokines. IL-17 can also induce matrix metalloproteinases (MMPs) (Stamp et 
al., 2004). The IL-17 receptor-B was 15 fold, 7 fold and 7 fold upregulated in NKT cells 
compared to NK cells, conventional CD4+ T cells and Treg cells, respectively. Further genes 
were DAO1, which performs oxidative deamination of neutral D-amino acids and whose 
function for T cell activity is not known (Konno et al., 1993). LIGHT is a member of the TNF 
family with co-stimulatory capacities in the context of TCR signaling (Shi et al., 2002). MMP9 
is important in tissue remodeling, recruitment of leukocytes to sites of inflammation and in 
processing of cytokines (Odaka et al., 2005).RORA is a member of the steroid hormone 
nuclear receptor superfamily and can bind melatonin which activates IL-2 production 
(Guerrero et al., 2000). 
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Genes with decreased expression levels in NKT cells included caspase 1, caspase 11, 
integrin- α4β1, L-selectin, KLF2 and vimentin. L-selectin showed the strongest 
downregulation with 13 fold, 10 fold and 10 fold in NKT cells compared to NK cells, 
conventional CD4+ T cells and Treg cells, respectively (Table 2). 
 
 
Caspase 1 cleaves the pro-inflammatory cytokines pro-IL-1β and pro-IL-18 to mature 
cytokines and has pro-apoptotic capacities (Shi, 2002; Pirhonen et al., 1999). Caspase 11 is 
a mediator of septic shock response and induced in most cells upon pro-inflammatory stimuli 
(Kang et al., 2002). Integrin-α4β1 and L-selectin are both important in cell migration. Integrin-
α4β1 plays a role in lymphopoiesis and inflammatory recruitment of leukocytes (Rivera-
Nieves et al., 2005). L-selectin is important for trafficking of lymphocytes to lymph nodes 
(Galkina et al., 2003). Vimentin is required for lymphocyte rigidity and involved in 
transendothelial migration (Brown et al., 2001), whereas KLF2, a transcription factor involved 
in cell regulation during inflammation is also anti-proliferative and a pro-survival factor (Lin et 
al., 2003; SenBanerjee et al., 2004; Wu and Lingrel, 2004). Genes in table 2 depict the most 
Table 2: Genes uniquely regulated in NKT cells 
Fold difference between mRNA levels 
of NK cells, CD4+CD25- and 
CD4+CD25+ T cells vs. NKT cells 
NK cells CD4+CD25- CD4+CD25+ 
Sequence 
name 
NCBI 
Accession 
number 
Gene 
-10.54 -4.77 -3.05 Biklk NM_007546 Bcl2-interacting killer-like = 
Blk 
-13.88 -2.46 -4.99 Cmkbr1l2 NM_009914 chemokine receptor 3 (CCR3) 
-3.20 -4.09 -3.33 Cmkar3 NM_009910 chemokine receptor 3 
(CXCR3) 
-7.32 -2.30 -4.63 Dao1 NM_010018 D-amino acid oxidase = 
DAO1 
-14.69 -6.96 -7.32 Il17br NM_019583 IL-17 receptor B 
-3.48 -3.12 -6.43 Il12rb1 NM_008353 interleukin 12 receptor-β1 
-2.10 -2.08 -4.07 Tnfsf14 NM_019418 LIGHT 
-5.47 -3.80 -5.74 Mmp9 NM_013599 matrix metalloproteinase 9 
(MMP-9) 
-7.16 -3.09 -3.41 AW045613 AW045613 RORA / RZR = RAR-related 
orphan receptor α 
8.71 2.63 2.87 Casp1 NM_009807 caspase 1 
4.46 3.17 3.30 Casp11 NM_007609 caspase 11 
7.81 2.54 3.22 Itga4 NM_010576 Integrin-α4β1 / VLA-4 
4.44 3.54 3.94 Klf2 NM_008452 Kruppel-like factor 2 (KLF2) 
13.37 9.86 9.73 Sell NM_011346 L-selectin 
6.04 5.03 3.72 Vim NM_011701 vimentin 
Genes that were up and downregulated in NKT cells compared to NK cells, conventional CD4+ T cells and Treg cells are 
shown. Data were obtained by microarray analysis as described in section 3.3.4. Depicted are: fold differences of genes 
found in 2 independent microarray analysis, sequence name, NCBI accession number and name of the gene. Genes in black 
color are downregulated uniquely in all cell types compared to NKT cells, i.e. upregulated in NKT cells. Genes depicted in 
blue are upregulated uniquely in all cell types compared to NKT cells, i.e. downregulated in NKT cells. Only genes with P 
values <0.05 and a minimum of 2 fold difference are shown 
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prominent genes up- or downregulated in NK cells, conventional CD4+ T cells and Treg cells 
compared with NKT cell expression levels. These genes describe what could be a unique 
gene expression profile of NKT cells; either displaying genes only expressed in NKT cells or 
being significantly more up- or downregulated in comparison to other cells.  
 
5.1.3 Genes with expression levels shared by NK cells, conventional 
CD4+ T cells or Treg cells and NKT cells 
Table 3 depicts some of the most prominent and interesting genes found with an increased 
or decreased expression in NKT cells in comparison to one or more cell types examined in 
these assays. These genes represent those which are not unique for NKT cells but are rather 
shared with NK cells, conventional CD4+ T cells and Treg cells. For instance, genes with high 
expression levels in NKT cells and NK cells, but not in CD4+ T cells are attributable to innate 
immunity-like properties of NKT cells. 
 
Genes upregulated in NK cells, but downregulated in CD4+ T cells compared to NKT cells 
were: Annexin A1, RANTES, CCL6 and NKG2D. Genes similarly expressed in NK and NKT 
cells but with clearly lower expression to CD4+ T cells were: ATAC, CCR2, CXCR4, FasL, 
LFA-1 (integrin-αL), IFNγ and L-CCR. Similar expression levels for NK and NKT cells, but 
increased expression in CD4+ T cells were detected for: CD30, integrin-α6 and OX40. 
Comparable gene expression between NKT cells and CD4+ T cells was found for the 
following genes: CD6, IGTP, IL-4 receptor, IL-7 receptor and IL-15. With the exception of IL-
15, which was upregulated in NK cells over NKT cells, CD6, IGT, IL-4 receptor and IL-7 
receptor were similarly expressed in NKT cells and CD4+ T cells but downregulated in NK 
cells. Type II IL-1 receptor expression was increased in conventional CD4+ T cells and 
unchanged in NK cells and Treg cells. Upregulation in Treg cells and similar expression in 
NK cells and conventional CD4+ T cells compared to NKT cells was found for the IL-2 
receptor gene. TLR4 was expressed stronger in NK cells, similar in conventional CD4+ T 
cells and less in Treg cells. 
 
Expression of lymphotactin, CCL5, CCR2, CXCR4, FasL, LFA-1, IFNγ, NKG2D and 
granzyme B were already described for NKT cells (Emoto et al., 1999a; Faunce and Stein-
Streilein, 2002; Gumperz et al., 2002; Kennedy et al., 2000; Kim et al., 2002; Leite-de-
Moraes et al., 2000; Matsuda et al., 2002; Metelitsa et al., 2003). Expression of CD30 was 
described for a NKT cell lymphoma (Tao et al., 2002). 
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Expression of IL-2 receptor, IL-4 receptor and IL-7 receptor has not been specifically 
demonstrated for NKT cells. However, IL-2 receptor is expressed on activated T and B cells 
as well as on NK cells (Smith, 1989) and IL-4 receptor is expressed on hemopoietic and 
nonhemopoietic cells (Lowenthal et al., 1988). IL-7 receptor is important for T-cell 
development from hematopoietic stem cells and present in thymocytes (Akashi et al., 1998; 
Di Santo and Rodewald, 1998). 
 
 
Genes, thus far not attributed to NKT cells are annexin A1, CCL6, CD6, IGTP, L-CCR, 
integrin-α6, IL-1 receptor, type II and OX40. OX40 is a co-stimulatory molecule and 
necessary for ongoing cell survival after antigen stimulation (Bansal-Pakala et al., 2004). 
Annexin A1 is an inflammatory mediator which acts in an autocrine/paracrine way to limit 
leukocyte infiltration into inflamed tissue sites (Perretti and Gavins, 2003). CCL6 is a 
chemotactic agent for monocytes, macrophages and, to a lesser extent, CD4+ T cells and 
Table 3: Gene expression levels of NK cells, CD4+CD25- and CD4+CD25+ T cells compared to NKT cells 
Fold difference between mRNA levels 
of NK cells, CD4+CD25- and 
CD4+CD25+ T cells vs. NKT cells 
NK cells CD4+CD25- CD4+CD25+ 
Sequence 
name 
NCBI 
Accession 
number 
Gene 
3.77 -3.96 -5.65 Anxa1 NM_010730 annexin A1  
0.60 -8.97 -10.40 Scyc1 NM_008510 ATAC / Lymphotactin 
5.10 -10.55 -5.55 Scya5 NM_013653 CCL5 / RANTES 
3.81 -5.95 -8.83 Scya6 NM_009139 C10 / CCL6 
-6.27 1.50 1.63 Cd6 NM_009852 CD6 
1.59 -4.41 -6.38 Cmkbr2 NM_009915 chemokine receptor 2 (CCR2) 
1.28 -2.94 -2.02 Sdfr1 NM_009145 CXCR4 (stromal cell derived 
factor receptor 1) 
-1.03 -12.45 -7.06 Tnfsf6 NM_010177 Fas ligand (FasL) 
-0.02 -3.59 -2.44 Itgal M60778 LFA-1 (integrin-αL) 
1.33 -4.89 -2.47 Ifng M28621 IFNγ 
-2.92 -0.03 -1.08 Igtp NM_018738 IFNγ induced GTPase (IGTP) 
-1.12 -1.29 -2.73 Il2rb NM_008368 interleukin 2 receptor 
-2.84 0.09 0.18 Il4ra NM_010557 interleukin 4 receptor 
-6.04 -1.59 0.15 Il7r NM_008372 interleukin 7 receptor 
-1.27 -2.07 -4.17 L-CCR NM_017466 L-CCR (LPS inducible C-C 
chemokine receptor) 
5.04 -5.49 -4.85 D6H12S2489E AF039026 NKG2D 
0.68 3.20 6.72 Tnfsf8 NM_009403 CD30 
10.49 1.85 -2.12 Gzmb NM_013542 granzyme B 
0.20 2.85 3.38 Itga6 NM_008397 Integrin-α6 
-1.77 5.29 1.64 AV224004 AV224004 Interleukin 1 receptor, type II 
4.02 -0.56 -0.10 Il15 NM_008357 interleukin 15 
0.60 5.79 2.19 Tnfrsf4 NM_011659 OX40 / CD134 
5.28 -1.67 -2.40 Tlr4 NM_021297 toll-like receptor 4 
Genes that were up and downregulated in NKT cells compared to NK cells, conventional CD4+ T cells or Treg cells are 
shown. Data were obtained by microarray analysis as described in section 3.3.4. Depicted are: fold differences of genes 
found in 2 independent microarray analysis, sequence name, NCBI accession number and name of the gene. Negative 
values show downregulation in the respective cell type compared to NKT cells and positive values upregulation, i.e. 
downregulation in NKT cells. Only genes with P values <0.05 are shown and only genes with a minimum of 2 fold difference 
in expression levels are considered to be regulated. 
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eosinophils (Berger et al., 1996). The LPS-inducible CC chemokine receptor (L-CCR) is an 
orphan chemokine receptor that was recently identified in macrophages and could be 
important in the early phase to inflammation (Oostendorp et al., 2004). CD6 is a co-
stimulatory protein for immature thymocytes and could promote thymocyte survival (Singer 
2002). IL-1 receptor, type II is a decoy receptor for it’s ligand IL-1β and lacks the 
cytoplasmatic signaling part. Thus, expression reduces IL-1β signaling (Dower et al., 1994). 
IGTP is a member of the 47kDa GTPase protein family and probably involved in defense 
against bacterial infection (Butcher et al., 2005; Kaiser et al., 2004) whereas Integrin-α6 is 
important in cell adhesion and migration (Chung et al., 2004).  
 
Microarray results were confirmed by RT-PCR for the following genes: BLK, CCR3, IL-17 
receptor B, KL2, L-selectin, ATAC, FasL and CCL5.  
 
Furthermore, FACS analysis was performed to examine expression of genes, upregulated in 
NKT cells. Vα14Jα18 transgenic (tg) mice were used since they possess approximately 3 
times more NKT cells than C57BL/6 mice, thus fascilitating FACS analysis of NKT cells. 
Spleen cells were stained with anti-NK1.1, anti-CD3, anti-CD4, anti-CD25, anti-CD11a (LFA-
1), anti-FasL, anti-CXCR4 antibodies and αGalCer-CD1d tetramer. Surface expression of 
LFA-1, FasL and CXCR4 was analyzed.  
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Figure 12: Spleen NKT and CD4+ cells of Vα14Jα18 tg mice were stained for surface expression of LFA-1, FasL and 
CXCR4. NKT cells were detected with antibodies against NK1.1 and CD3 and with αGalCer-CD1d tetramer. CD4+ T cells 
were detected with anti-CD4 and anti-CD25 antibodies. a) Spleen cells gated for NK1.1 expression and analyzed for 
expression of LFA-1 and for the invariant NKT cell TCR. b) Spleen cells gated for the expression of FasL or CXCR4. FasL 
and CXCR4 expressing NKT cells were detected with anti-NK1.1 antibody and αGalCer-CD1d tetramer (upper row). FasL 
and CXCR4 expressing CD4 T cells were detected by anti-CD4 and anti-CD25 antibody (lower row). Percentages of 
positive cells are indicated in the quadrants. Dead cells were excluded by PI staining and only viable cells were sorted. 
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Twenty-one % of NKT cells expressed LFA-1 on their surface and 1.47 % were positive for 
FasL expression. Moreover, 2.56 % NKT cells were stained positive for CXCR4 expression. 
In comparison, 0.15 % Treg cells and 2.29 % conventional CD4+ T cells were positive for 
FasL expression. CXCR4 cell surface expression was detected for 1.11 % conventional 
CD4+ T cells and for 0.08% Treg cells (Figure 12). Thus, data obtained by microarray 
analysis could be verified by FACS analysis. 
 
5.1.4 Transcriptome analysis of naïve NKT cells vs. activated NKT cells 
NKT cells recognize and get activated by lipid antigens presented in the context of CD1d. 
NKT cells fulfill a variety of diverse functions, however it is not known what mechanisms 
underlie NKT cell activation and which genes are expressed upon activation.  
 
To detect genes, expressed in activated NKT cells and to define an expression profile, RNA 
of activated NKT cells was compared to RNA from naïve, non-activated NKT cells. To 
specifically activate NKT cells 2 µg/mouse of αGalCer was injected i.v. into the base of the 
tail of C57BL/6 mice. Since NKT cells get rapidly activated after αGalCer administration mice 
were sacrificed 1 h after injection (Fujii et al., 2003; Lisbonne et al., 2004). Splenic NKT cells 
were purified as described above by depletion of B cells, macrophages, DCs and CD8+ T 
cells by MACS. Subsequently, NKT cells were positively selected using FACS sorting. The 
purity of the sorted populations was confirmed by FACS analysis. Activated NKT cells were ≥ 
91 % and naïve, non-stimulated NKT cells were ≥ 92 % pure. RNA was isolated, analysed for 
28s and 18s RNA peaks and quantified. The amount of RNA was in the range of 10 ng/µl for 
activated and naïve NKT cells. The RNA of isolated cell populations were labeled with Cy5 or 
Cy3, respectively and hybridized to Agilent custom made microarrays, as described above. 
Data were analyzed using the Rosetta 
Inpharmatics Resolver software. 
Significantly up- and downregulated 
genes were selected for naïve and 
activated NKT cells by correlating the 
ratio between the two colors of each 
measured sample from one array with 
the ratio of the same sample in the 
colorswaped second array. In order to 
verify transcriptome analysis, injection of 
αGalCer i.v. into C57BL/6 mice was 
repeated, RNA was isolated and 
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Figure 13: Correlation blots of Log(10) ratios deducted from 2 
independent hybridizations of Cy5 and Cy3 labeled RNA 
isolated from naïve and activated NKT cells. Significantly 
different ratios were anticorrelated between the 2 hybridizations 
and are depicted in purple. Ratios depicted in blue were 
unchanged between both hybridizations and red or green ratios 
were only present in one of the two hybridizations 
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microarray analysis was performed to compare the 2 microarray analysis with each other. 
Only genes differentially regulated in both arrays were further used to analyze the gene 
expression profile of activated vs. naïve NKT cells (Figure 13). RNA of naïve NKT cells was 
used as reference to analyze gene expression of activated NKT cells.  
One hundred forty-two genes were found in total in the different arrays with 38 genes 
upregulated and 3 genes downregulated in αGalCer-activated NKT cells in both comparisons 
(Table 4). Interleukin 16, MHC class I (H-2K) and NKR-P1C showed 2 fold lower expression 
in activated NKT cells. IL-16 is a T cell chemotactic factor and protects against apoptosis 
(Wilson et al., 2004). MHC class I is involved in antigen presentation (Kaufmann and 
Schaible, 2005; Lehner and Cresswell, 2004). NKR-P1C is a marker for NK and NKT cells, 
also known as NK1.1, and downregulation is known for NKT cells (Ljutic et al., 2005; Wilson 
et al., 2003). 
 
 
 
 
Table 4: Genes upregulated in activated NKT cells 
Fold difference between 
mRNA levels of naïve and 
activated NKT cells 
Sequence 
name 
NCBI Accession 
number 
Gene 
4.04 Scyc1 NM_008510 ATAC / Lymphotactin 
18.48 Egr1 NM_007913 early growth response 1 
transcriptional factor (EGR1) 
8.05 Csf2 X03019 GM-CSF 
15.53 Ifng M28621 IFNγ 
28.66 Il13 NM_008355 interleukin 13 
3.37 Il17 NM_010552 interleukin 17 
4.83 Il2 NM_008366 interleukin 2 
9.70 Il4 NM_021283 interleukin 4 
2.48 L-CCR NM_017466 L-CCR 
4.00 Tnfsf14 NM_019418 LIGHT 
4.55 Scya3 NM_011337 MIP-1 α 
7.98 Scya4 NM_013652 MIP-1 β 
4.45 Map3k8 NM_007746 mitogen activated protein kinase 
kinase kinase 8 = Map3K8 
6.89 Myd118 NM_008655 MyD118 / Gadd45 
5.70 Myc NM_010849 myelocytomatosis oncogene c-
Myc 
5.86 Nr4a1 NM_010444 nuclear receptor/immediate-early 
gene Nurr77 
12.05 Tnf NM_013693 tumour necrosis factor / TNF 
-2.04 Il16 NM_010551 interleukin 16 
-2.27 LOC56628 NM_019909 MHC class I antigen (H-2K) 
-2.15 Ly55c NM_008527 NK1.1 / NKR-P1C 
Genes that were up and downregulated upon i.v. injection of αGalCer to stimulate NKT cells are shown. Genes were 
upregulated in splenic C57BL/6 mice NKT cells. Data were obtained by microarray analysis as described in section 4.3.4. 
Depicted are fold differences of genes found in 2 independent microarray analyses, name of the gene and NCBI accession 
number. Genes depicted in black are upregulated, genes depicted in blue are downregulated in activated NKT cells. Only 
genes with P values <0.05 are shown.  
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Genes with increased expression levels can be classified into two groups. One group 
consists of cytokines and chemokines with immuno-stimulating and -regulation properties. 
IFNγ, IL-13 and TNF were the most significantly upregulated genes, showing 15 fold, 28 fold 
and 12 fold stronger gene expression in activated NKT cells, respectively. GM-CSF was 
detected with an 8 fold increased expression and IL-4 exhibited a 9 fold upregulation. ATAC 
and IL-17 exhibited a 4 fold and 3 fold increased expression, respectively. GM-CSF is a 
major growth and differentiation factor and activates cells of the immune system to react on 
infections (Krutzik et al., 2005; Zhang et al., 1999). IL-4 is the main Th2 cytokine (Olofsson, 
1991). ATAC is a chemokine attractant mainly produced by CD8+ T cells and NK cells 
(Dorner et al., 2002). IL-17 is mainly produced by CD4+ T cells and induces production of IL-
6 and IL-8 (Stamp et al., 2004). Moreover, genes for IL-2, L-CCR, LIGHT, MIP-1α and MIP-
1β showed stronger expression levels in activated NKT cells. The other group of genes 
upregulated in NKT cells after stimulation is composed of signal transduction molecules, 
transcription factors and early response genes. EGR1 (early growth response 1 
transcriptional factor) is rapidly induced by after activation to transduce the proliferative 
signal and is anti-apoptotic (Adamson and Mercola, 2002). It showed 18 fold upregulated in 
activated NKT cells. Map3K8, which is part of the Map Kinase signaling pathway triggered by 
growth factors and cytokines (Beinke et al., 2004), exhibits a 4 fold increased expression. 
Gadd45, (MyD118), is anti-apoptotic, involved in growth arrest and cell cycle control (Mak 
and Kultz, 2004) and was upregulated 7 fold. Moreover, c-Myc, expressed in proliferating 
cells and important in controlling proliferation, differentiation and apoptosis (Brunner and 
Martin, 2004) had 6 fold increased expression levels. Nurr77 was detected with a 6 fold 
higher expression. It is rapidly induced by various stress stimuli, including TNF and involved 
in regulation of apoptosis (Rajpal et al., 2003) (Table 4).  
 
RT-PCR was performed for IFNγ, IL-13, IL-17 to validate results from gene expression 
profiling of activated NKT cells.  
 
FACS analysis was performed to detect TNFα, IL-4 and IFNγ production by NKT cells after 
stimulation. Two µg/mouse of αGalCer was injected i.v. into the base of the tail of Vα14Jα18 
tg mice. After 2 h, mice were sacrificed and spleens were removed. Spleen cells were 
analyzed for intracellular expression of TNFα, IFNγ and IL-4. Cells were stained with anti-
NK1.1, anti-TNFα, anti-IFNγ, anti-IL-4 antibodies and αGalCer-CD1d tetramer (Figure 14). 
To analyze NKT cells for TNFα expression, spleen cells were gated for TNFα expression. 
TNFα-positive cells were analyzed for surface coexpression of NK1.1 and the NKT cell TCR. 
Nine % of naïve NKT cells were positive for TNFα production. In contrast, activation by 
αGalCer increased TNFα producing NKT cell numbers to 14.97 % (Figure 14). IFNγ and IL-4 
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production by NKT cells was detected by gating spleen cells for NK1.1 expression. NKT cells 
were identified by αGalCer-CD1d tetramer and analyzed for intracellular expression of IFNγ 
or IL-4. Thirteen % naïve NKT cells were positive for IFNγ and 10.99 % for IL-4 showing 
strong IFNγ and IL-4 presence in naïve NKT cells. Following 2 h of αGalCer treatment, 30.89 
% NKT cells were positive for IFNγ and 25.18 % for IL-4. FACS analysis of TNFα, IL-4 and 
IFNγ in naïve and activated NKT cells showed elevated levels of these cytokines even in 
naïve mice. After 2 h of stimulation with αGalCer, strong induction of these cytokines was 
detected by intracellular cytokine staining (Figure 14). 
 
Results obtained from microarray analysis indicate that NKT cells possess the ability to 
respond to and produce various cytokines and respond strongly and rapidly on TCR 
stimulation.  
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Figure 14: Spleen NKT cells of naïve and αGalCer treated Vα14Jα18 tg mice were stained for intracellular expression 
of TNFα, IFNγ and IL-4. NKT cells were detected with antibody against NK1.1 and with αGalCer-CD1d tetramer. a) 
Spleen cells gated for TNFα expression and analyzed for expression of NK1.1 and invariant NKT cell TCR. b) Spleen 
cells gated for the expression of NK1.1. IFNγ and IL-4 expressing NKT cells were detected with antibodies against 
IFNγ or IL-4 and αGalCer-CD1d tetramer. Upper row: spleen cells of naïve mice; lower row: spleen cells of αGalCer 
treated mice. Percentages of positive cells are indicated in the quadrants. Dead cells were excluded by PI staining 
and only viable cells were sorted. 
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5.2 Endogenous NKT cell lipid ligands 
The best described antigen for NKT cells is αGalCer, a glycosphingolipid derived from the 
marine sponge Agelas mauritianus. It is a surrogate antigen with unclear physiological 
relevance. In most studies of NKT cell function, NKT cells have been stimulated with 
αGalCer and investigated by αGalCer-CD1d tetramers. The galactose moiety of αGalCer is 
attached by an α-glycosidic linkage at C1 of the galactose to the ceramide moiety (Figure 
15). This α-configuration is rarely found in mammalian organisms. A terminal α1→3 linked 
galactose or n-acetyl-galactose 
sugar residue were detected for 
oligosaccharide antigens such 
as blood groups A and B, the 
xeno-antigen, the Forssman 
antigen, and the iso-globoside 3 
(iGb3) glycolipid (Heissigerova et 
al., 2003). Most mammalian 
glycolipids consist of β-linkages 
between glucose or galactose 
residues and the lipid part of 
glycolipids.  
 
Mature NKT cells display a low-
level autoreactivity suggesting 
the presence of an unknown 
endogenous CD1d restricted 
antigen presented continuously 
on the surface of APCs (Brigl et al., 2003). Globotrihexosylceramide (Gb3), a neutral 
glycosphingolipid of the globoside series possesses structural similarity to αGalCer in terms 
of the α-configuration of the sugar-lipid linkage. Gb3 is ubiquitous in mammalian organisms. 
It is a cleavage product of Gb4, degraded within in the lysosome by αGalactosidase A 
(αGalA) finally yielding galactose and lactosylceramid. 
 
To test whether Gb3 is the endogenous antigen which is recognized by NKT cells and leads 
to TCR mediated activation, T cell stimulation assays were performed. Murine A20 cells 
transfected with CD1d and parental A20 cells, were incubated with αGalCer, ConA, Gb3 and 
lactosylceramide. After 3 h, NKT cells from Vα14Jα18 tg mice were added and cytokines 
were measured after 24 h. Lipids were dissolved in DMSO and DMSO alone was used as 
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Figure 15: a) Structures of αGalCer, Gb3, iGb3 and lactosylceramide.  
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negative control. αGalCer and ConA 
were used as positive control antigens 
since they induce strong production of 
IFNγ and IL-4 by NKT cells (Figure 16). 
DMSO and lactosylceramide did not 
elicit induction of NKT cells measurable 
by IFNγ or IL-4 production (Figure 16). 
This was expected, since 
lactosylceramide lacks the terminal 
galactose in α-configuration. However, 
Gb3 could not stimulate primary murine 
NKT cells (Figure 16) This result shows 
that Gb3 is not recognized by NKT cells 
and is therefore not the endogenous 
ligand. 
 
 
5.2.1 iGb3: the endogenous NKT cell antigen 
iGb3, the isoform of Gb3, was recently described as the endogenous NKT cell ligand. iGb3 
elicits a potent NKT cell response and is necessary for NKT cell development (Zhou et al., 
2004). Gb3 and iGb3 differ only in the position that the terminal galactose residue is attached 
to. Gb4 possesses a terminal 1→4 linked galactose, whereas the terminal galactose of iGb3 
is attached in a 1→3 linkage (Figure 15). 
To examine NKT cell responses to iGb3 more closely, αGalA deficient cells, deficient in iGb3 
degradation, from patients with Fabry disease were compared to cells from healthy donors. 
Blood samples from Fabry patients were obtained in collaboration with Professor Dr. Michael 
Beck, University Children's Hospital of the University of Mainz.  
DCs derived from PBMCs of Fabry patients and healthy donors were incubated with a 
polyclonal human NKT cell line. This experimental set up provides the opportunity to closely 
monitor DC - NKT cell interactions and examine effects of antigen availability and control of 
NKT cell activation. Immature DCs were generated from blood of Fabry patients or healthy 
donors. DCs were incubated either with iGb3 (10 µg/ml) or with CD40L, for 5 h to see 
whether DCs are able to present iGb3 and stimulate NKT cells. CD40L induces maturation of 
immature DCs to mature DCs, leading to an increased presentation of antigens on the cell 
surface (Fujii et al., 2004). NKT cells from a polyclonal human NKT cell line were added and 
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Figure 16: IFNγ production of murine NKT cells of Vα14 tg mice 
incubated with different antigens at 1 µg/ml. A20-CD1d and A20 
APCs were loaded with lipids, splenic T cells from Vα14Jα281 tg 
mice were added, and IFNγ was determined 24 h later. Data are 
expressed as the mean IFNγ concentration, +/- SD of triplicates. 
One of three experiments is shown. 
Results 
 
58 
incubated for 24 h. Proliferation and cytokine production was measured by [3H] thymidine 
incorporation and ELISA, respectively. 
  
iGb3 presented by DCs from healthy individuals induced substantial IFNγ and IL-4 production 
(Figure 17) and proliferation. CD40L-matured DCs did not induce significantly more cytokine 
production (Figure 17) than the DMSO negative control. Rather, Fabry DCs failed to provoke 
iGb3 induced production of cytokines by NKT cells (Figure 17). However, addition of CD40L 
caused an increase in IFNγ production by NKT cells compared to DMSO. αGalCer and ConA 
were used as positive controls. The lack of cytokine production by iGb3 in Fabry patient 
derived DCs could not be explained at this point. Nevertheless, this result indicates a 
mechanism of NKT cell activation-control by antigen availability. CD40L induces maturation 
of immature DCs leading to increased antigen presentation, which supports this finding. 
CD40L mediated increase of IFNγ production was only detectable when DCs from Fabry 
patients were used. It should be noted that iGb3 induced cytokine production, in the 
presence of APCs generated from healthy individuals, was quite variable between different 
donors. Nevertheless, availability of antigen and antigen presentation appears crucial for the 
control of NKT cell activation. 
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Figure 17: Cytokine production of a human Vα24 NKT cell line stimulated with different antigens or CD40L in the presence of 
irradiated DCs as APCs. DCs were derived from blood of healthy donors or Fabry patients as indicated. Cytokines were 
measured by ELISA after 24 h. CD40L was added to immature DCs for 6h after incubation with antigen for 3 h and prior to 
addition of NKT cells. Data are expressed as the mean IFNγ concentration, +/- SD of triplicates. One of 3 experiments is 
shown. 
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5.2.2 iGb3 and iGb3 analogues 
Professor Dr. Peng George Wang, University of Detroit, who initially provided us with iGb3, 
chemically synthesized iGb3 analogues to test lipid antigens structurally related to iGb3 for 
their antigenic capacity. Furthermore, experiments were designed to elucidate the question 
of NKT cell activation-control in more detail. The purity of all synthesized compounds was 
confirmed by NMR and mass-spectrometry analysis. 
 
PW15 varies from iGb3 by displaying two saturated acyl chains, whereas iGb3 has a double 
bond in one acyl chain. PW16 is a precursor of αGlycosylceramide (αGlcCer) and PW17 is 
composed of the sugar moiety of iGb3 and the ceramide part of αGalCer. PW18 is 
structurally identical with PW16 but possesses a β-configuration connecting sugar to lipid 
moiety, thus being a βGlcCer precursor (Figure 18). 
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Figure 18: Structures of iGb3 (PW3) and analogues. 
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DCs from healthy donors were incubated with iGb3, PW15, PW16, PW17 and PW18 for 6 h. 
APCs were additionally preincubated for 1 h either with or without Jirmiycin, which 
specifically blocks αGalA.  
 
Furthermore, a mixture of saposin A and C was added to one well of APCs incubated with 
iGb3 1 h prior to antigen addition. Saposins are lysosomal proteins which mobilize lipids from 
lysosomal membranes and facilitate their association with CD1 molecules (Kang and 
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Figure 19: Cytokine production of a human Vα24 NKT cell line stimulated with different antigens in the presence of 
irradiated DCs.1x105 DCs and 1x105 NKT cells were used. Antigens were used at 1 µg/ml unless differently stated. 
Cytokines were measured by ELISA after 24 h. a) IFNγ production in the absence (left graph) or presence (right graph) of 
Jirimycin. b) IL-4 production in the absence (left graph) or presence (right graph) of Jirimycin. DCs were derived from blood 
of healthy donors and Fabry Patients. Jirimycin (20 µg/ml) was used to specifically block the the enzyme α-Galactosidase 
A; Saposins (Mix of Saposins A and C; 30 µg/ml). Data are expressed as the mean IFNγ concentration, +/- SD of triplicates 
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Cresswell, 2004; Winau et al., 2004). Human NKT cells from a polyclonal NKT cell line were 
added and culture supernatant was removed after 24 h and analyzed for IFNγ and IL-4 by 
ELISA. DMSO was used as the negative control and αGalCer and ConA as the positive 
controls (Figure 19).  
 
In contrast to previous observations, iGb3 used at concentrations of 1 µg/ml or 10 µg/ml did 
not induce IFNγ or IL-4 production by NKT cells. This discrepancy cannot be explained. 
PW16 and PW18 induced substantial cytokine production with PW16 being more potent than 
PW18.  
 
This result proved that DCs processed the antigens from their precursor structure to their 
biological active form, for surface presentation and NKT cell induction. PW17 induced low 
IFNγ and IL-4 production whereas PW15, similar to iGb3, did not stimulate NKT cells. 
Addition of saposins did not have any effect. Addition of Jirimycin led to an increase in 
cytokine production by NKT cell for PW17 and PW18. PW17 induced significantly more IFNγ 
and IL-4 in the presence of jirimycin. Jirimycin also enhanced PW18 induced IFNγ but not IL-
4 production (Figure 19). The increase in cytokine production induced by PW17 in the 
presence of jirimycin strongly correlates with the hypothesis that NKT cell activation is 
critically dependent on antigen availability.  
 
To measure the capacity of iGb3 and iGb3 analogues to selectively expand human NKT 
cells, PBMCs from healthy donors and Fabry patients were incubated with αGalCer, ConA, 
iGb3 and iGb3 analogues at different concentrations. After 4 days, PBMCs were analyzed 
and NKT cell numbers were examined by FACS analysis (Figure 20). Incubation of PBMCs 
with lipid antigens induced T cell stimulation as detected by the increase in numbers of T cell 
blastocysts (Figure 20 a). An increase of the NKT cell population was detected upon the 
incubation with PW17, iGb3 and αGalCer but not in the absence of antigen. Incubation of 
healthy donor PBMCs with αGalCer, ConA, PW17 and iGb3 induced a striking increase in 
NKT cell numbers (Figure 20 b). The optimal concentration of lipid antigens to stimulate NKT 
cells is 100 ng/ml (Sidobre et al., 2002). This concentration induced a strong increase in NKT 
cell numbers. Upon αGalCer stimulation, 19.49 % NKT cells were detected and 18.86 % 
NKT cells upon iGb3 stimulation. In the absence of antigen, 10.19 % NKT cells were 
detected. Both lipids were used at 100 ng/ml. Higher concentrations of iGb3, αGalCer or 
PW17 (1 - 10 µg/ml) induced strong NKT cell responses (Figure 20 b). PBMCs isolated from 
Fabry patients, showed a strikingly different response. ConA which is an unspecific T cell 
stimulus, and used as CD1d independent positive control, still increased T cell numbers to 
22.57 % compared with 12 % in the absence of antigen. After αGalCer-treatment, 11.7 % 
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NKT cells were detected and 12.36 % NKT cells after iGb3 stimulation (Figure 20 c). Thus, 
incubation of PBMCs from Fabry patients with αGalCer and iGb3, exhibited a lack of NKT 
cell response compared to healthy PBMCs. Even more striking differences were observed 
when Fabry PBMCs were incubated with higher concentrations of antigen. One µg/ml iGb3 
or αGalCer lead to a reduction of NKT cells to 8.43 % or 9.5 %, respectively. Treatment with 
10 µg/ml of iGb3 or PW17 caused a dramatic reduction of NKT cell numbers to 1.25 % 
(PW17) and 1.4 % (iGb3) (Figure 20 c).  
These results suggest that a deficiency in lysosomal processing and degradation, leading to 
an accumulation of NKT cell ligands, has a critical impact in the regulation of NKT cell 
activation. 
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Figure 20: FACS analyses of human Vα24 NKT cells. a) (left) FACS blots of NKT cells analyzed by their morphology. 
Activated T cells exhibit a different morphology detected by a shift on the FSC parameter axis. Regions for analysing PBLs 
are shown. (right) PI staining to exclude dead cells. B) Frequency of hVα24 NKT PBL from healthy donors. c) Frequency of 
hVα24 NKT PBL from Fabry patients. NKT cells were double-stained with antibodies against NK1.1 and Vα24 TCR chain. 
PBMCs (1x106) were cultured for 4 d with different lipid antigens or medium alone, as indicated. Percentages of positive cells 
are indicated in the quadrants. Dead cells were excluded by PI staining. One of 3 experiments is shown. 
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5.3 Mycobacterial PIM is a natural NKT cell ligand 
A characteristic feature of NKT cells is 
the recognition of lipid antigens 
presented by APCs through CD1d. 
The marine sponge-derived lipid 
αGalCer, in the context of CD1d, is a 
potent stimulator of all Vα14Jα281 T 
cell receptor (TCR) expressing NKT 
cells in mice and their cognates in 
man expressing a Vα24JαQ TCR. For 
years, αGalCer was the only known 
ligand for NKT cells and bacterial 
lipids recognized by NKT cells were 
not identified. Mycobacteria possess a 
unique, lipid rich cell wall and shed 
lipids while residing in phagosomes of macrophages 
(Fischer et al., 2001). The question was whether 
mycobacterial cell wall lipids induce a NKT cell 
response. A preceding study from this group 
identified Phosphatidylinosotol-mannoside (PIM) as 
lipid antigen, presented by CD1d and recognized by 
NKT cells (Fischer et al., 2004). The CD1d binding 
PIM preparation also induced a potent IFNγ release 
by splenic Vα14Jα281 tg T cells in a CD1d-
dependent manner (Fischer et al., 2004)and Figure 
21). In contrast to αGalCer, PIM did not induce IL-4. 
To further analyze PIM-reactive NKT cells, CD1d 
tetramers were loaded with PIM and FACS staining 
was performed. Spleen cells of C57BL/6 mice were 
isolated and stained with CD1d tetramers loaded 
with αGalCer or PIM. Tetramer staining of C57BL/6 
splenocytes revealed 2.2% αGalCer-CD1d tetramer-
positive and 0.6% PIM-CD1d tetramer-positive NKT 
cells (Figure 22). 
Moreover, CD1d-tetramer staining revealed that in 
C57BL/6 mice ∼ 30% of liver NKT cells reacted to 
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Figure 21: Recognition of mycobacterial PIM by CD1d-restricted T 
cells. A20-CD1d and A20 APC were loaded with lipids, splenic T 
cells from Vα14Jα281 tg mice were added, and IFNγ was 
determined 48 h later. Data are expressed as the mean IFNγ
concentration, +/- SD of triplicates. 
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Figure 22: Tetramer staining of spleen NKT cells 
from C57BL/6 mice. CD1d-tetramers were 
loaded with αGalCer or Phosphatidylinositol-
mannoside (PIM). Cells were stained with APC-
conjugated anti-CD3, FITC-conjugated anti-
NK1.1 and PE-conjugated anti-TLR2. Cells 
shown were gated for CD3 expression. 
Percentages of positive cells are indicated in the 
quadrants and are shown in European format. 
Dead cells were excluded by PI-staining.  
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αGalCer-CD1d tetramers and ∼ 0.26% to PIM-CD1d tetramers (Figure 23).  
 
The tetramer-TCR interactions were blocked by preincubation of cells with unlabeled PIM-
CD1d tetramers, confirming the specificity of the tetramer construct. Tetramers loaded with 
PG, a lipid shown to bind CD1d but not to induce a T cell response, did not stain liver T cells 
from B6 mice (Fischer et al., 2004). In CD1d-/- and Jα281-/- mice lacking CD1d-restricted T 
cells, PIM-CD1d tetramer-positive T cells were not detectable, further confirming the 
specificity of the tetramer staining. These data indicate that ∼ 25% of all spleen NKT cells as 
defined by αGalCer-CD1d tetramer staining, can react to PIM (Figure 23). This result 
explains why the observed IFNγ response was almost similar to PIM and αGalCer. 
NK1.1
410310210110010
0 ,6 3 %
410310210110010
0 ,0 7 %
410310210110010
0 ,0 8 %
410310210110010
0 ,0 5 %
410310210110010
0 ,0 7 %
410310210110010
0 ,0 6 %
410310210110010
410
310
210
110
010
0 ,0 9 %
410310210110010
410
310
210
110
010
3 1 ,8 6 %
410310210110010
410
310
210
110
010
0 ,2 6 %
410310210110010
0 ,0 8 %
410310210110010
0 ,5 1 %
410310210110010
410
310
210
110
010
0 ,0 5 %
C57BL6 Jα281 -/- CD1d -/-
CD
1d
 
Te
tP
E
PG-Tet
PIM-Tet
PIM-Tet
+ Block
αGalCer-
Tet
CD
1d
 
Te
tP
E
 
Figure 23: Tetramer staining of liver lymphocytes from C57BL/6, CD1d -/-, or Jα281-/-mice. Cells were stained with APC-
conjugated anti-CD3 mAb, FITC-conjugated anti-NK1.1, and PE-conjugated CD1d tetramers loaded with the indicated lipids. 
Unlabeled PIM-CD1d tetramers were used for blocking. Dead cells were excluded by PI-staining. Percentages of positive 
cells are indicated in the quadrants and are shown in European format. Block: unlabeled PIM-CD1d-tetramer. 
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αGalCer-reactive NKT cells display a very limited TCR repertoire with constant Vα chain 
paired with the vβ chains Vβ8, Vβ7, or Vβ2 (Porcelli et al., 1993). To characterize PIM-
reactive NKT cells further and determine whether PIM-reactive NKT cells could be a subset 
of αGalCer-reactive NKT cells, liver NKT cells of Vα14Jα281 were stained with antibodies 
against a variety of Vβ chains and with PIM- or αGalCer- loaded CD1d tetramers. Forty-eight 
% of αGalCer- and 0.56 % of PIM-
reactive NKT cells were double 
positive for CD1d tetramer and Vβ8 
staining (Figure 24) and 14 % of 
αGalCer- and 0.2 % of PIM-reactive 
NKT cells were detected for Vβ7 
expression. Vβ2 and CD1d tetramer 
double-positive NKT cells were not 
detectable for either αGalCer or PIM-
reactive NKT cells. Furthermore, only 
0.36 % αGalCer- and 0.04% of PIM- 
reactive NKT cells were double 
positive for CD1d tetramer and Vβ11 
(Figure 24). These results 
demonstrate predominant expression 
of Vβ8 and Vβ7, revealing no 
differences in Vβ usage between 
αGalCer and PIM-reactive NKT cells. 
 
To investigate for differences between PIM and αGalCer-reactive NKT cells during an 
infection, C57BL/6 mice were infected with 2x106 M. bovis BCG. Mycobacteria were injected 
i.p. into 3 mice per group and after 1, 3, 8 and 270 days (d), spleen and liver were removed 
and analyzed for frequencies of NKT cells. NKT cells were stained by anti-NK1.1 antibody 
and CD1d tetramer. The αGalCer-CD1d tetramer+ and NK1.1+ liver NKT cells showed an 
increase in cell numbers 1 d after infection, but a significant decrease in cell numbers was 
detected on d 3 and d 8 after infection. These cells started to reappear 270 d after infection, 
indicated by slightly increased cell numbers. The αGalCer-CD1d tetramer+ but NK1.1- cells 
showed a slight increase in cell numbers during d 1 to d 8 after infection and dropped back to 
initial cell numbers after 9 months (Figure 25). 
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Figure 24: Vβ expression of liver NKT cells from Vα14 tg mice. Cells 
were stained with APC-conjugated anti-CD3 mAb, FITC-conjugated 
anti-Vβ chains, and PE-conjugated CD1d tetramers loaded with the 
indicated lipids. Dead cells were excluded by PI-staining. 
Percentages of positive cells are indicated in the quadrants and are 
shown in European format. 
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Relative results from FACS analysis of Vβ usage and analysis of NKT cell numbers during 
mycobacterial infections show no major differences between αGalCer-reactive and PIM-
reactive NKT cells. These results suggest that PIM specific NKT cells constitute a smaller 
subset within the NKT cell population as defined by αGalCer recognition. 
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Figure 25: NKT cell numbers during infection with M. bovis BCG. C57BL/6 mice were infected i.p. with 2x106 bacteria. 
Liver lymphocytes were stained with APC-conjugated anti-CD3 mAb, FITC-conjugated anti-NK1.1, and PE-conjugated 
CD1d tetramers loaded with the indicated lipids. Dead cells were excluded by PI-staining. Data are expressed as mean 
percentage of positively stained cells, +/- SD of 3 mice. Infection studies were done twice 
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5.4 TCR vs. TLR induced NKT cell activation 
NKT cell activation can be mediated directly by CD1d presented antigens recognized by the 
NKT cell TCR (Kawano et al., 1997). Alternatively, recognition of conserved bacterial 
structures through Toll-like receptors on APCs activates the APC to produce IL-12. This IL-
12, in turn, activates NKT cells which recognize their endogenous lipid antigen presented by 
CD1d (Brigl et al., 2003). 
As described in the previous paragraph, we identified PIM as a CD1d presented, natural NKT 
cell antigen. The next experiments were designed to follow up on this project and to 
investigate further antigenic capacities of mycobacterial lipids.  
 
5.4.1 Mycobacterial PIMs induce NKT cell activation via TCR and TLR 
To further asses the role of TLRs in activation of NKT cells and to discriminate direct, TCR 
mediated and indirect, TLR mediated NKT cell activation, PIM containing lipid fractions were 
isolated from M. bovis BCG. PIM containing lipid fractions were isolated as described in 
section 4.2.4. Crude lipid extracts were analyzed for their capacity to activate human cells 
through TLR2. Antigens examined were: crude PIM extracts, whole lipid extracts, 
phosphatidylinositol (PI) and phospolipase A treated PIM (lyso-PIM). PI binds to CD1d but 
fails to elicit a CD1d-mediated NKT cell response, Lyso-PIM, lacking one acyl-chain is devoid 
of the ability to activate NKT cells via CD1d presentation (Fischer et al., 2004). Bacterial 
lipopeptide (BLP; Pam3CSK4) was shown to activate a TLR2 transfected cell line (Aliprantis 
et al., 1999a). BLP was used as positive control. TLR2 activation was detected as described 
in section 4.1.14. The 293-cells transfected with exogenous hTLR2 activate NF-κB in 
response to BLP. In order to asses NF-κB activation, an NF-κB luciferase reporter gene 
consisting of an artificial promotor composed of a multimer of 5 NF-κB sites driving the firefly 
luciferase gene, is cotransfected with a constitutively active Renilla-luciferase reporter gene. 
Antigens were dissolved in DMSO, incubated with TRL2 expressing 293-cells for 8 h and 
subsequently NF-κB activity was measured. The 293-cells were transfected with the empty 
vector (pRKN) to detect TLR2-independent NF-κB activation. Lipids were used at a range of 
0.02 - 5 µg/ml.  
Whole lipid extracts as well as crude PIM extracts were recognized by human TLR2 and 
induced significant NF-κB induction in a dose dependent manner. PI did not induce NF-κB 
but interestingly, lyso-PIM did neither (Figure 26). Moreover, αGalCer was not recognized by 
TLR2 and failed to activate NF-κB (data not shown). Unspecific NF-κB activation was 
minimal and substracted from depicted values. A fold induction of ≥ 4 is considered as 
significant TLR2-mediated NF-κB induction. 
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In comparison to PIM, PI lacks the mannose sugar part and phospholipase A treatment of 
PIM results in the removal of one acyl chain (Figure 27; PIM shown as PIM4).  
This result suggests that both the structure 
of the lipid part and the presence of a certain 
sugar moiety is important for TLR2 
recognition and subsequent NF-κB 
activation.  
Crude lipid fractions were further fractionated 
and purified by liquid chromatography 
employing a silica gel column and increasing 
mixtures of chloroform / methanol. After 
isolation, lipid fractions were analyzed by 
one-dimensional HPTLC (Figure 28).  
Fractions were dissolved in a mixture of 
chloroform / methanol and separated on HPTLC using a mixture of chloroform/acetic 
acid/methanol/water in a 40/25/3/6 relation, respectively. Crude PIM extracts and pure PIM1,2 
were used as markers and chromatography buffer was included to discriminate positive 
staining from buffer contamination. Lipids were detected by α-naphtol. Using α-naphtol, 
carbohydrate residues are stained blue, whereas red staining indicates absence of 
carbohydrates. Figure 28 depicts lipid fractions separated by HPTLC showing different lipids 
within isolated fractions. Fractions 1 - 13 contain lipids that were more soluble in the HPTLC 
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Figure 26: NF-κB activation triggered through TLR2-mediated recognition of lipids isolated from M. bovis BCG. The 293 
cells transfected with human TLR2 were incubated with different lipids and lipid extracts for 8 h at the concentrations 
indicated. NF-kB induction through hTLR2 was detected using a firefly dual luciferase driven reporter assay. BLP: 
Bacterial lipopeptide (Pam3CSK4).PIM: phosphatidylinositolmannoside; PI: phospatidylinositol; lyso PIM: phospholipase A 
treated PIM. Data are expressed as the mean fold induction of NF-κB, +/- SD of triplicates. RLU: relative light units. 
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Figure 27: Structures of phospatidylinositol (PI), 
phospatidylinositol-tetramannoside (PIM4) and lyso-PIM4. 
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solvent and characteristic bands for phosphatidylinositol-mono/di-mannoside (PIM1,2) was 
detected. Higher mannosylated PIMs, like Phospatidylinositol-tetramannoside (PIM4), was 
detected within fractions 14 - 23 indicated by the dense spot at the base each lane. 
Remaining buffer ingredients appear to be present in fraction 5. 
 
 
To analyze the isolated lipid fractions for their potential to elicit a CD1d-dependent NKT cell 
response, 3x104 HeLa cells were incubated overnight with different lipid fractions at 1 µg/ml. 
On the next day, 1.5x105 human NKT cells from a polyclonal NKT cell line were added. After 
6 h, TNFα was measured in the cell culture supernatant by ELISA. αGalCer was used as 
positive control and DMSO as negative control since lipids were dissolved in DMSO. 
αGalCer and fraction 7 elicited a potent NKT cell response detected by TNFα production. 
None of the other lipid fractions provoked a NKT cell response (Figure 29). 
 
The same fractions were also analyzed for their capacity to be recognized by human TLR2 
and thereby inducing NF-κB activation. Lipids were dissolved in DMSO and used at a 
concentration range from 1 - 5 µg/ml. TLR2-mediated NF-κB activation was measured the 
same way as described above. M. bovis BCG whole lipid extracts and M. tuberculosis lysate 
were also examined. BLP was used at a concentration of 0.1 - 100 ng/ml as positive control. 
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Figure 28: Thin layer chromatography of lipid fractions isolated from M. bovis BCG. Lipids were fractionated using a silica 
column and eluted by a chloroform / methanol gradient. Subsequently, lipids were separated in one dimension using 
HPTLC plates and detected by α-naphtol staining.PIM4, phosphatidylinositol-tetra-mannoside; PIM1,2 phosphatidylinositol-
mono /di-mannoside; buffer: Sepharose 200 column chromatography buffer 
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Transfectants containing 
the empty vector lacking 
TLR2 were added as 
negative control for TLR2 
independent NF-κB 
activation. Lipid fractions 7, 
16, 19 and 21 induced NF-
κB activation up to a 
concentration of 4 µg/ml 
and showed a decline of 
induction with higher 
concentrations. M. bovis 
BCG whole lipid extracts 
and M. tuberculosis lysate 
were recognized by human 
TLR2 and induced NF-κB 
increasingly strong with increasing concentrations. Lipid fractions 11 and 12 were not 
capable of inducing a response. Unspecific NF-κB activation was minimal and subtracted 
from depicted values (Figure 30). A fold induction of ≥ 4 is considered as significant TLR2-
mediated NF-κB induction. 
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Figure 30: NF-κB activation triggered through TLR2-mediated recognition of lipids isolated from M. bovis BCG. (Left) Crude PIM 
fractions were further fractionated and purified and the resulting fractions were analysed for their capacity to induce TLR2 
activation. (Right) BLP or vector control. The 293 cells transfected with human TLR2 were incubated with different lipids and 
lipid extracts for 8 h at the concentrations indicated. NF-kB induction through hTLR2 was detected using a firefly dual luciferase 
driven reporter assay. BLP: Bacterial lipopeptide (Pam3CSK4). Data are expressed as the mean fold induction of NF-κB, +/- SD 
of triplicates 
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Figure 29: TNFα release by human NKT cells. CD1d expressing HeLa cells 
(3x104) were incubated overnight with different lipid fractions. NKT cells (1,5x104) 
were added for 6h and TNFα was measured in the cell culture supernatant. 
Results shown are in triplicates. 
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Experiments for CD1d-mediated NKT cell activation and TLR2-mediated NF-κB activation 
revealed that lipid fraction 7 induced responses in both assays. Lipid fractions 16, 19 and 21 
induced only TLR2-mediated responses. Therefore, fraction 7 of the lipid purification seemed 
to contain a lipid species that has both the capacity to induce human NKT cells specifically 
and is also recognized by human TLR2. This capacity was absent in fractions 16, 19 and 21. 
 
5.4.2 Mass-spectrometry analysis of TLR and TCR activating lipid 
fractions 
As a consequence, MALDI-MS was performed to reveal structural differences within lipid 
fractions 7, 16, 19 and 21. The aim was to detect the NKT cell activating lipid in fraction 7. 
Moreover, analysis of lipid structures would reveal structural elements required for TLR2 
recognition. Lipids were dissolved in a mixture of chloroform / methanol at a concentration of 
5 µg/ml and mixed with 2,5-Dihydroxybenzoic acid (DHB) as matrix for MALDI-MS. The 
spectra were recorded in both positive and negative mode and at two types of expansion: 
m/z 500 – 3,000 and m/z 1,000 – 3,000. Internal calibration was achieved by using synthetic 
peptides with known molecular mass as internal markers. Negative mode MALDI-MS did not 
yield clear spectra but using positive mode parameters, MALDI-MS was successful. The 
reference spectrum of crude PIM extracts was recorded by Martine Gilleron and Germain 
Puzo at the Institut de Pharmacologie et de Biologie Structurale, Centre National de la 
Recherche Scientifique, Toulouse Cedex, France (Figure 31). MALDI-MS spectra of lipid 
fractions 7, 16, 19 and 21 were recorded at the mass-spectrometry facility of the MPI for 
Infection Biology. 
In fraction 7, a cluster of smaller peaks at the range of 1233.97 to 1640.61 Da was detected 
without any predominant peak within this cluster. Some of the peaks could be attributed to 
known PIM structures: PIM2Ac1 (Mass 941.72) and PIM6Ac1 (Mass: 1598.37) were clearly 
detected. A mass of 1456.49 was detected which is close to PIM2Ac3 which has a mass of 
1459.49. Peaks with masses higher than 1640.61 could not be identified and other peaks 
within the detected cluster could not be assigned. Lower case letters indicate numbers of 
mannoses or acylation grade, e.g. PIM6Ac1 is monoacylated phosphatidylinositol-
hexamannoside. A more definite result was obtained with fractions 16, 19 and 21. PIM6Ac2 
with two C18 acyl chains (1869.61 Da) or two C16 acyl chains (1828.7 Da), PIM6Ac3 (2108.15 
Da) and PIM6Ac4 (2388.42 Da) were detected in fractions 16, 19 and 21. PIM2Ac3 (1495.96) 
was detected in fractions 16 and 21 and PIM2Ac2 (1217.98) was detected in fraction 21. 
Minor peaks between the molecular masses of 995.51 to 1525.06 were detectable in 
fractions 16, 19 and 21 with a cluster of them appearing in fraction 21 (Figure 31). Due to the 
lack of clear peaks in fraction 7 no individual compound could be pinpointed with the ability to 
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activate NKT cells as well as being recognized by TLR2. Peaks, indicating the masses of 
highly mannosylated PIMs were not detected in fraction 7 but present in all other fractions, 
indicating TLR2 recognition of highly mannosylated PIMs but no recognition of lower 
mannosylated PIM species. 
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b) Fraction 7 
 
Figure 31: MALDI-MS analysis of lipid fractions isolated from M. bovis BCG. Lipids were dissolved in a mixture of CHCL3-
CH3OH at a concentration of 1 mg/ml. DHB was used as matrix and spectra were recorded in positive mode at an expansion 
of m/z 1000 3000. a) Reference spectrum of crude PIM extracts showing the respective lipids for each encircled peak. b) lipid 
fraction 7. 
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c) Fraction 16 
 
 
d) Fraction 19 
 
Figure 31 continued: MALDI-MS analysis of lipid fractions isolated from M. bovis BCG. Lipids were dissolved in a mixture of 
CHCL3-CH3OH at a concentration of 1 mg/ml. DHB was used as matrix and spectra were recorded in positive mode at an 
expansion of m/z 1000 3000. c) lipid fraction 16 d) lipid fraction 19. 
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5.4.3 Toll-like receptor expression by NKT cells 
TLR2 and TLR4 recognize a wide range of bacterial cell wall products including lipoproteins, 
LAM, LPS and peptidoglycan and contribute to innate immune responses to mycobacterial 
infections (Medzhitov, 2001; Underhill and Ozinsky, 2002). To examine if NKT cells could 
recognize bacterial antigens via TLRs, FACS analysis of extracellular and intracellular 
expression of TLR2 and TLR4 on NKT cells was performed. 
Spleen and liver NKT cells of Vα14Jα281 tg mice were co-stained with antibodies against 
murine TLR2 or TLR4 as well as NK1.1 and CD3 (Figure 32). Surface expression of TLR2 on 
NKT cells could not be detected above background level stained by an IgG2b isotype control 
antibody. Analysis of TLR4 expression on NKT cells was performed using cells from 
Vα14Jα18 tg as well as TLR4-/- mice. Furthermore, TLR4 blocking antibodies were 
employed. TLR4 expression was detected for 0.12 % and 0.17 % of spleen and liver NKT, 
respectively. This positive staining was decreased to 0.04 % and 0.1 % positive cells in 
spleen and liver, respectively by the use of unconjugated anti-TLR4 blocking antibodies. 
TLR4-/- mice showed TLR4 expression on 0.02 % spleen and 0.07 % liver NKT cells. This 
indicates unspecific antibody binding.  
 
 
e) Fraction 21 
 
Figure 31 continued: MALDI-MS analysis of lipid fraction isolated from M. bovis BCG. Lipids were dissolved in a mixture of 
CHCL3-CH3OH at a concentration of 1 mg/ml. DHB was used as matrix and spectra were recorded in positive mode at an 
expansion of m/z 1000 3000. e) lipid fraction 21 
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However, the detection of minute percentages of TLR4 positive NKT cells cannot be 
considered as a TLR4+ NKT cell population. The low expression level was predominantly 
unspecific not depicting a clearly defined population of TLR4+ NKT cells by FACS. FACS 
analysis of intracellular TLR4 expression did also not reveal any TLR4+ NKT cells. 
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Figure 32: a) TLR2 expression of murine NKT cells: Spleen and liver NKT cells of Vα14 transgenic mice were stained for 
TLR2 expression. Cells were stained with APC-conjugated anti-CD3, FITC-conjugated anti-NK1.1 and PE-conjugated anti-
TLR2. Cells shown were gated for CD3 expression. IgG2b antibodies were used as isotype control staining. One of three 
experiments is shown. b) TLR4 expression of murine NKT cells. Spleen and liver NKT cells of Vα14 transgenic mice and 
TLR4 knock out (-/-) mice were used. Cells were stained with APC-conjugated anti-CD3, FITC-conjugated anti-NK1.1and 
PE-conjugated anti-TLR4. Block: unconjugated anti-TLR4 antibody. Cells shown were gated for CD3 expression and 
percentages of positive cells are indicated in the quadrants and are shown in European format. 
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6 Discussion 
NKT cells possess very diverse capacities and are involved in a variety of immune responses 
(Godfrey and Kronenberg, 2004). 
A unique gene expression pattern of NKT cells was depicted by transcriptome analysis. The 
pattern showed an activated, effector phenotype, expression of distinct cytokine- and 
chemokine receptors and a tight control of autoreactivity. Additionally, discovery of shared 
gene expression patterns with other, distinct lymphocyte populations revealed innate and 
adaptive immunity-like features of NKT cells. Analysis of activated NKT cells showed 
substantial increase in gene expression for effector and immuno-regulatory factors, such as 
cytokines and chemokines combined with strict regulation of NKT cell activity and apoptosis. 
 
Analysis of NKT cell stimulation by the endogenous antigen iGb3 under normal physiological 
conditions and in lysosomal storage disorders revealed that regulation of antigen availability 
is crucial for NKT cell activation and control of NKT cell activity.  
 
In addition, mycobacterial antigens for NKT cells were identified and NKT cells, reactive to 
these lipids, were characterized. Furthermore it was shown that distinct mycobacterial lipids 
are capable of eliciting both, a specific CD1d-mediated NKT cell activation and a broad 
immune activation by TLR2 activation. 
 
6.1 Defining NKT cells through their gene expression 
pattern 
One aim of this thesis was to define NKT cell properties by analysis of their gene expression 
pattern. Global analysis of genes, differently regulated in NKT cells in comparison to other 
lymphocyte populations provides a view on the diverse functions and properties of NKT cells. 
Up to date, NKT cell characterization by means of gene expression patterns has not been 
reported. 
 
Specific attribution of genes to distinct cell populations by microarray analysis requires tight 
control of sample preparation. It is indispensable that genes, detected in microarray analysis 
are truly cell type specific genes. This was achieved by purification of cells via MACS and 
FACS sorting, exclusion of dead cells and maintenance of the cells at 4°C. This ensured that 
isolated population were highly pure, viable and not activated. Activation of cells would result 
in alterations in gene expression during the purification.  
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The lower purity of NKT cell sorts was surprising but can be attributed to two factors. 
Limitations of the FACS sorter, for instance to exclude all dead cell and cell doubles, and 
quantitative variation of NK1.1 and Vα14 TCR surface expression by NKT cells (Emoto et al., 
1999b; Hammond et al., 1999). Analysis of sorted NKT cells detected a well-defined cell 
population with very little contamination (Figure 7). Specificity of microarray analysis was 
additionally controlled by combining results from two independent experiments. Only 
expression of genes found up- or downregulated in both experiments were considered cell 
type specific. Additionally, only genes with a minimum of 2 fold differences in expression 
levels and P-values smaller than 0.05 were chosen. 
Methods employed are the most sophisticated tools available at present and controls chosen 
were designed to ensure reliability of microarray results. A significant number of genes 
already known to be expressed by NKT cells were detected in microarray analysis, thus 
validating the fidelity and specificity of microarray derived data. 
 
6.1.1 The NKT cell: portrayal by means of gene expression profiling 
6.1.1.1 A unique genetic imprint of NKT cells 
Genes with a higher expression in NKT cells compared to other lymphocyte populations 
portray a set of genes exclusively expressed in NKT cells or at least exhibiting a unique 
expression pattern. Among these 15 genes, expression of only 3 genes was previously 
described for NKT cells (Table 2). These are: CXCR3, IL-12 receptor-β1 and integrin-α4β1 
(Franitza et al., 2004; Kim et al., 2002; Kitamura et al., 1999). 
 
Rapid NKT cell responses are due to expression of chemokine and cytokine receptors 
CXCR3 is a chemokine receptor for homing to non-lymphoid tissue. IL-12 receptor binds the 
pro-inflammatory cytokine IL-12 and integrin-α4β1 is involved in the recruitment of T cells to 
sites of inflammation. In addition to CXCR3 and IL-12 receptor-β1, NKT cells expressed 
CCR3 and IL-17 receptor-B. CCR3 is also involved in attraction of lymphocytes to sites of 
inflammation and IL-17 receptor-B binds IL-17, a pro-inflammatory cytokine like IL-12. IL-12 
receptor is not expressed on resting, conventional T cells and IL-17 induces production of 
other cytokines, e.g. IL-6 and IL-8. The strong ability of NKT cells to rapidly respond to pro-
inflammatory cytokines can be explained by the expression of IL-12 receptor-β1 and IL-17 
receptor-B on resting, non-activated NKT cells. Additionally, elevated expression of 
chemokine receptors CXCR3 and CCR3 implies rapid recruitment to sites of inflammation 
and fast response to inflammatory mediators. This set of chemokine/cytokine receptors 
enable NKT cells to rapidly respond to external stimuli.  
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NKT cells display an activated, effector phenotype 
The recruitment of leukocytes into tissues depends on a series of adhesive and activation 
steps mediated by adhesion molecules and chemokine–receptor interactions (Johnston and 
Butcher, 2002). Expression of chemokine receptors and adhesion molecules on T cells is 
developmentally regulated, while chemokine expression is often tightly controlled by 
cytokines that restrict their tissue distribution. This results in distinct migratory patterns of 
leukocyte subsets (Kunkel and Butcher, 2002). For example, all naïve T cells uniformly 
express L-selectin and CCR7, which mediate access to lymphoid tissues through high 
endothelial venules and have a role in T-cell localization in the paracortex of lymph nodes. 
By contrast, memory and effector T cells are heterogeneous in their expression of chemokine 
receptors and adhesion molecules, and have diverse trafficking behaviors (Kim et al., 2002).  
The chemokine receptor and adhesion molecule expression pattern of NKT cells resemble 
that of activated, effector T cells, i.e. expression of chemokine receptors for homing to non-
lymphoid tissue (Gumperz et al., 2002; Lee et al., 2002) and Table 2). Decreased expression 
of L-selectin and vimentin indicates reduced trafficking to lymph nodes and acquired ability 
for extravasation. Increased expression of MMP-9 contributes to the activated phenotype of 
NKT cells since it is important in tissue remodeling and extravasation. Moreover, Emoto et al 
described the expression of LFA-1 on NKT cells and demonstrated that LFA-1-/- mice exhibit 
markedly decreased numbers of NKT cells in the liver, stressing the importance of tissue 
homing receptors for NKT cell localization (Emoto et al., 1999a). LFA-1 belongs to the family 
of β2 integrins and is involved in initiating leukocyte transmigration and extravasation. In 
contrast, decreased expression of integrin-α4β1 by NKT cells implies reduced trafficking to 
sites of inflammation. This discrepancy cannot be explained. However, NKT cells contain 
distinct subsets with differential expression of chemokines, chemokine receptors and 
adhesion receptors. This could provide a mechanism to deliver specific NKT cell subsets to 
distinct tissues and deliver a specific immuno-regulatory function. 
 
Proliferation of resting NKT cell is tightly controlled 
BLK, caspase-1, caspase-11 and KLF2 are involved in regulation of apoptosis. Whereas BLK 
is pro-apoptotic and upregulated in NKT cells, caspase-1 and caspase-11 are not only 
involved in regulation of apoptosis. Caspase-1 is involved in cytokine processing (Pirhonen 
et al., 1999) and caspase-11 is a mediator of septic shock responses and induced in most 
cells upon pro-inflammatory stimuli. Activation of caspase-1 is under the control of caspase-
11. Expression of caspase-11 is induced by LPS and caspase-11-/- mice exhibit significantly 
reduced levels of IL-1α and IL-1β after LPS stimulation (Wang et al., 1996). IL-1 in turn, is 
involved in septic shock (Kang et al., 2002). Additionally, IL-1β inhibits the induction of KLF2 
(SenBanerjee et al., 2004). KLF2, equipped with anti-apoptotic capacities, was 
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downregulated in NKT cells. In contrast to BLK, caspase-1, caspase-11 and KLF2 exhibited 
decreased expression levels in NKT cells (Table 2).  
Increased expression of BLK together with downregulation of caspase-1, caspase-11 and 
KLF-2 demonstrate that immunoregulatory functions and proliferation of NKT cells are 
specifically controlled. Naïve, resting NKT cells were described to be autoreactive even in the 
absence of antigen stimulation. Upregulation of pro-apoptotic genes and downregulation of 
anti-apoptotic genes in non-activated NKT cells ensures strict control of NKT cell activity and 
enables rapid shut down of NKT cell responses. By this mechanism, exacerbated immune 
reactions leading to pathological consequences can be avoided. 
 
It is apparent that diverse control mechanisms exist to avoid overreaction by NKT cells. This 
includes upregulation of genes limiting proliferation and selected downregulation of genes 
with immuno-stimulatory functions. It is noteworthy that IL-17 is involved in amplifying effects 
of IL-1β as well as in the induction of MMPs (Sylvester et al., 2004). Responses to IL-17 and 
regulation of IL-1β could therefore be of central importance for NKT cell functions. 
 
6.1.1.2 NKT cells possess innate-immunity like, effector and regulatory functions 
Genes with expression levels comparable between NKT cells and either NK cells or 
conventional T cells characterize NKT cell properties as either properties of innate or 
adaptive immunity. 
 
Expression of genes coding for lymphotactin, CCL5, CCR2, CXCR4, FasL, LFA-1, IFNγ, 
NKG2D, CD30 and granzyme B were already described for NKT cells (Emoto et al., 1999a; 
Faunce and Stein-Streilein, 2002; Gumperz et al., 2002; Kennedy et al., 2000; Kim et al., 
2002; Leite-de-Moraes et al., 2000; Matsuda et al., 2002; Metelitsa et al., 2003; Tao et al., 
2002) (Table 3). The diversity of these genes demonstrates that NKT cells are able to 
perform effector functions and act as regulators of immune responses at the interface of 
innate and adaptive immunity. 
 
Similar expression of lymphotactin, CCR2, CXCR4, FasL, L-CCR, CD30, integrin-α6 and 
OX40 in NKT cells and NK cells indicate properties of NKT cells related to innate immunity 
(Table 3). These genes are involved in responses to chemokines and important for cell 
migration and extravasation to sites of inflammation. Expression levels of IFNγ were 
comparable in NK and NKT cells and showed decreased expression in conventional T cells. 
However, production of IFNγ concomitant with IL-4 production is a hallmark of NKT cell as is 
of central importance in NKT cell function.  
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Genes with similar expression levels in NKT cells and conventional T cells suggest adaptive 
immunity-like qualities of NKT cells. Similar expression was detected for CD6, IGTP, IL-4 
receptor, IL-7 receptor and interleukin 15. However, IL-4 receptor, IL-7 receptor, interleukin 
15 and IGTP are not exclusively expressed in T cells, but stress the ability of NKT cells to 
respond to broad stimuli like infections and contribute to Th1 and Th2 immune responses 
(Akashi et al., 1998; Butcher et al., 2005; Carson et al., 1994; Lowenthal et al., 1988). 
  
Additionally, similar expression levels of IL-2 receptor were detected in NKT cells as well as 
NK cells and conventional T cells. IL-2 promotes proliferation, differentiation, and survival of 
target cells and augments the innate host defense through its effects on NK cells. Expression 
of IL-2 receptor on NKT cells underlines their ability to be activated by a wide range of 
activation signals and participate in various immune responses. 
 
Expression levels of annexin A1, RANTES, CCL6, NKG2D, granzyme B and TLR4 in NKT 
cells was intermediate between expression levels in NK cells and conventional T cells (Table 
3). These genes were upregulated in NKT cells compared to conventional T cells but 
downregulated to expression levels in NK cells. These genes rather play a role in innate 
immunity and expression of these genes in NKT cells illustrates properties of innate immunity 
for NKT cells. However, decreased expression levels in NKT cells compared to NK cells 
indicates that functions of these genes are not as prevalent as in cells of the innate immunity. 
 
6.1.2 Activated NKT cells: self-control, effector functions and immuno-
regulation 
Activation of NKT cells is rapid and induces immuno-regulatory and effector function of NKT 
cells. Concomitant and extensive production of various cytokines is a hallmark of the 
immuno-regulatory function of NKT cells. In contrast to conventional and regulatory T cells, 
NKT cells do not only suppress immune responses but actively enhance and modulate 
reactions to infection and inflammation.  
 
Effector and immuno-regulatory capacities of NKT cells 
Microarray analysis of activated NKT cells revealed a substantial increase in expression 
levels of 10 different cytokine and chemokines (Table 4). Among them, GM-CSF, IFNγ, IL-2, 
IL-4, IL-13, TNFα, MIP-1α, MIP-1β, lymphotactin were previously reported for αGalCer 
activated NKT cells (Leite-de-Moraes et al., 2002; Matsuda et al., 2003; Fuss et al., 2004; 
Harada et al., 2004; Jiang et al., 2005; Kim et al., 2002; Mi et al., 2003). IL-17 production by 
NKT cells has not been reported. IL-17 is pro-inflammatory and induces the production of 
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other cytokines. It is noteworthy that expression of some genes, e.g. IL-13 and MIP-1α, 
detected for activated NKT cells could only be found in distinct NKT cell subsets. However, 
production of GM-CSF, IL-2, IFNγ, TNFα and IL-4 is characteristic for all activated NKT cells. 
Concomitant production of Th1 (IFNγ, GM-CSF, IL-2, TNFα) and Th2 (IL-4) cytokines 
represents a unique capacity of NKT cells. Production of various cytokines and chemokines 
with diverse regulatory and stimulating properties highlight the capacity of NKT cells to 
influence and modulate immune responses. 
 
Self-control of NKT cell activity 
Strong upregulation of genes controlling cell proliferation was detected for activated NKT 
cells. Upregulation of the anti-apoptotic gene Gadd45/MyD118 was previously reported in 
activated NKT cells. Moreover, expression of EGR1, Map3K8, c-Myc and Nurr77 was 
detected in activated NKT cells by microarray analysis (Table 4).  
EGR1, c-Myc and Nurr77 are involved in regulation of apoptosis, with EGR1 exhibiting anti-
apoptotic properties after cell activation (Adamson and Mercola, 2002; Brunner and Martin, 
2004; Mak and Kultz, 2004; Rajpal et al., 2003). Map3K8 is part of the Map Kinase pathway 
transducing growth factor and cytokine-induced activation signals (Beinke et al., 2004). 
Upregulation of these genes demonstrate induction of apoptosis control in order to regulate 
adequate NKT cell responses.  
 
A model for self-control of NKT cell activity is proposed: naïve NKT cells express pro-
apoptotic genes to prevent activation and increased autoreactivity in the absence of infection 
or inflammation. At this stage, NKT cells also express cytokine and chemokine receptors for 
rapid activation. Upon activation by their cognate antigens (self or non-self) NKT cells 
produce anti-apoptotic and apoptosis regulating genes for prolonged survival and appropriate 
inactivation after stimulation. This provides the opportunity to perform their various effector 
and regulatory function as implied by upregulation of various cytokines and chemokines after 
activation. 
 
The appearance of apoptosis and cell cycle control genes shows that proliferation and cell 
responses after activation are tightly controlled. This ensures that NKT cell responses are 
adequate and rapidly turned off. NKT cells respond rapidly and vigorously to foreign antigen 
stimulation produce IFNγ and IL-4 after stimulation (Smyth and Godfrey, 2000). Moreover, it 
is obvious that NKT cells produce a much greater amount of different cytokines after 
stimulation, which influence other cells of the immune system and helps to coordinate 
appropriate immune responses. 
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6.2  NKT cell activity: induction by iGb3 is controlled 
through antigen availability 
Lysosomal storage disorders are a family of over 40 distinct genetic diseases, each of which 
is a specific defect in lysosomal function. These defects lead to the accumulation of 
compounds, which are normally degraded, within lysosomes. Lysosomal storage disorders 
can be classified broadly by the type of material that is accumulated (e.g. lipid storage 
disorders, mucopolysaccharidoses, glycoproteinoses), although many of these conditions 
show significant similarities in pathological outcome. Morbus Gaucher and Fabry disease are 
the most prevalent forms of lysosomal storage disorders (Brady, 1982). Morbus Gaucher, the 
most frequent lysosomal storage disorder, is caused by a defective lysosomal enzyme, acid-
β-glucosidase (GlcCerase), leading to glucosylceramide (GlcCer) accumulation, particularly 
in cells of the macrophage lineage. 
Fabry disease, also referred to as Anderson-Fabry disease, is an X-chromosome-linked 
recessive lysosomal storage disorder caused by a defective lysosomal αGalactosidase A 
(αGalA, also termed ceramide trihexosidase). αGalA is the lysosomal enzyme responsible 
for the breakdown of globotriaosylceramide (Gb3) and related glycosphingolipids (Desnick 
and Brady, 2004). These glycosphingolipids have a terminal α-galactosyl residue and are 
components of most cell membranes. Gb3 is normally broken down by αGalA to galactose 
and lactosylceramide. The deficiency of αGalA leads to progressive accumulation of Gb3 
within the lysosomes of most cells types in the plasma. If untreated, Fabry disease is 
characterized by renal, cardiac, and cerebrovascular manifestations and premature death. A 
milder phenotype occurs in patients with reduced but detectable αGalA activity. Severe forms 
of Fabry disease predominantly affect males, whereas female (heterozygous) carriers show 
mild to severe degrees of the disease. This is caused by random X-chromosomal inactivation 
(Desnick et al., 2003). 
 
In vivo relevance of iGb3 
Zhou et al described iso-globotrihexosylceramide (iGb3) as the endogenous NKT cell 
antigen. Absence of iGb3 blocks NKT cell development (Zhou et al., 2004). Gb3 and iGb3 
differ only in the position of the terminal galactose. Gb3 displays a 1→4 attachment and a 
1→3 linkage is found in iGb3. Although a minor structural difference, Gb3 does not activate 
NKT cells (Figure 16). Modifications of NKT cell antigens were previously shown to have a 
major impact on successful presentation by CD1d (Kawano et al., 1997). Zhou et al showed 
that β-hexosaminidase b-/- (Hexb-/-) mice have decreased NKT cell numbers due to a 
lysosomal defect in iGb3 generation from iGb4 by β-hexosaminidase A and B (Sango et al., 
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1996). Moreover, iGb3 stimulates NKT cells in a similar manner as αGalCer. Synthesis of 
iGb3 from lactosylceramide by lactosylceramide-4-α-galactosyltransferase (iGb3 synthase) 
leads to iGb3 synthesis in the Golgi apparatus. However, iGb3 degradation and loading of 
lipids onto CD1d occurs in lysosomes (Figure 
33). It needs to be further studied to which 
extend iGb3 is available for CD1d loading and 
presentation in HexB-/- mice. 
The report by Zhou et al did not address 
regulation of NKT cell activation in normal 
mice, where iGb3 presence could lead to 
autoreactivity. iGb4 is also not the only 
substrate of HexB, with disialoganglisoside 
(GM2), asialoGM2 (GA2) and 
globotetrahexosylceramide (Gb4) as further 
HexB substrates (Sandhoff and 
Christomanou, 1979). Deficiency in β-
hexosaminidase A and B leads also to Gb4 
accumulation, a characteristic of Sandhoff disease, whereas deficiency in β-hexosaminidase 
A only, leads to GM2 accumulation known as Tay-Sachs disease (Platt et al., 2003). 
Previously, other endogenouse lipids were described as lipid antigens presented by CD1d. 
Disialoganglioside (GD3), a ganglioside expressed on human melanoma, is able to elicit a 
NKT cell response. However, GD3 is only present in human melanoma cells and NKT cell 
activation depends on cross-presentation by professional APCs (Wu et al., 2003).  
 
iGb3 is common in mammalian organisms and ubiquitously present under normal 
physiological conditions (Kuehn et al., 1992). This raises the question of regulation of antigen 
availability and NKT cell activation control. Brigl et al showed that NKT cell activation can be 
achieved by two different pathways: direct TCR mediated activation of NKT cells by ligands 
presented by CD1d or TLR mediated APC-activation and IL-12 production in combination 
with recognition of endogenous self lipids by NKT cells. APC-derived IL-12 is important for 
NKT cell activation in the latter scenario (Brigl et al., 2003). The in vivo relevance of iGb3 as 
endogenous CD1d ligand was demonstrated by failure of HexB-/- mice to activate NKT cells 
during salmonella infection (Mattner et al., 2005). In contrast, NKT cells in HexB-/- mice 
responded normally to infection with sphingomonas and lipids thereof. Salmonella and 
sphingomonas are both gram- bacteria but sphingomonas is LPS-negative whereas LPS is 
present in the cell wall of salmonella. Furthermore, sphingomonas is an infrequent pathogen 
with low virulence (Hsueh et al., 1998). Salmonella LPS activates APCs via TLR4 whereas 
 
GalNAc β1,3 Gal α1,3 Gal β1,4 Gcl β1,1 Cer
GalNAc + Gal α1,3 Gal β1,4 Gcl β1,1 Cer
Gal + Gal β1,4 Gcl β1,1 Cer
β-Hexosaminidase
α-Galactosidase A
iGb4 synthase
iGb3 synthase
Figure 33: Schematic of iGb3 synthesis in the golgi (black 
arrows) and degradation in lysosomes (red arrows). From 
top to bottom, iGb4, iGb3 and Lactosylceramide. Gb3 is 
synthesized and degraded the same way. 
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sphingomonas lipids are directly recognized by the NKT cell receptor via CD1d. Moreover, 
Griffonia simplicifolia I-B4 (IB4), a lectin binding terminal α-galactose, inhibited recognition of 
iGb3 by NKT cells (Kinjo et al., 2005; Mattner et al., 2005). Taken together, dependency on 
an endogenous NKT cell antigen / CD1d ligand during TLR-mediated activation was 
demonstrated. 
 
Regulation of NKT cell activation during lysosomal storage diseases 
The critical question is how NKT cell activation is regulated since ubiquitous presence of 
iGb3 would cause continous NKT cell stimulation. Activation induced cell death could lead to 
NKT cell depletion. Under physiological conditions, Gb3 and iGb3 are rapidly degraded by 
lysosomal αGalA, probably reducing antigen availability. In case of defects in enzymatic 
degradation antigens accumulate and surmount the concentration threshold for effective 
CD1d loading and NKT cell stimulation. Cells from Fabry patients, deficient for αGalA contain 
increased levels of Gb3 and probably iGb3. 
 
CD40L treatment of immature DCs induces maturation and enhanced antigen presentation 
(Fujii et al., 2004). CD40L matured DCs from Fabry patients, stimulated NKT cells indicating 
that availability of endogenous antigens on the cell surface is below threshold in unstimulated 
APCs and increased in mature DCs (Figure 17). Lack of NKT cell activation even upon 
maturation of DCs from healthy individuals, pinpoint antigen availability as an important 
regulator for NKT cell activation. Surprisingly, CD40L matured DCs from Fabry patients failed 
to induce a NKT cell response upon exogenous loading of iGb3. It was speculated that the 
concentration of added antigen was cytotoxic. However, DCs from healthy donors loaded 
with the same amount of iGb3 stimulated NKT cells. Deficiency of lysosomal lipid 
degradation resulting in massive lipid accumulation within the endosomal system could 
influence the antigen processing and presentation machinery. CD1d molecules bind their 
cognate antigen in the endosomal system. Congestion or deviation of this system could 
hinder CD1d-mediated NKT cell activation. 
 
Investigations about the effect of Fabry disease on the immune system are very limited. 
Immune-deficiencies or differences in immune responses in Fabry patients compared to 
healthy individuals have not been reported. Examination of CD1d-expression by DCs from 
Fabry patients did not reveal any differences to that of DCs from healthy donors (data not 
shown). Lack of differences in NKT cell numbers of Fabry patients and healthy individuals 
further indicate that such a condition does not influence the immune status. It further shows 
that accumulation of Gb3 and iGb3 does not alter the NKT cell compartment.  
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Effects of IL-12 and IL-15 on NKT cell activation by iGb3 
It has been shown that APC derived IL-12 can bias the self-reactive NKT cell response 
toward IFNγ and induce NKT cell responses after antigen recognition by TLRs (Brigl et al., 
2003; Vincent et al., 2002). IL-15 is important in the development and expansion NKT cells 
(Matsuda et al., 2002). However, various concentrations of IL-12 or IL-15 did not effect NKT 
cell responses (data not shown). Treatment of DCs from Fabry patients or healthy donors 
with IL-12 or IL-15 in the presence or absence of iGB3 did not induce NKT cells activation. 
This was unexpected considering reports showing IL-12 induced NKT cell activation and its 
lack in the absence of iGb3 (Brigl et al., 2003; Mattner et al., 2005). Additional factors such 
as co-stimulatory molecules / receptors could be important for effective NKT cell induction. 
 
iGb3 / iGb3 analogues and regulation of antigen availability 
iGB3 analogues were chemically synthesized to analyse the influence of modifications on 
lipid or sugar moiety of antigens for NKT cell activation. Moreover, they were used to 
examine the uniqueness of iGb3 as the only endogenous NKT cell antigen and to investigate 
the specificity of iGb3 recognition by NKT cells. Changes within sugar or lipid residues of 
CD1d ligands drastically change recognition by NKT cells (Fischer et al., 2004; Kawano et 
al., 1997).  
For instance, the presence and configuration of double bonds within the acyl chain were 
important for CD1d binding whereas a higher degree of unsaturation led to a stronger NKT 
cell response (Rauch et al., 2003). Moreover, Sakai et al showed that βGalCer does not 
induce NKT cell responses stressing the importance of an α-configuration for the terminal 
sugar (Sakai et al., 1999). PW15 and PW17 differed only slightly from iGb3 as depicted in 
figure 18. PW15 possesses a saturated acyl chain whereas iGb3 displays a double bond in 
the respective acyl chain. PW17 is a chimera of the iGb3 sugar moiety and the αGalCer lipid 
moiety. Because PW17 comprises the αGalCer lipid part and the iGb3 sugar moiety it should 
be the ideal antigen for NKT cells. Removal of the terminal galactose of PW16 and PW18 by 
β-galactosidase results in αGlcCer and βGlcCer, respectively (Figure 18). αGlcCer was 
previously shown to activate NKT cells whereas βGlcCer fails to elicit a NKT cell response 
(Kawano et al., 1997). This observation was confirmed by strong cytokine induction by 
PW16. However, PW18 did also elicit a NKT cell response though weaker compared to 
PW16 or αGalCer. Moreover, lactosylceramide, which has a double bond instead of a 
hydroxyl group present in PW18, does not activate NKT cells, which is contradictory to 
previous observations (Kawano et al., 1997; Sakai et al., 1999). PW17 induced a less 
vigorous NKT cell response. iGb3 analogues were tested with DCs from healthy donors, 
containing functional αGalA which rapidly degrades iGb3 and iGb3 analogues PW15 and 
PW17. Jirimycin, a specific inhibitor of αGalA was used to block αGalA activity in DCs from 
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healthy donors. This should increase the amount of iGb3 available for antigen presentation 
and thus lead to NKT cell stimulation. Jirimycin addition increased IFNγ and IL-4 production. 
In the case of PW17 this strengthens the hypothesis that NKT cell activation is controlled by 
antigen availability. NKT cell responses to PW18 were slightly elevated in the presence of 
jirimycin, probably due to elevated b-galactosidase activity in the absence of αGalA (Figure 
19). This phenomenon has been observed previously for other enzymes involved in 
lysosomal degradation (Mayes et al., 1981). 
 
Stimulation of NKT cells by iGb3 and iGb3 analogues through DCs of healthy donors or 
Fabry patients was subject to considerable variability. This ranged from profound IFNγ and 
IL-4 production and proliferation to minute or even missing responses. Addition of iGb3 to 
DCs incubated with αGalCer did not inhibit or influence NKT cell activation demonstrating no 
inhibitory effect of iGb3. Reasons for this observation should therefore be attributed either to 
differences concerning APCs or NKT cells. APCs showed normal capacities for antigen 
processing and NKT cell stimulation as shown by the profound responses induced by PW16. 
FACS analysis showed normal expressions of DC specific marker such as CD11c and CD1b 
(data not shown) indicating that the DC phenotype did not contribute to these variations. NKT 
cells used in these experiments were from a human polyclonal NKT cell line. This cell-line 
was generated on the basis of cell-morphology and Vα14 TCR expression and was shown to 
respond to αGalCer. Nevertheless, it is possible that minor differences between NKT cell 
lines cause these variations. 
 
Activation induced cell death of NKT cells 
Despite all the discrepancies mentioned before, iGb3 induced a strong increase in NKT cell 
numbers in bulk cultures. NKT cell numbers were drastically increased in PBMCs of healthy 
donors cultured for 4 days in the presence of iGb3 and iGb3 analogues at various 
concentrations. Strikingly, the opposite was the case when PBMCs from Fabry patients were 
used (Figure 20). Decreases in NKT cell numbers to minimal levels by higher concentration 
of antigen could be attributed to activation induced cell death of NKT cells. As described 
above, antigen availability is crucial to regulate NKT cell activation. Increased presentation of 
iGb3 on the surface of APCs, even in the absence of infection, could lead to a pre-activated 
phenotype of NKT cells; a characteristic also revealed by microarray analysis. Addition of 
iGb3 would lead to increased antigen availability and amplified NKT cell activation. This 
could finally result in activation induced cell death as revealed by drastically reduced cell 
numbers. Activation induced cell death is controversially discussed for NKT cells. Leite-de-
Moraes et al showed activation induced cell death of NKT cells after stimulation with IL-12 
and IL-18 and Fas/FasL interaction (Leite-de-Moraes et al., 2000). Conversely, it was 
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demonstrated that NKT cells are relatively resistant to activation induced cell death 
compared to other T cells and rather downregulate their TCR thereby disappearing from 
detection (Emoto et al., 1999a; Harada et al., 2004). However, analysis of gene expression in 
activated NKT cells indicates the existence of sophisticated mechanisms to control NKT cell 
activity and to balance prolonged survival and apoptosis. It remains to be elucidated which 
factors and conditions influence this balance. 
 
The results suggest that a deficiency in lysosomal processing and degradation, leading to an 
accumulation of NKT cell ligands, is critically important for regulation of NKT cells. Moreover, 
continuous presence of iGb3 in the case of enzyme deficiency with additional appearance of 
NKT cell ligands, causes dramatic loss of NKT cells by activation induced cell death. 
 
6.3 Characterization of PIM-reactive NKT cells 
Mycobacterial PIM was identified by our group as a bacterial antigen recognized in a CD1d-
restricted fashion by NKT cells (Fischer et al., 2004). None of the other mycobacterial lipids 
tested showed binding to CD1d, including LAM a lipid antigen for human CD1b (Brigl and 
Brenner, 2004). 
 
The only CD1d-restricted antigen from a pathogen described until recently was the GPI 
anchor of proteins derived from parasitic protozoans such as Plasmodium spec., although 
these data remain controversial (Schofield et al., 1999; Molano et al., 2000; Procopio et al., 
2002). Intact PIM is recognized by T cells in a CD1d-restricted way (Figure 21). The high 
frequency of αGalCer-CD1d tetramer+ T cells, compared with the lower frequency of PIM-
CD1d tetramer+ T cells, could be explained by assuming that PIM-reactive NKT cells 
constitute a distinct subpopulation of NKT cells within the αGalCer-reactive NKT cells. This 
hypothesis was supported by findings that both NKT cell populations predominantly 
expressed the Vβ8 TCR chain together with the invariant TCR α-chain. Infection of mice with 
M. bovis BCG led to a decrease in detection of reactive NKT cells confirming a previous 
report (Emoto et al., 1999a) (Figure 25). The frequency of PIM-reactive NKT cells, although 
with lower cells number followed a similar kinetic upon M. bovis BCG infection. However, this 
indicates further that PIM-reactive NKT cells are functionally and structurally similar to 
αGalCer-reactive NKT cells. The difference in reactivity to αGalCer or PIM could be 
explained by fine differences in the sequence of the TCR. The low frequency of PIM-reactive 
NKT cells did not allow purification of sufficient numbers of PIM-reactive NKT cells for 
subsequent sequence analysis. Decreased NKT cell numbers during infection is 
controversial. Previously, it was published that NKT cells undergo apoptosis after stimulation 
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(Emoto et al., 1999a; Leite-de-Moraes et al., 2000; Osman et al., 2000). Recent data showed 
that NKT cells rather downregulate their TCR and surface markers after activation and are 
therefore not detectable by CD1d tetramer staining (Crowe et al., 2003; Matsuda et al., 2000; 
Seino et al., 2004). It could be hypothesized that both scenarios occur, i.e. some NKT cells 
downregulate their TCR while others undergo apoptosis after stimulation. The slight increase 
in cell numbers of PIM-reactive, tetramer+ but NK1.1-negative NKT cells indicate that some 
NKT cells could disappear from detection by downregulation of their surface markers (Figure 
25). However, this may not explain the marked loss in the overall number of NKT cells after 
infection. 
 
Apart from αGalCer, none of the tested lipids, including PIM, induced a notable IL-4 
response in NKT cells. αGalCer analogues, selectively inducing IL-4, but not IFNγ, suggest 
that distinct moieties of the glycolipid antigens determine the cytokine pattern; probably by 
modulation of APCs (Miyamoto et al., 2001). Since PIM displays less antigenic potency than 
αGalCer, the lack of IL-4 induction by PIM could suggest a higher signalling threshold for IL-
4. The potency of an antigen would thereby determine the type and the vigorousness of an 
immune response. IFNγ is a key cytokine during mycobacterial infections. It promotes Th1 
cell development and leads to macrophage activation. Thus, recognition of mycobacterial 
PIM, presentation by CD1d and subsequent activation of NKT cells could play a role in the 
immune response during infection with Mycobacterium tuberculosis (Szalay et al., 1999). The 
fact that mice, deficient for CD1d are equally susceptible to a high-dose i.v. inoculum of M. 
tuberculosis as are wild-type B6 mice (Behar et al., 1999) does not exclude a conditional role 
for CD1d-restricted T cells in infection. This is supported by a report showing that 
homozygous, Jα281-/- mice, devoid of NKT cells, appear to be more susceptible than 
heterozygous mice, at least in later stages of tuberculosis (Sugawara et al., 2002). 
Furthermore, glycosphingolipids and sulfatide variants of sphingomonas were recently shown 
to activate NKT cells in a CD1d-dependent manner and contribute to immune responses and 
survival of mice infected with these bacteria (Kinjo et al., 2005; Mattner et al., 2005; Wu et 
al., 2005). Yet, sphingomonas is an infrequent pathogen with low virulence (Hsueh et al., 
1998).  
 
These results demonstrate capacities for CD1d-restricted T cells ranging from autoimmunity 
and immune regulation to antimicrobial host defence, by recognition of bacterial lipid 
antigens and subsequent IFNγ production. 
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6.4 Toll like receptor vs. T cell receptor mediated 
recognition of mycobacterial lipids 
CD1d-mediated NKT cell activation involves antigen presentation and specific recognition of 
the respective antigen through the TCR. Like MHC class I presentation, CD1d-mediated 
antigen presentation is part of the adaptive immune response. It is antigen specific and 
requires antigen processing and presentation by professional APCs (Pan et al., 1999; 
Prigozy et al., 2001). Recognition of pathogenic microbes by the innate immune system is 
facilitated by TLRs. TLRs recognize pathogen associated molecular patterns (PAMPs) which 
are highly conserved structures found in many bacteria, parasites and viruses (Medzhitov, 
2001). TLR-mediated immune activation constitutes a major defence mechanism of innate 
immunity. Innate and adaptive immunity are highly interwoven with each other and bacteria 
elicit both innate and adaptive immune responses, yet at different timepoints (Michalek et al., 
2002; Smith et al., 2005). NKT cells have a preactivated phenotype and respond vigorously 
to antigenic stimulation. Additionally, they are thought to play an immuno-regulatory role at 
the interface of innate and adaptive immunity (Kronenberg and Gapin, 2002).  
 
TLR2 activation of mycobacterial lipids 
Whole lipid extracts as well as crude PIM fractions elicited a clear NF-κB activation in a dose 
dependent manner which depends on recognition by TLR2. In contrast, PI and lyso-PIM, 
which are structurally similar to PIM, were not recognized by TLR2 (Figure 26). Notably, 
removal of one acyl chain from PIM by phospolipase A creates lyso-PIM and results in loss 
of TRL2 activation. PI represents the core structure of various mammalian cell membrane 
lipids and GPI anchored proteins and did not activate TLR2. GPIs consist of a conserved 
glycan structure, ethanolamine-phosphate-6Manα1-2Manα1-6Manα1-4GlcNα(1-6)-linked to 
PI. Their function is to anchor certain cell surface proteins in distinct membrane domains 
(Englund, 1993). PI and GPI are conserved throughout evolution, although exhibiting 
significant biosynthetic differences between mammals and microbes (Tiede et al., 1999). 
Bacterial GPI is a direct target of the innate immune system inducing pro-inflammatory 
responses (Ropert and Gazzinelli, 2000). Additionally, PI constitutes the core component of 
PIM, but lacks the sugar moiety composed of mannose residues (Brennan and Besra, 1997). 
Nevertheless, lack of NF-κB induction by PI was expected, since it is part of host cell 
structures (Villeneuve et al., 2005). In line with previous publications, lack of NF-κB induction 
by PI and lyso-PIM confirms that distinct bacterial structures differ in their biological activity 
depending on affinity to TLRs (Moreillon and Majcherczyk, 2003; Morr et al., 2002). TLR2 
recognition of PI would result in constant induction of immune responses against 
endogenous structures, leading to autoreactivity.  
Discussion 
 
90 
These results emphasize the importance of discrimination between conserved mammalian 
and bacterial structures to evoke a TLR mediate innate immune response.  
 
Dual antigenic potential of mycobacterial lipids 
It has been demonstrated previously that mycobacterial PIMs are recognized by TLR2 and 
activate NKT cells in a TCR independent manner (Gilleron et al., 2001; Gilleron et al., 2003). 
Analysis of fractions isolated from crude PIM extracts detected fraction 7 to elicit CD1d-
dependent NKT cell activation as well as TLR2-mediated NF-κB induction (Figures 29 and 
30). None of the other lipid fractions induced NKT cells in a CD1d-dependent manner, but 
were recognized by TLR2. This indicates that only fraction 7 contains a compound capable of 
specific TCR-mediated as well as non-specific activation of immunity. However, structural 
analysis of the different fractions by MALDI-MS did not determine this compound 
unequivocally. In fraction 16, predominantly PIM6Ac3 and PIM6Ac4 were detected as the 
major compounds. Minor peaks indicate the presence of other, minor compounds. Along with 
PIM6Ac2, PIM6Ac3 and PIM6Ac4 were also detected in fractions 19 and 21. Strikingly, 
PIM6Ac3, PIM6Ac4 and PIM6Ac2 were absent from fraction 7. MALDI-MS of fraction 7 revealed 
a cluster of peaks from the range of 1233.97 to 1640.51 Da (Figure 31). These peaks appear 
only when measured in positive mode MALDI-MS, indicating that they are not negatively 
charged. Moreover, masses (m/z) indicate that these compounds have a low number of 
mannoside residues. Furthermore, all peaks are distant from each other by 14 mass units 
which is representative for CH2 groups. Therefore, compounds detected in fraction 7 contain 
fatty acids of different length. This indicates that the active compound in fraction 7 could be a 
low mannosylated PIM. Conversely, some of the peaks found in fraction 7 were detected in 
fraction 16 and 21. Within these fractions they were only very minor compounds, whereas 
they constitute the only peaks present in fraction 7. It was shown that, enriched low 
mannosylated PIM2 recruit NKT cells upon s.c. injection, but in a TCR-independent manner 
(Gilleron et al., 2001; Mempel et al., 2002). Additionally, semipurified PIM2 fractions failed to 
trigger selective expansion of both human and murine NKT cells (Fischer et al., 2004). Moura 
et al showed that mycobacterial lipids inhibit T cell activation (Moura and Mariano, 1997). In 
line with this observation our findings could indicate that lipids present in fraction 16, 19 and 
21 but absent in fraction 7 can suppress activation of NKT cells. Further purification of the 
different fractions and analysis by NMR and GC-MS will allow identification of these active 
lipids within these fractions to attribute the distinct activating properties. 
 
Direct activation of NKT cells by TLRs expressed on their cell surface could also attribute to 
immune responses to mycobacteria. mRNA expression of TLR2 in NKT cells was previously 
described (Shimizu et al., 2002). However, this could not be verified by FACS analysis for 
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surface and/or intracellular expression of TLR2 and TLR4 on NKT cells. Therefore, direct 
activation of NKT cell-expressed TLR2 and TLR4 can be excluded. 
 
In summary, different PIMs released by mycobacteria may be responsible for attraction of 
NKT cells to the site of infection in a TCR independent way and further activation can occur 
through a TCR-dependent activation step of NKT cell population. 
 
A model of NKT cell activation by mycobacterial lipids 
A three step model for NKT cell activation can be proposed: 
1) TCR independent NKT cell activation 
NKT cells are recruited in a TCR independent manner to sites of infections and play a 
vital role in the formation of granulomas. This recruitment was shown to be associated 
with the presence of mycobacterial PIMs but irrespective of the presence of CD1d 
(Apostolou et al., 1999; Gilleron et al., 2001). The underlying mechanism remains to be 
identified. 
 
2) APC / TLR / IL-12 mediated, TCR dependent NKT cell activation 
TLRs expressed on professional APCs recognize bacterial PAMPS and lead to activation 
of the APCs resulting in IL-12 production. Endogenous ligands presented by CD1d are 
specifically recognized by the NKT cell TCR. This results in a pre-activation of NKT cells. 
NKT cells are fully activated by APC derived IL-12 in combination with TCR dependent 
recognition of endogenous lipids. Missing presentation of endogenous ligands abolishes 
NKT cell activation. 
 
3) CD1d mediated and antigen specific TCR dependent NKT cell activation 
Bacterial lipid antigens are taken up and processed by professional APCs. Subsequently 
these antigens are loaded onto CD1d in lysosomes and presented on the cell surface. 
CD1d presented antigens are specifically recognized by the invariant TCR and yield in 
NKT cell activation as shown for lipid antigens from mycobacteria, sphingomonas and 
ehrlichia. 
 
Combined presence of these pathways highlight the antimicrobial NKT cell functions by 
surveying both endogenous and bacterial glycosphingolipids by a TCR dependent manner, 
as well as being recruited to sites of infection in a TCR independent manner. Supportive of 
this, transcriptome analysis demonstrate the vast capacities of NKT cells to respond to 
various stimuli and to perform a variety of effector and regulatory functions during immune 
responses. 
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6.5 Towards an understanding of NKT cells 
A global picture on NKT cell properties and functions as well as regulation of NKT cell activity 
could be revealed. NKT cells show an early response to infection mediated by rapid 
activation and characterized by constitution of a wide arsenal of effector and immuno-
regulatory functions. They can be non-specifically induced by inflammation and are important 
for establishing granuloma-like lesions. This activation was demonstrated to be a TCR 
independent process of NKT cell recruitment to sites of infection. Furthermore, activation of 
NKT cells by bacterial antigens can be either direct, TCR mediated by ligands presented by 
CD1d. Alternatively, TLR mediated APC-activation leads to IL-12 production which activates 
NKT cells recognizing their endogenous lipid antigen presented by CD1d. Activation of NKT 
cells via the recognition of endogenous antigens is critically dependent on antigen 
availability. 
NKT cells are by definition self-reactive displaying a pre-activated status which is tightly 
controlled. Upon activation, effector functions of NKT cells are initiated as revealed by 
increased expression of various cytokines and chemokines. This enables NKT cells to 
competently regulate and modulate immune responses. Both, naïve and activated NKT cells 
display elevated expression of apoptosis regulating genes providing NKT cells with high 
degree of self-control to precisely regulate their own activity. 
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7 Summary 
NKT cells are involved in the regulation of a wide range of immune responses. They play a 
role in autoimmunity, antitumour responses, host defence to infections and in allergy and 
inflammation. In contrast to classical T cells, NKT cells respond to lipid antigens and rapidly 
produce IFNγ and IL-4 as well as other cytokines with immuno-regulatory capacities. 
Although various publications describe NKT cells in infections, inflammation or antitumour 
immunity there is only very limited information about the mechanism of NKT cell activation. 
Moreover, natural antigens were not known until recently. 
 
1) Microarray analysis comparing NKT cells to NK cells, conventional CD4+ T cells and 
regulatory T (Treg) cells were designed to examine a global gene expression profile of 
NKT cells in the absence or presence of an exogenous stimulus. The profiles revealed a 
NKT cell specific gene expression pattern as well as expression of genes which NKT 
cells share with NK cells, conventional CD4+ T cells and Treg cells.  
The latter ones allow the distinction between those genes which are rather attributed to 
innate responses, i.e. shared with NK cells or those of the T cell-effector / -regulatory 
phase, i.e. shared with effector T cells or Treg cells. This suggests broad functional 
capacities of NKT cells. 
The group of genes, uniquely regulated in NKT cells codes for cytokine and chemokine 
receptors, regulators of cell proliferation / activation and proteins involved in cell migration 
and cytokine processing. This profile demonstrates capability of NKT cells for vigorous 
reaction to various stimuli, rapid response by cytokine and chemokine production and 
strict self-control of activity.  
Genes with similar expression levels of NKT cells and NK cells, conventional CD4+ T 
cells or Treg cells expanded the knowledge of innate immunity-like or adaptive immunity-
like properties of NKT cells. Detection of additional cytokines, chemokines, 
cytokine/chemokine receptors, as well as granzyme B or FasL emphasizes regulatory 
and effector functions of NKT cells. 
Genes induced upon αGalCer mediated activation of NKT cells consisted almost 
exclusively of cytokines, chemokines and proliferation control genes. Among these genes 
were IFNγ, IL-4, TNFα, IL-17, lymphotactin, Gadd45/Myd118 and Map3K8. This collection 
of genes proves the profound ability of NKT cells to modulate immune responses by 
prolonged and substantial production of cytokines and chemokines. 
 
2) Microarray analysis increased the insight into the genetic profile of NKT cells and 
revealed gene expression patterns of activated NKT cells. However, regulation of NKT 
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cell activation by endogenous and exogenous antigens still remains to be determined. 
Regulation of NKT cell activation was examined by employing the endogenous NKT cell 
ligand iGb3 as well as PBMCs from patients with Fabry disease. Fabry patients have a 
genetic defect for the lysosomal αGalA and display an extensive sphingolipidosis. 
Comparison of normal cells and those from patients with Fabry disease revealed that 
regulation of antigen availability plays a crucial role in regulation of NKT cell activation. 
Moreover, uncontrolled appearance and increased concentrations of the endogenous 
antigen iGb3 led to substantial decrease in NKT cell number, presumably by activation 
induced cell death. 
 
3) In addition to the endogenous ligand iGb3, NKT cells recognize bacterial lipid antigens. A 
preceding study from this group showed that mycobacterial PIM is recognized by NKT 
cells in a CD1d specific, TCR mediated fashion. We could show that PIM are recognized 
by human and murine NKT cells and induce IFNγ and IL-4 production. Subsequent 
experiments to characterize PIM-reactive NKT cells were performed in this thesis. FACS 
analysis and infection studies with M. bovis BCG showed that PIM-reactive NKT cells are 
a small subset within αGalCer-reactive NKT cells specifically recognizing mycobacterial 
lipids. 
 
4) Mycobacterial lipids were furthermore analyzed for their capacity to elicit TLR2-mediated 
immune responses in addition to or substitution for an NKT cell response. It was 
demonstrated that different lipid fractions isolated from M. bovis BCG were recognized by 
TLR2 and elicited a potent NF-κB activation. One of these fractions also induced a CD1d-
mediated NKT cell response. So far, structural analysis by MALDI-MS of the different 
fraction did not help to identify the antigen with dual capacity for specific TCR- and 
unspecific TLR- mediated immune activation. Further purification and analysis of NKT cell 
activation will help to determine this compound. This will also determine the structural 
requirements for TLR and TCR recognition. 
 
NKT cells could be described as immuno-regulatory, self-limiting cells additionally equipped 
with effector functions. This décor represents the fundamental basis for their ability to 
modulate diverse immune responses. The existence of multiple activation mechanisms by 
bacterial antigens enables NKT cells to efficiently monitor the immune system and participate 
either in a broad, unspecific or pathogen/antigen specific fashion. NKT cell subsets could be 
vital for the recognition of distinct pathogens as demonstrated for mycobacteria, 
sphingomonas and ehrlichia. 
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8 Zusammenfassung 
NKT-Zellen sind an der Regulation einer Vielzahl von Immunantworten beteiligt. Sie spielen 
eine Rolle in Autoimmunität, Tumorerkennung, Schutz gegen Infektionen und in allergischen 
und entzündlichen Prozessen. NKT-Zellen erkennen, im Vergleich zu klassischen T Zellen, 
nicht-körpereigene Glykolipidantigene und produzieren eine Vielfalt von Zytokinen mit 
immuno-regulatorischen Eigenschaften sehr schnell nach Aktivierung. Darüber hinaus 
besitzen NKT-Zellen die einzigartige Fähigkeit IFNγ und IL-4 gleichzeitig zu produzieren. 
Obwohl Funktionen von NKT-Zellen in diversen Immunantworten beschrieben wurde, gibt es 
nur sehr limitiert Informationen über die Mechanismen der Aktivierung von NKT-Zellen. 
Zudem waren bis vor kurzem keine natürlichen NKT-Zell-Antigene bekannt. 
 
1) Microarray Analysen wurden durchgeführt um ein Genexpressionsprofil von NKT-Zellen 
zu erhalten. Dazu wurden NKT-Zellen mit NK-Zellen, konventionellen CD4+ T-Zellen und 
regulatorischen T-Zellen (Treg) sowie in An- oder Abwesenheit eines exogenes Stimulus 
untersucht. Es konnte ein NKT-Zell-spezifisches Genexpressionsprofil erstellt werden. 
Darüber hinaus zeigte sich, dass sich die Expression bestimmter Gene in NKT-Zellen 
und NK-Zellen, konventionellen CD4+ T-Zellen oder Treg-Zellen gleicht und 
Eigenschaften sowohl der angeboren als auch der adaptiven Immunantwort NKT-Zellen 
zugeordnet werden können. Expression von Genen die Zytokine und Chemokine, 
Zytokin/Chemokin Rezeptoren aber auch Granzyme B oder FasL codieren, betonen die 
regulatorischen und Effektorfunktionen von NKT-Zellen und zeigen die vielfältigen 
funktionellen Kapazitäten von NKT-Zellen auf. 
NKT-Zell-spezifische Expression konnte für eine Reihe von Genen, involviert in 
Regulation der Zellproliferation / Aktivierung, Zellmigration, Prozessierung von Zytokinen 
und für Zytokin- und Chemokin-Rezeptoren, nachgewiesen werden. Dies demonstriert 
die Fähigkeit von NKT-Zellen zur raschen Antwort auf verschiedene Stimuli, schnellen 
Produktion von Zytokinen und Chemokinen und verdeutlicht eine strikte Selbstkontrolle 
der Aktivität. 
In αGalCer-aktivierten NKT-Zellen konnten fast ausschließlich Gene für Zytokine, 
Chemokine und zur Proliferationskontrolle detektiert werden. Unter diesen Genen waren: 
IFNγ, IL-4, TNFα, IL-17, lymphotactin, Gadd45/Myd118 and Map3K8. Das 
Expressionsprofil aktivierter NKT-Zellen belegt die ausgeprägte Regulation der Aktivität 
und die Kapazität zur vielfältigen Modulation von Immunantworten durch extensive 
Zytokin- und Chemokin-Produktion. 
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2) Mit Hilfe der Transkriptome Analyse konnte das genetische Profil von NKT-Zellen und 
das Expressionsmuster nach NKT-Zell-Aktivierung demonstriert werden. Die Regulation 
der NKT-Zell-Aktivierung durch endogene und exogene Antigene jedoch nicht geklärt 
werden. Der endogene NKT-Zell-Liganden iGb3 und Lymphozyten von Patienten mit der 
Fabry Krankheit wurden benutzt um die Regulation der NKT-Zell-Aktivierung zu 
untersuchen. Fabry Patienten haben einen genetischen Defekt für das lysosomale 
Enzym αGalA und entwickeln eine ausgeprägte Sphingolipidose. Vergleiche von 
normalen Zellen und Zellen von Fabry Patienten zeigten, dass die Regulation der 
Antigenverfügbarkeit ausschlaggebend für die Regulation der NKT-Zell-Aktivierung ist. 
Darüber hinaus konnte gezeigt werden, dass unkontrolliertes Vorhandensein und erhöhte 
Konzentration des endogenen Liganden iGb3, zu einer erheblichen Verringerung der 
NKT-Zell-Zahl, vermutlich durch Aktivierungs-induzierten Zelltod, führt. 
 
3) NKT-Zellen erkennen neben iGb3 auch bakterielle Lipidantigene. Eine frühere Arbeit 
dieser Gruppe konnte zeigen, dass mycobakterielles PIM durch den T-Zell-Rezeptor 
(TZR) der NKT-Zellen, in CD1d-abhängiger Weise erkannt wird. Wir konnten zeigen, 
dass PIM von humanen und murinen NKT-Zellen erkannt wird und die Produktion von 
IFNγ und IL-4 induziert. Die Charakterisierung der PIM-reaktiven NKT-Zellen wurden im 
Rahmen dieser Arbeit durchgeführt. FACS Analyse und Infektionsstudien mit M. bovis 
BCG zeigten, dass PIM-reaktive NKT-Zellen eine Subpopulation innerhalb der αGalCer-
reaktiven NKT-Zellen sind. 
 
4) Mycobakterielle Lipide wurden weiterhin auf ihre Fähigkeit untersucht, eine TLR2-
vermittelte Immunantwort, zusätzlich oder anstelle einer NKT Zellaktivierung, 
hervorzurufen. Es wurde gezeigt, dass verschiedene Lipidfraktionen von M. bovis BCG 
von TLR2 erkannt werden und zur Aktivierung von NF-κB führen. Eine dieser Fraktionen 
induzierte darüber hinaus auch eine CD1d-vermittelte NKT-Zell-Antwort. MALDI-MS-
Analyse der verschiedenen Fraktionen konnte das Antigen mit Potential zur 
unspezifischen TLR2- und spezifischen NKT-Zell-Aktivierung allerdings nicht eindeutig 
identifizieren. Weitere Aufreinigungen und Analyse der NKT-Zell-Aktivierung werden 
helfen diese Substanz zu identifizieren und die strukturellen Anforderungen für die 
Erkennung von Antigenen durch TLR2 und TZR aufzuklären. 
 
NKT-Zellen konnten als immunregulatorische, selbst-limitierende, zusätzlich mit Effektor-
Funktionen ausgestattete, Zellen beschrieben werden. Diese Ausstattung bildet die 
elementare Basis für die Fähigkeit der NKT-Zellen verschiedenste Immunantworten zu 
modulieren. Die Existenz mehrerer NKT-Zell-Aktivierungsmechanismen durch bakterielle 
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Antigene befähigt zur effizienten Beobachtung des Immunsystems und zur Teilnahme an 
Immunantworten, entweder in einer unspezifischen- oder Antigen/Pathogen-spezifischen Art 
und Weise. NKT-Zell-Subpopulationen könnten für die Erkennung bestimmter Pathogene, 
wie Mycobakterium sp., Sphingomonas sp. and Ehrlichia sp., unerlässlich sein. 
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